{"doc_id": 0, "doc": {"person_id": 115967197, "visit_occurrence_id": 109834825, "death_date": null, "visit_concept_name": "Outpatient Visit", "visit_start_datetime": "2017-10-09 00:00:00", "visit_end_datetime": "2017-10-09 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Outpatient Visit, started at 2017-10-09 00:00:00, ended at 2017-10-09 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- First trimester pregnancy\n- High risk pregnancy\n- Illness\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 92, "patient_first_visit_date": "2012-10-05 14:12:00", "patient_last_visit_date": "2021-03-30 16:05:00", "end_obs_date": "2018-10-09", "hypertension_type": "new", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 7, "cumulated_visit_num": 7, "cumulated_approximate_token_count": 4962, "visit_cumulated": "## Visit\nThis visit record, was from Emergency Room Visit, started at 2012-10-05 14:12:00, ended at 2012-10-07 09:35:00\nThe patient in this visit was 31 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 93 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 12.51 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 29.0 (second)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.29 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 120 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- Prothrombin time (PT): 14.1 (second)\n- Body height: 5' 2\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.40 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 88.0 (femtoliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 268 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n\n### Procedure\n- Ultrasound, abdominal, real time with image documentation; complete\n- Laparoscopic cholecystectomy\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Laparoscopy, surgical; cholecystectomy\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Level III - Surgical pathology, gross and microscopic examination Abortion, induced Abscess Aneurysm - arterial/ventricular Anus, tag Appendix, other than incidental Artery, atheromatous plaque Bartholin's gland cyst Bone fragment(s), other than pathologi\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Cholelithiasis AND cholecystitis without obstruction\n- Gallbladder calculus with acute cholecystitis and no obstruction\n- Right upper quadrant pain\n- Epigastric pain\n- Primary diagnosis: Acute cholecystitis\n- Leukocytosis\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2012-10-06, presumably until 2012-10-06\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2012-10-05, presumably until 2012-10-06\n- pantoprazole 20 MG Delayed Release Oral Tablet, through Oral route, started on 2012-10-05, presumably until 2012-10-05\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2012-10-06, presumably until 2012-10-06\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2012-10-07, presumably until 2013-10-07, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day as needed.\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2012-10-06, presumably until 2012-10-07\n- piperacillin 4000 MG / tazobactam 500 MG Injection, through Intravenous route, started on 2012-10-05, presumably until 2012-10-05\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2012-10-05, presumably until 2012-10-06\n- 2 ML ondansetron 2 MG/ML Injection, started on 2012-10-05, presumably until 2012-10-05\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, started on 2012-10-05, presumably until 2012-10-06\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2012-10-07, presumably until 2013-04-05, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain.\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2012-10-05, presumably until 2012-10-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2012-10-06 00:00:00, ended at 2012-10-06 00:00:00\nThe patient in this visit was 31 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bupivacaine hydrochloride 2.5 MG/ML Injectable Solution, started on 2012-10-06, presumably until 2012-10-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2016-11-12 00:00:00, ended at 2016-11-12 00:00:00\nThe patient in this visit was 35 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Choriogonadotropin.intact+Beta subunit [Units/volume] in Serum or Plasma: 34192 (milli-international unit per milliliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.10 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 7 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.44 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.53 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.0 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.85 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.9 (percent)\n- MCH [Entitic mass] by Automated count: 28.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 85.9 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 296 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2016-11-12 13:39:00, ended at 2016-11-12 16:12:00\nThe patient in this visit was 35 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.53 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 7 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.9 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.3 (percent)\n- MCV [Entitic volume] by Automated count: 85.9 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.85 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 296 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.44 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.0 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.10 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 28.8 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.9 (percent)\n- Choriogonadotropin.intact+Beta subunit [Units/volume] in Serum or Plasma: 34192 (milli-international unit per milliliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.3 (percent)\n\n### Procedure\n- Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, first trimester (< 14 weeks 0 days), transabdominal approach; single or first gestation\n- Collection of venous blood by venipuncture\n- Ultrasound, pregnant uterus, real time with image documentation, transvaginal\n\n### Condition\n- Primary diagnosis: Threatened miscarriage\n- First trimester pregnancy\n- Genitourinary tract hemorrhage\n- Gestation period, 8 weeks\n- Spotting per vagina in pregnancy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2017-09-15 00:00:00, ended at 2017-09-15 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 76 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 6 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.8 (percent)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 200 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 85.5 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.53 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 307 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.49 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCH [Entitic mass] by Automated count: 28.5 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.4 (thousand per microliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2017-09-15 20:29:00, ended at 2017-09-15 22:41:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 76 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.53 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.4 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 200 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- MCH [Entitic mass] by Automated count: 28.5 (picogram)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.49 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.8 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 85.5 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 307 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 6 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Gestation less than 9 weeks\n- Primary diagnosis: Mild hyperemesis gravidarum\n- Vomiting\n- Nausea\n\n### Drug\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2017-09-15, presumably until 2018-09-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed for Nausea (nausea or vomiting)\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-09-15, presumably until 2017-09-15\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2017-09-15, presumably until 2017-09-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-10-09 00:00:00, ended at 2017-10-09 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- First trimester pregnancy\n- High risk pregnancy\n- Illness\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive their first ever diagnosis of Essential hypertension within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2012-10-05 14:12:00, ended at 2012-10-07 09:35:00\nThe patient in this visit was 31 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 93 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 12.51 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 29.0 (second)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.29 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 120 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- Prothrombin time (PT): 14.1 (second)\n- Body height: 5' 2\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.40 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 88.0 (femtoliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 268 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n\n### Procedure\n- Ultrasound, abdominal, real time with image documentation; complete\n- Laparoscopic cholecystectomy\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Laparoscopy, surgical; cholecystectomy\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Level III - Surgical pathology, gross and microscopic examination Abortion, induced Abscess Aneurysm - arterial/ventricular Anus, tag Appendix, other than incidental Artery, atheromatous plaque Bartholin's gland cyst Bone fragment(s), other than pathologi\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Cholelithiasis AND cholecystitis without obstruction\n- Gallbladder calculus with acute cholecystitis and no obstruction\n- Right upper quadrant pain\n- Epigastric pain\n- Primary diagnosis: Acute cholecystitis\n- Leukocytosis\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2012-10-06, presumably until 2012-10-06\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2012-10-05, presumably until 2012-10-06\n- pantoprazole 20 MG Delayed Release Oral Tablet, through Oral route, started on 2012-10-05, presumably until 2012-10-05\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2012-10-06, presumably until 2012-10-06\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2012-10-07, presumably until 2013-10-07, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day as needed.\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2012-10-06, presumably until 2012-10-07\n- piperacillin 4000 MG / tazobactam 500 MG Injection, through Intravenous route, started on 2012-10-05, presumably until 2012-10-05\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2012-10-05, presumably until 2012-10-06\n- 2 ML ondansetron 2 MG/ML Injection, started on 2012-10-05, presumably until 2012-10-05\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, started on 2012-10-05, presumably until 2012-10-06\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2012-10-07, presumably until 2013-04-05, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain.\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2012-10-05, presumably until 2012-10-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2012-10-06 00:00:00, ended at 2012-10-06 00:00:00\nThe patient in this visit was 31 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bupivacaine hydrochloride 2.5 MG/ML Injectable Solution, started on 2012-10-06, presumably until 2012-10-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2016-11-12 00:00:00, ended at 2016-11-12 00:00:00\nThe patient in this visit was 35 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Choriogonadotropin.intact+Beta subunit [Units/volume] in Serum or Plasma: 34192 (milli-international unit per milliliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.10 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 7 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.44 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.53 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.0 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.85 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.9 (percent)\n- MCH [Entitic mass] by Automated count: 28.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 85.9 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 296 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2016-11-12 13:39:00, ended at 2016-11-12 16:12:00\nThe patient in this visit was 35 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.53 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 7 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.9 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.3 (percent)\n- MCV [Entitic volume] by Automated count: 85.9 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.85 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 296 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.44 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.0 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.10 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 28.8 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.9 (percent)\n- Choriogonadotropin.intact+Beta subunit [Units/volume] in Serum or Plasma: 34192 (milli-international unit per milliliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.3 (percent)\n\n### Procedure\n- Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, first trimester (< 14 weeks 0 days), transabdominal approach; single or first gestation\n- Collection of venous blood by venipuncture\n- Ultrasound, pregnant uterus, real time with image documentation, transvaginal\n\n### Condition\n- Primary diagnosis: Threatened miscarriage\n- First trimester pregnancy\n- Genitourinary tract hemorrhage\n- Gestation period, 8 weeks\n- Spotting per vagina in pregnancy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2017-09-15 00:00:00, ended at 2017-09-15 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 76 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 6 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.8 (percent)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 200 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 85.5 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.53 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 307 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.49 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCH [Entitic mass] by Automated count: 28.5 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.4 (thousand per microliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2017-09-15 20:29:00, ended at 2017-09-15 22:41:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 76 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.53 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.4 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 200 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- MCH [Entitic mass] by Automated count: 28.5 (picogram)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.49 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.8 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 85.5 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 307 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 6 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Gestation less than 9 weeks\n- Primary diagnosis: Mild hyperemesis gravidarum\n- Vomiting\n- Nausea\n\n### Drug\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2017-09-15, presumably until 2018-09-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed for Nausea (nausea or vomiting)\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-09-15, presumably until 2017-09-15\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2017-09-15, presumably until 2017-09-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-10-09 00:00:00, ended at 2017-10-09 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- First trimester pregnancy\n- High risk pregnancy\n- Illness\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive their first ever diagnosis of Essential hypertension within the next year (we could not find any prior history of this condition in their medical records before)\n- the condition of hypertension means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "6d2f9f268c6962869346308bbd248a7d0d974b3a3874000cc068eb9db775e4a9", "prompt_hash": "382aa539f66cc7bde5e69a8704394ea1c569270c28d12ffca16019ff1387f81f", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 1, "doc": {"person_id": 115967631, "visit_occurrence_id": 150348663, "death_date": null, "visit_concept_name": "Office Visit", "visit_start_datetime": "2020-02-09 08:42:20", "visit_end_datetime": "2020-02-09 09:51:28", "visit_length_in_hours": 1.1522222222222223, "integrated_visit_record": "## Visit\nThis visit record, was from Office Visit, started at 2020-02-09 08:42:20, ended at 2020-02-09 09:51:28\nThe patient in this visit was 22 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Behavioral and qualitative analysis of voice and resonance\n\n### Condition\n- Dysphonia\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 89, "patient_first_visit_date": "2016-06-20 10:15:08", "patient_last_visit_date": "2022-04-17 13:33:28", "end_obs_date": "2021-02-08", "hypertension_type": "new", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "recurrent", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 15, "cumulated_visit_num": 15, "cumulated_approximate_token_count": 3258, "visit_cumulated": "## Visit\nThis visit record, was from Office Visit, started at 2016-06-20 10:15:08, ended at 2016-06-20 11:17:07\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Illness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-23 14:42:04, ended at 2017-02-23 14:51:19\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- escitalopram 10 MG Oral Tablet, through Oral route, presumably until 2022-04-17, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- buspirone hydrochloride 5 MG Oral Tablet, through Oral route, presumably until 2022-04-17, with intended 0 refill(s). Instructions: take 5 mg by mouth every day\n- topiramate 100 MG Oral Tablet, through Oral route, presumably until 2022-04-17, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2017-06-09 00:00:00, ended at 2017-06-09 00:00:00\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.46 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 4.42 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.86 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 127 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 45.8 (percent)\n- MCH [Entitic mass] by Automated count: 27.2 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 40.6 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.92 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 219 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 58 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 82.1 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2017-06-09 04:42:00, ended at 2017-06-09 06:53:00\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 82.1 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 127 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 27.2 (picogram)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.86 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.46 (million per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.92 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 4.42 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 40.6 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 58 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 45.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 219 (thousand per microliter)\n\n### Procedure\n- Ultrasound, transvaginal\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Hypokalemia\n- Disorder of female genital organs\n- Primary diagnosis: Loss of consciousness\n- Pain in pelvis\n\n### Drug\n- ibuprofen 800 MG Oral Tablet, through Oral route, started on 2017-06-09, presumably until 2018-06-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2017-06-09, presumably until 2017-12-06, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-07-26 18:26:35, ended at 2017-07-26 19:35:57\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Dysmenorrhea\n\n### Drug\n- 24 HR naproxen 750 MG Extended Release Oral Tablet, through Oral route, started on 2017-07-26, presumably until 2017-07-26, with intended 1 refill(s). Instructions: take 1 Tab by mouth as directed Take one tab Q 4-8 hrs with meals\n- naproxen 500 MG Oral Tablet, through Oral route, started on 2017-07-26, presumably until 2018-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day with meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-08-06 08:50:06, ended at 2017-08-06 09:46:35\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- Insertion of intrauterine device (IUD)\n\n### Condition\n- Dysmenorrhea\n\n### Drug\n- levonorgestrel 0.000833 MG/HR Intrauterine System, through Intrauterine route, started on 2017-08-06, presumably until 2017-08-06, with intended 0 refill(s). Instructions: 1 Intra Uterine Device by Intrauterine route One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-25 17:22:19, ended at 2017-09-25 17:58:47\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abdominal pain\n- Dysmenorrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-02-01 15:04:35, ended at 2018-02-01 15:37:40\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Generalized abdominal pain\n\n### Drug\n- levonorgestrel 0.000833 MG/HR Intrauterine System, through Intrauterine route, with intended 0 refill(s). Instructions: 1 Device by Intrauterine route One Time\n- hyoscyamine sulfate 0.125 MG Sublingual Tablet, through Oral route, started on 2018-02-01, presumably until 2022-04-17, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day as needed (pain)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-04-04 12:44:38, ended at 2018-04-04 13:41:52\nThe patient in this visit was 21 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Inflammation of cervix\n- Primary diagnosis: Pain in pelvis\n\n### Drug\n- naproxen 500 MG Oral Tablet, through Oral route, started on 2018-04-04, presumably until 2019-04-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day with meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-04-25 08:06:00, ended at 2018-04-25 23:59:00\nThe patient in this visit was 21 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, transvaginal\n- Ultrasound, pelvic (nonobstetric), real time with image documentation; complete\n\n### Condition\n- Pain in pelvis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-05-28 16:36:46, ended at 2018-05-28 17:51:40\nThe patient in this visit was 21 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dysmenorrhea\n- Premenstrual tension syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-08 09:11:00, ended at 2019-07-08 23:59:00\nThe patient in this visit was 22 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest; 2 views\n\n### Condition\n- Allergic rhinitis due to pollen\n- Cough\n- Abnormal breathing\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-08-11 08:30:00, ended at 2019-08-11 23:59:00\nThe patient in this visit was 22 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Cough\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-30 08:07:36, ended at 2019-12-30 08:57:56\nThe patient in this visit was 22 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Laryngoscopy, flexible or rigid telescopic, with stroboscopy\n\n### Condition\n- Primary diagnosis: Cough\n\n### Drug\n- clarithromycin 500 MG Oral Tablet, started on 2019-12-02, presumably until 2022-04-17, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-09 08:42:20, ended at 2020-02-09 09:51:28\nThe patient in this visit was 22 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Behavioral and qualitative analysis of voice and resonance\n\n### Condition\n- Dysphonia\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive their first ever diagnosis of Essential hypertension within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-06-20 10:15:08, ended at 2016-06-20 11:17:07\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Illness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-23 14:42:04, ended at 2017-02-23 14:51:19\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- escitalopram 10 MG Oral Tablet, through Oral route, presumably until 2022-04-17, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- buspirone hydrochloride 5 MG Oral Tablet, through Oral route, presumably until 2022-04-17, with intended 0 refill(s). Instructions: take 5 mg by mouth every day\n- topiramate 100 MG Oral Tablet, through Oral route, presumably until 2022-04-17, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2017-06-09 00:00:00, ended at 2017-06-09 00:00:00\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.46 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 4.42 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.86 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 127 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 45.8 (percent)\n- MCH [Entitic mass] by Automated count: 27.2 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 40.6 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.92 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 219 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 58 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 82.1 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2017-06-09 04:42:00, ended at 2017-06-09 06:53:00\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 82.1 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 127 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 27.2 (picogram)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.86 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.46 (million per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.92 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 4.42 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 40.6 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 58 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 45.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 219 (thousand per microliter)\n\n### Procedure\n- Ultrasound, transvaginal\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Hypokalemia\n- Disorder of female genital organs\n- Primary diagnosis: Loss of consciousness\n- Pain in pelvis\n\n### Drug\n- ibuprofen 800 MG Oral Tablet, through Oral route, started on 2017-06-09, presumably until 2018-06-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2017-06-09, presumably until 2017-12-06, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-07-26 18:26:35, ended at 2017-07-26 19:35:57\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Dysmenorrhea\n\n### Drug\n- 24 HR naproxen 750 MG Extended Release Oral Tablet, through Oral route, started on 2017-07-26, presumably until 2017-07-26, with intended 1 refill(s). Instructions: take 1 Tab by mouth as directed Take one tab Q 4-8 hrs with meals\n- naproxen 500 MG Oral Tablet, through Oral route, started on 2017-07-26, presumably until 2018-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day with meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-08-06 08:50:06, ended at 2017-08-06 09:46:35\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- Insertion of intrauterine device (IUD)\n\n### Condition\n- Dysmenorrhea\n\n### Drug\n- levonorgestrel 0.000833 MG/HR Intrauterine System, through Intrauterine route, started on 2017-08-06, presumably until 2017-08-06, with intended 0 refill(s). Instructions: 1 Intra Uterine Device by Intrauterine route One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-25 17:22:19, ended at 2017-09-25 17:58:47\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abdominal pain\n- Dysmenorrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-02-01 15:04:35, ended at 2018-02-01 15:37:40\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Generalized abdominal pain\n\n### Drug\n- levonorgestrel 0.000833 MG/HR Intrauterine System, through Intrauterine route, with intended 0 refill(s). Instructions: 1 Device by Intrauterine route One Time\n- hyoscyamine sulfate 0.125 MG Sublingual Tablet, through Oral route, started on 2018-02-01, presumably until 2022-04-17, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day as needed (pain)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-04-04 12:44:38, ended at 2018-04-04 13:41:52\nThe patient in this visit was 21 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Inflammation of cervix\n- Primary diagnosis: Pain in pelvis\n\n### Drug\n- naproxen 500 MG Oral Tablet, through Oral route, started on 2018-04-04, presumably until 2019-04-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day with meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-04-25 08:06:00, ended at 2018-04-25 23:59:00\nThe patient in this visit was 21 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, transvaginal\n- Ultrasound, pelvic (nonobstetric), real time with image documentation; complete\n\n### Condition\n- Pain in pelvis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-05-28 16:36:46, ended at 2018-05-28 17:51:40\nThe patient in this visit was 21 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dysmenorrhea\n- Premenstrual tension syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-08 09:11:00, ended at 2019-07-08 23:59:00\nThe patient in this visit was 22 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest; 2 views\n\n### Condition\n- Allergic rhinitis due to pollen\n- Cough\n- Abnormal breathing\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-08-11 08:30:00, ended at 2019-08-11 23:59:00\nThe patient in this visit was 22 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Cough\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-30 08:07:36, ended at 2019-12-30 08:57:56\nThe patient in this visit was 22 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Laryngoscopy, flexible or rigid telescopic, with stroboscopy\n\n### Condition\n- Primary diagnosis: Cough\n\n### Drug\n- clarithromycin 500 MG Oral Tablet, started on 2019-12-02, presumably until 2022-04-17, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-09 08:42:20, ended at 2020-02-09 09:51:28\nThe patient in this visit was 22 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Behavioral and qualitative analysis of voice and resonance\n\n### Condition\n- Dysphonia\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive their first ever diagnosis of Essential hypertension within the next year (we could not find any prior history of this condition in their medical records before)\n- the condition of hypertension means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "5cefe9f6ed6138e55c0ad34b9fc0be2eded1bcdcfd679bf96c62573b41e4726e", "prompt_hash": "32a01f3b1b6954ec5aa24177032287681118001fc7237b63d8cb132ab8f9d90c", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 2, "doc": {"person_id": 115967662, "visit_occurrence_id": 74340640, "death_date": null, "visit_concept_name": "Outpatient Visit", "visit_start_datetime": "2015-05-29 10:01:00", "visit_end_datetime": "2015-05-29 23:59:00", "visit_length_in_hours": 13.966666666666667, "integrated_visit_record": "## Visit\nThis visit record, was from Outpatient Visit, started at 2015-05-29 10:01:00, ended at 2015-05-29 23:59:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, hip, unilateral; complete, minimum of 2 views\n- Radiologic examination, pelvis; 1 or 2 views\n\n### Condition\n- Joint pain of pelvic region\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 109, "patient_first_visit_date": "2014-04-02 10:22:59", "patient_last_visit_date": "2016-06-18 12:52:51", "end_obs_date": "2016-05-28", "hypertension_type": "new", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 12, "cumulated_visit_num": 12, "cumulated_approximate_token_count": 3578, "visit_cumulated": "## Visit\nThis visit record, was from Office Visit, started at 2014-04-02 10:22:59, ended at 2014-04-02 12:04:14\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 0\" (inch (US))\n\n### Procedure\n- Radiologic examination, pelvis; 1 or 2 views\n- Radiologic examination, hip, unilateral; complete, minimum of 2 views\n\n### Condition\n- Primary diagnosis: Degenerative joint disease of pelvis\n\n### Drug\n- naproxen sodium 220 MG Oral Tablet, through Oral route, presumably until 2014-05-10. Instructions: take  by mouth 2 times a day as needed.\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route. Instructions: take 20 mg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2014-04-02 10:23:00, ended at 2014-04-02 23:59:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, pelvis; 1 or 2 views\n- Radiologic examination, hip, unilateral; complete, minimum of 2 views\n\n### Condition\n- Degenerative joint disease of pelvis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-10 09:30:27, ended at 2014-05-10 11:18:23\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 0\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Pre-surgery evaluation\n\n### Condition\n- Diverticulitis of colon\n- Primary diagnosis: Joint pain of pelvic region\n- Congenital deformity of hip joint\n- Gastroesophageal reflux disease\n- Restless legs\n\n### Drug\n- naproxen sodium 220 MG Oral Tablet, through Oral route. Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-10 11:22:04, ended at 2014-05-10 11:42:38\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 0\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-10 11:55:00, ended at 2014-05-10 23:59:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.5 (percent)\n- MCH [Entitic mass] by Automated count: 25.2 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 77.7 (femtoliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.9 (nanogram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 3.28 (milli-international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.95 (million per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Prothrombin time (PT): 13.5 (second)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 326 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 35.9 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Pre-surgery evaluation\n\n### Condition\n- Diverticulitis of colon\n- Gastroesophageal reflux disease\n- Joint pain of pelvic region\n- Restless legs\n- Congenital deformity of hip joint\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2014-05-24 00:00:00, ended at 2014-05-24 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium chloride 0.154 MEQ/ML Irrigation Solution, through Topical route, started on 2014-05-24, presumably until 2014-05-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-05-24 00:00:00, ended at 2014-05-24 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for open procedures involving hip joint; total hip arthroplasty\n\n### Condition\n- Degenerative joint disease of pelvis\n\n### Drug\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2014-05-24, presumably until 2014-05-24\n- cefazolin 1000 MG Injection, started on 2014-05-24, presumably until 2014-05-24\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2014-05-24, presumably until 2014-05-24\n- bupivacaine hydrochloride 7.5 MG/ML Injection, through Intravenous route, started on 2014-05-24, presumably until 2014-05-24\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2014-05-24, presumably until 2014-05-24\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-05-24, presumably until 2014-05-24\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-05-24, presumably until 2014-05-24\n- ketamine 100 MG/ML Injectable Solution, started on 2014-05-24, presumably until 2014-05-24\n- 10 ML morphine sulfate 1 MG/ML Injection, started on 2014-05-24, presumably until 2014-05-24\n- 10 ML tranexamic acid 100 MG/ML Injection, through Intravenous route, started on 2014-05-24, presumably until 2014-05-24\n- midazolam 1 MG/ML Injectable Solution, started on 2014-05-24, presumably until 2014-05-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-05-24 12:30:00, ended at 2014-05-27 13:10:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Body height: 5' 0\" (inch (US))\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.79 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.9 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 224 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 89.4 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n\n### Procedure\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Hip bearing surface, metal-on-polyethylene\n- Collection of venous blood by venipuncture\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Physical therapy evaluation\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Radiologic examination, pelvis; 1 or 2 views\n- Total replacement of hip\n- Pre-surgery evaluation\n- Occupational therapy evaluation\n\n### Condition\n- Acute postoperative pain\n- Restless legs\n- Diverticulitis of colon\n- Primary diagnosis: Joint pain of pelvic region\n- Congenital deformity of hip joint\n- Gastroesophageal reflux disease\n\n### Drug\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2014-05-24, presumably until 2014-05-24\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2014-05-25, presumably until 2014-05-27\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2014-05-24, presumably until 2014-05-24\n- Streptococcus thermophilus, through Oral route, started on 2014-05-25, presumably until 2014-05-27\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2014-05-25, presumably until 2014-05-27\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2014-05-25, presumably until 2014-11-21, with intended 0 refill(s). Instructions: inject 0.4 mL subcutaneous (under the skin) daily.\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2014-05-24, presumably until 2014-05-25\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2014-05-24, presumably until 2014-11-21, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day. Take while taking opioids. Hold for loose stools.\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2014-05-24, presumably until 2014-05-26\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2014-05-24, presumably until 2014-05-27\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2014-05-25, presumably until 2014-11-21, with intended 1 refill(s). Instructions: take 1 Packet by mouth daily. Take while on opioids. Hold for loose stool.\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-05-24, presumably until 2014-05-25\n- Lactobacillus delbrueckii subsp. bulgaricus, through Oral route, started on 2014-05-25, presumably until 2014-05-27\n- gabapentin 100 MG Oral Capsule, through Oral route, started on 2014-05-25, presumably until 2014-05-25\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2014-05-24, presumably until 2014-11-21, with intended 0 refill(s). Instructions: take 1-3 Tabs by mouth every 4 hours as needed for Pain.\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2014-05-25, presumably until 2014-05-25\n- Lactobacillus acidophilus, through Oral route, started on 2014-05-25, presumably until 2014-05-27\n- Bifidobacterium bifidum, through Oral route, started on 2014-05-25, presumably until 2014-05-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-06-12 00:00:00, ended at 2014-06-12 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Prosthetic arthroplasty of hip\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-11 11:49:00, ended at 2014-07-11 23:59:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, pelvis; 1 or 2 views\n- Radiologic examination, hip, unilateral; 1 view\n\n### Condition\n- Joint pain of pelvic region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-11-21 10:32:16, ended at 2014-11-21 12:31:16\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Degenerative joint disease of pelvis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-05-29 10:01:00, ended at 2015-05-29 23:59:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, hip, unilateral; complete, minimum of 2 views\n- Radiologic examination, pelvis; 1 or 2 views\n\n### Condition\n- Joint pain of pelvic region\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive their first ever diagnosis of Essential hypertension within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-04-02 10:22:59, ended at 2014-04-02 12:04:14\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 0\" (inch (US))\n\n### Procedure\n- Radiologic examination, pelvis; 1 or 2 views\n- Radiologic examination, hip, unilateral; complete, minimum of 2 views\n\n### Condition\n- Primary diagnosis: Degenerative joint disease of pelvis\n\n### Drug\n- naproxen sodium 220 MG Oral Tablet, through Oral route, presumably until 2014-05-10. Instructions: take  by mouth 2 times a day as needed.\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route. Instructions: take 20 mg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2014-04-02 10:23:00, ended at 2014-04-02 23:59:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, pelvis; 1 or 2 views\n- Radiologic examination, hip, unilateral; complete, minimum of 2 views\n\n### Condition\n- Degenerative joint disease of pelvis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-10 09:30:27, ended at 2014-05-10 11:18:23\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 0\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Pre-surgery evaluation\n\n### Condition\n- Diverticulitis of colon\n- Primary diagnosis: Joint pain of pelvic region\n- Congenital deformity of hip joint\n- Gastroesophageal reflux disease\n- Restless legs\n\n### Drug\n- naproxen sodium 220 MG Oral Tablet, through Oral route. Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-10 11:22:04, ended at 2014-05-10 11:42:38\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 0\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-10 11:55:00, ended at 2014-05-10 23:59:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.5 (percent)\n- MCH [Entitic mass] by Automated count: 25.2 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 77.7 (femtoliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.9 (nanogram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 3.28 (milli-international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.95 (million per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Prothrombin time (PT): 13.5 (second)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 326 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 35.9 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Pre-surgery evaluation\n\n### Condition\n- Diverticulitis of colon\n- Gastroesophageal reflux disease\n- Joint pain of pelvic region\n- Restless legs\n- Congenital deformity of hip joint\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2014-05-24 00:00:00, ended at 2014-05-24 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium chloride 0.154 MEQ/ML Irrigation Solution, through Topical route, started on 2014-05-24, presumably until 2014-05-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-05-24 00:00:00, ended at 2014-05-24 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for open procedures involving hip joint; total hip arthroplasty\n\n### Condition\n- Degenerative joint disease of pelvis\n\n### Drug\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2014-05-24, presumably until 2014-05-24\n- cefazolin 1000 MG Injection, started on 2014-05-24, presumably until 2014-05-24\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2014-05-24, presumably until 2014-05-24\n- bupivacaine hydrochloride 7.5 MG/ML Injection, through Intravenous route, started on 2014-05-24, presumably until 2014-05-24\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2014-05-24, presumably until 2014-05-24\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-05-24, presumably until 2014-05-24\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-05-24, presumably until 2014-05-24\n- ketamine 100 MG/ML Injectable Solution, started on 2014-05-24, presumably until 2014-05-24\n- 10 ML morphine sulfate 1 MG/ML Injection, started on 2014-05-24, presumably until 2014-05-24\n- 10 ML tranexamic acid 100 MG/ML Injection, through Intravenous route, started on 2014-05-24, presumably until 2014-05-24\n- midazolam 1 MG/ML Injectable Solution, started on 2014-05-24, presumably until 2014-05-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-05-24 12:30:00, ended at 2014-05-27 13:10:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Body height: 5' 0\" (inch (US))\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.79 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.9 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 224 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 89.4 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n\n### Procedure\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Hip bearing surface, metal-on-polyethylene\n- Collection of venous blood by venipuncture\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Physical therapy evaluation\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Radiologic examination, pelvis; 1 or 2 views\n- Total replacement of hip\n- Pre-surgery evaluation\n- Occupational therapy evaluation\n\n### Condition\n- Acute postoperative pain\n- Restless legs\n- Diverticulitis of colon\n- Primary diagnosis: Joint pain of pelvic region\n- Congenital deformity of hip joint\n- Gastroesophageal reflux disease\n\n### Drug\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2014-05-24, presumably until 2014-05-24\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2014-05-25, presumably until 2014-05-27\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2014-05-24, presumably until 2014-05-24\n- Streptococcus thermophilus, through Oral route, started on 2014-05-25, presumably until 2014-05-27\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2014-05-25, presumably until 2014-05-27\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2014-05-25, presumably until 2014-11-21, with intended 0 refill(s). Instructions: inject 0.4 mL subcutaneous (under the skin) daily.\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2014-05-24, presumably until 2014-05-25\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2014-05-24, presumably until 2014-11-21, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day. Take while taking opioids. Hold for loose stools.\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2014-05-24, presumably until 2014-05-26\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2014-05-24, presumably until 2014-05-27\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2014-05-25, presumably until 2014-11-21, with intended 1 refill(s). Instructions: take 1 Packet by mouth daily. Take while on opioids. Hold for loose stool.\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-05-24, presumably until 2014-05-25\n- Lactobacillus delbrueckii subsp. bulgaricus, through Oral route, started on 2014-05-25, presumably until 2014-05-27\n- gabapentin 100 MG Oral Capsule, through Oral route, started on 2014-05-25, presumably until 2014-05-25\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2014-05-24, presumably until 2014-11-21, with intended 0 refill(s). Instructions: take 1-3 Tabs by mouth every 4 hours as needed for Pain.\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2014-05-25, presumably until 2014-05-25\n- Lactobacillus acidophilus, through Oral route, started on 2014-05-25, presumably until 2014-05-27\n- Bifidobacterium bifidum, through Oral route, started on 2014-05-25, presumably until 2014-05-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-06-12 00:00:00, ended at 2014-06-12 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Prosthetic arthroplasty of hip\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-11 11:49:00, ended at 2014-07-11 23:59:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, pelvis; 1 or 2 views\n- Radiologic examination, hip, unilateral; 1 view\n\n### Condition\n- Joint pain of pelvic region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-11-21 10:32:16, ended at 2014-11-21 12:31:16\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Degenerative joint disease of pelvis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-05-29 10:01:00, ended at 2015-05-29 23:59:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, hip, unilateral; complete, minimum of 2 views\n- Radiologic examination, pelvis; 1 or 2 views\n\n### Condition\n- Joint pain of pelvic region\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive their first ever diagnosis of Essential hypertension within the next year (we could not find any prior history of this condition in their medical records before)\n- the condition of hypertension means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "3d3bacee159ce66419ffd8ed1625c63eea52252f6490890d91e394330c42c62a", "prompt_hash": "534a7d0fdcbc4db76c74c827419b8d454da4a974ceb919bac41fefe2dabb5dc4", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 3, "doc": {"person_id": 115967924, "visit_occurrence_id": 85358796, "death_date": null, "visit_concept_name": "Hospital", "visit_start_datetime": "2016-04-24 00:00:00", "visit_end_datetime": "2016-04-24 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Hospital, started at 2016-04-24 00:00:00, ended at 2016-04-24 00:00:00\nThe patient in this visit was 57 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- midazolam 1 MG/ML Injectable Solution, started on 2016-04-24, presumably until 2016-04-24\n\n", "approximate_token_count": 99, "patient_first_visit_date": "2014-10-03 14:30:00", "patient_last_visit_date": "2018-07-08 11:13:00", "end_obs_date": "2017-04-24", "hypertension_type": "new", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 1, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "recurrent", "intestinal_cancer_one_year_diagnosis": 1, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 17, "cumulated_visit_num": 17, "cumulated_approximate_token_count": 4295, "visit_cumulated": "## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-03 14:30:00, ended at 2014-10-03 23:59:00\nThe patient in this visit was 55 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n\n### Condition\n- Primary malignant neoplasm of rectosigmoid junction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-13 12:12:00, ended at 2014-10-13 14:02:00\nThe patient in this visit was 55 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.354\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of rectum\n- Pure hypercholesterolemia\n\n### Drug\n- rosuvastatin calcium 10 MG Oral Tablet, through Oral route, presumably until 2015-03-07, with intended 0 refill(s). Instructions: take 10 mg by mouth Every Day.\n- ranitidine 150 MG Oral Tablet, through Oral route, presumably until 2015-03-07, with intended 0 refill(s). Instructions: take 150 mg by mouth 2 times a day.\n- sucralfate 1000 MG Oral Tablet, through Oral route, presumably until 2015-03-07, with intended 0 refill(s). Instructions: take 1 g by mouth 4 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-13 14:03:00, ended at 2014-10-13 23:59:00\nThe patient in this visit was 55 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.0 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 2 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.64 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.5 (thousand per microliter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 192 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.7 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 98 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of rectum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-02 13:32:00, ended at 2014-11-02 23:59:00\nThe patient in this visit was 55 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Lymphadenopathy\n- Primary malignant neoplasm of rectum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-11-03 00:00:00, ended at 2014-11-03 00:00:00\nThe patient in this visit was 55 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of rectum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-01-17 00:00:00, ended at 2015-01-17 00:00:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of rectum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-02-02 12:36:00, ended at 2015-02-02 14:29:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.354\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of rectum\n- Neoplasm defined only by topography: Rectum, NOS\n\n### Drug\n- polyethylene glycol 3350 236000 MG / potassium chloride 2970 MG / sodium bicarbonate 6740 MG / sodium chloride 5860 MG / sodium sulfate 22740 MG Powder for Oral Solution, through Oral route, started on 2015-02-02, presumably until 2015-02-03, with intended 0 refill(s). Instructions: take 4,000 mL by mouth One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-02-02 14:30:00, ended at 2015-02-02 23:59:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Primary malignant neoplasm of rectum\n- Digestive symptom\n- Disease of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-03-07 10:30:00, ended at 2015-03-07 13:29:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.094\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of rectum\n\n### Drug\n- atorvastatin 10 MG Oral Tablet, through Oral route, presumably until 2015-09-21, with intended 0 refill(s). Instructions: take 10 mg by mouth Every Day.\n- esomeprazole 40 MG Delayed Release Oral Capsule, through Oral route, presumably until 2015-03-30, with intended 0 refill(s). Instructions: take 40 mg by mouth Every Day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-03-13 00:00:00, ended at 2015-03-13 00:00:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- polyethylene glycol 3350 236000 MG / potassium chloride 2970 MG / sodium bicarbonate 6740 MG / sodium chloride 5860 MG / sodium sulfate 22740 MG Powder for Oral Solution, through Oral route, started on 2015-03-13, presumably until 2015-03-15, with intended 0 refill(s). Instructions: take 4,000 mL by mouth One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2015-03-15 00:00:00, ended at 2015-03-15 00:00:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for intraperitoneal procedures in upper abdomen including laparoscopy; not otherwise specified\n\n### Condition\n- Primary malignant neoplasm of rectum\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, through Intravenous route, started on 2015-03-15, presumably until 2015-03-15\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2015-03-15, presumably until 2015-03-15\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2015-03-15, presumably until 2015-03-15\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2015-03-15, presumably until 2015-03-15\n- ertapenem 1000 MG Injection, started on 2015-03-15, presumably until 2015-03-15\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2015-03-15, presumably until 2015-03-15\n- 2 ML ondansetron 2 MG/ML Injection, started on 2015-03-15, presumably until 2015-03-15\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2015-03-15, presumably until 2015-03-15\n- midazolam 1 MG/ML Injectable Solution, started on 2015-03-15, presumably until 2015-03-15\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2015-03-15, presumably until 2015-03-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2015-03-15 00:00:00, ended at 2015-03-15 00:00:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bupivacaine hydrochloride 2.5 MG/ML Injectable Solution, started on 2015-03-15, presumably until 2015-03-15\n- sodium chloride 0.154 MEQ/ML Irrigation Solution, through Topical route, started on 2015-03-15, presumably until 2015-03-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2015-03-15 07:36:00, ended at 2015-03-17 13:47:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 157 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.33 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.46 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.45 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.49 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.3 (percent)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 99.9 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 149 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.0 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Body height: 5' 4\" (inch (US))\n- Glucose [Mass/volume] in Blood: 131 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.2 (percent)\n- MCH [Entitic mass] by Automated count: 34.2 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Collection of venous blood by venipuncture\n- Other anterior resection of rectum\n- Anastomosis of large intestine to large intestine\n\n### Condition\n- Pure hypercholesterolemia\n- Primary malignant neoplasm of rectum\n- Gastroesophageal reflux disease\n- Intestinal disaccharidase deficiency\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2015-03-15, presumably until 2015-03-16\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2015-03-16, presumably until 2015-03-16\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2015-03-15, presumably until 2015-03-17\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2015-03-15, presumably until 2015-03-16\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2015-03-16, presumably until 2015-03-17\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2015-03-16, presumably until 2015-03-16\n- atorvastatin 10 MG Oral Tablet, through Oral route, started on 2015-03-15, presumably until 2015-03-17\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2015-03-15, presumably until 2015-03-17\n- celecoxib 200 MG Oral Capsule, through Oral route, started on 2015-03-15, presumably until 2015-03-15\n- 2 ML ondansetron 2 MG/ML Injection, started on 2015-03-15, presumably until 2015-03-15\n- 1 ML ketorolac tromethamine 15 MG/ML Injection, started on 2015-03-15, presumably until 2015-03-16\n- 1 ML hydromorphone hydrochloride 2 MG/ML Prefilled Syringe, started on 2015-03-15, presumably until 2015-03-15\n- alvimopan 12 MG Oral Capsule, through Oral route, started on 2015-03-15, presumably until 2015-03-16\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2015-03-16, presumably until 2015-09-13, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-03-30 13:08:00, ended at 2015-03-30 23:59:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.094\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of rectum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-09-21 11:06:42, ended at 2015-09-21 11:41:05\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.37\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of rectum\n\n### Drug\n- rosuvastatin calcium 10 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 10 mg by mouth Every Day\n- polyethylene glycol 3350 236000 MG / potassium chloride 2970 MG / sodium bicarbonate 6740 MG / sodium chloride 5860 MG / sodium sulfate 22740 MG Powder for Oral Solution, through Oral route, started on 2015-09-21, presumably until 2015-09-21, with intended 0 refill(s). Instructions: take 4,000 mL by mouth One Time\n- prochlorperazine 10 MG Oral Tablet, started on 2015-06-14, presumably until 2015-06-14, with intended 0 refill(s)\n- psyllium 6000 MG Powder for Oral Suspension, through Oral route, started on 2015-09-21, presumably until 2015-09-21. Instructions: take 1 Packet by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-03-11 00:00:00, ended at 2016-03-11 00:00:00\nThe patient in this visit was 57 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- polyethylene glycol 3350 236000 MG / potassium chloride 2970 MG / sodium bicarbonate 6740 MG / sodium chloride 5860 MG / sodium sulfate 22740 MG Powder for Oral Solution, through Oral route, started on 2016-03-11, presumably until 2016-03-11, with intended 0 refill(s). Instructions: take 4,000 mL by mouth One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2016-04-24 00:00:00, ended at 2016-04-24 00:00:00\nThe patient in this visit was 57 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- midazolam 1 MG/ML Injectable Solution, started on 2016-04-24, presumably until 2016-04-24\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive their first ever diagnosis of Essential hypertension within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-03 14:30:00, ended at 2014-10-03 23:59:00\nThe patient in this visit was 55 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n\n### Condition\n- Primary malignant neoplasm of rectosigmoid junction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-13 12:12:00, ended at 2014-10-13 14:02:00\nThe patient in this visit was 55 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.354\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of rectum\n- Pure hypercholesterolemia\n\n### Drug\n- rosuvastatin calcium 10 MG Oral Tablet, through Oral route, presumably until 2015-03-07, with intended 0 refill(s). Instructions: take 10 mg by mouth Every Day.\n- ranitidine 150 MG Oral Tablet, through Oral route, presumably until 2015-03-07, with intended 0 refill(s). Instructions: take 150 mg by mouth 2 times a day.\n- sucralfate 1000 MG Oral Tablet, through Oral route, presumably until 2015-03-07, with intended 0 refill(s). Instructions: take 1 g by mouth 4 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-13 14:03:00, ended at 2014-10-13 23:59:00\nThe patient in this visit was 55 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.0 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 2 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.64 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.5 (thousand per microliter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 192 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.7 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 98 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of rectum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-02 13:32:00, ended at 2014-11-02 23:59:00\nThe patient in this visit was 55 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Lymphadenopathy\n- Primary malignant neoplasm of rectum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-11-03 00:00:00, ended at 2014-11-03 00:00:00\nThe patient in this visit was 55 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of rectum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-01-17 00:00:00, ended at 2015-01-17 00:00:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of rectum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-02-02 12:36:00, ended at 2015-02-02 14:29:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.354\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of rectum\n- Neoplasm defined only by topography: Rectum, NOS\n\n### Drug\n- polyethylene glycol 3350 236000 MG / potassium chloride 2970 MG / sodium bicarbonate 6740 MG / sodium chloride 5860 MG / sodium sulfate 22740 MG Powder for Oral Solution, through Oral route, started on 2015-02-02, presumably until 2015-02-03, with intended 0 refill(s). Instructions: take 4,000 mL by mouth One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-02-02 14:30:00, ended at 2015-02-02 23:59:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Primary malignant neoplasm of rectum\n- Digestive symptom\n- Disease of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-03-07 10:30:00, ended at 2015-03-07 13:29:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.094\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of rectum\n\n### Drug\n- atorvastatin 10 MG Oral Tablet, through Oral route, presumably until 2015-09-21, with intended 0 refill(s). Instructions: take 10 mg by mouth Every Day.\n- esomeprazole 40 MG Delayed Release Oral Capsule, through Oral route, presumably until 2015-03-30, with intended 0 refill(s). Instructions: take 40 mg by mouth Every Day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-03-13 00:00:00, ended at 2015-03-13 00:00:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- polyethylene glycol 3350 236000 MG / potassium chloride 2970 MG / sodium bicarbonate 6740 MG / sodium chloride 5860 MG / sodium sulfate 22740 MG Powder for Oral Solution, through Oral route, started on 2015-03-13, presumably until 2015-03-15, with intended 0 refill(s). Instructions: take 4,000 mL by mouth One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2015-03-15 00:00:00, ended at 2015-03-15 00:00:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for intraperitoneal procedures in upper abdomen including laparoscopy; not otherwise specified\n\n### Condition\n- Primary malignant neoplasm of rectum\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, through Intravenous route, started on 2015-03-15, presumably until 2015-03-15\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2015-03-15, presumably until 2015-03-15\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2015-03-15, presumably until 2015-03-15\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2015-03-15, presumably until 2015-03-15\n- ertapenem 1000 MG Injection, started on 2015-03-15, presumably until 2015-03-15\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2015-03-15, presumably until 2015-03-15\n- 2 ML ondansetron 2 MG/ML Injection, started on 2015-03-15, presumably until 2015-03-15\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2015-03-15, presumably until 2015-03-15\n- midazolam 1 MG/ML Injectable Solution, started on 2015-03-15, presumably until 2015-03-15\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2015-03-15, presumably until 2015-03-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2015-03-15 00:00:00, ended at 2015-03-15 00:00:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bupivacaine hydrochloride 2.5 MG/ML Injectable Solution, started on 2015-03-15, presumably until 2015-03-15\n- sodium chloride 0.154 MEQ/ML Irrigation Solution, through Topical route, started on 2015-03-15, presumably until 2015-03-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2015-03-15 07:36:00, ended at 2015-03-17 13:47:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 157 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.33 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.46 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.45 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.49 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.3 (percent)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 99.9 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 149 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.0 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Body height: 5' 4\" (inch (US))\n- Glucose [Mass/volume] in Blood: 131 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.2 (percent)\n- MCH [Entitic mass] by Automated count: 34.2 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Collection of venous blood by venipuncture\n- Other anterior resection of rectum\n- Anastomosis of large intestine to large intestine\n\n### Condition\n- Pure hypercholesterolemia\n- Primary malignant neoplasm of rectum\n- Gastroesophageal reflux disease\n- Intestinal disaccharidase deficiency\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2015-03-15, presumably until 2015-03-16\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2015-03-16, presumably until 2015-03-16\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2015-03-15, presumably until 2015-03-17\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2015-03-15, presumably until 2015-03-16\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2015-03-16, presumably until 2015-03-17\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2015-03-16, presumably until 2015-03-16\n- atorvastatin 10 MG Oral Tablet, through Oral route, started on 2015-03-15, presumably until 2015-03-17\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2015-03-15, presumably until 2015-03-17\n- celecoxib 200 MG Oral Capsule, through Oral route, started on 2015-03-15, presumably until 2015-03-15\n- 2 ML ondansetron 2 MG/ML Injection, started on 2015-03-15, presumably until 2015-03-15\n- 1 ML ketorolac tromethamine 15 MG/ML Injection, started on 2015-03-15, presumably until 2015-03-16\n- 1 ML hydromorphone hydrochloride 2 MG/ML Prefilled Syringe, started on 2015-03-15, presumably until 2015-03-15\n- alvimopan 12 MG Oral Capsule, through Oral route, started on 2015-03-15, presumably until 2015-03-16\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2015-03-16, presumably until 2015-09-13, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-03-30 13:08:00, ended at 2015-03-30 23:59:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.094\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of rectum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-09-21 11:06:42, ended at 2015-09-21 11:41:05\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.37\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of rectum\n\n### Drug\n- rosuvastatin calcium 10 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 10 mg by mouth Every Day\n- polyethylene glycol 3350 236000 MG / potassium chloride 2970 MG / sodium bicarbonate 6740 MG / sodium chloride 5860 MG / sodium sulfate 22740 MG Powder for Oral Solution, through Oral route, started on 2015-09-21, presumably until 2015-09-21, with intended 0 refill(s). Instructions: take 4,000 mL by mouth One Time\n- prochlorperazine 10 MG Oral Tablet, started on 2015-06-14, presumably until 2015-06-14, with intended 0 refill(s)\n- psyllium 6000 MG Powder for Oral Suspension, through Oral route, started on 2015-09-21, presumably until 2015-09-21. Instructions: take 1 Packet by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-03-11 00:00:00, ended at 2016-03-11 00:00:00\nThe patient in this visit was 57 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- polyethylene glycol 3350 236000 MG / potassium chloride 2970 MG / sodium bicarbonate 6740 MG / sodium chloride 5860 MG / sodium sulfate 22740 MG Powder for Oral Solution, through Oral route, started on 2016-03-11, presumably until 2016-03-11, with intended 0 refill(s). Instructions: take 4,000 mL by mouth One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2016-04-24 00:00:00, ended at 2016-04-24 00:00:00\nThe patient in this visit was 57 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- midazolam 1 MG/ML Injectable Solution, started on 2016-04-24, presumably until 2016-04-24\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive their first ever diagnosis of Essential hypertension within the next year (we could not find any prior history of this condition in their medical records before)\n- the condition of hypertension means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "2f8946aab9035e9ecc732786397cf833bf4a5cccd6d30e12f3f10b40affe0d8c", "prompt_hash": "d650bc9b107828053946356490a07f859d64a3c34f0fc764b47824f2b2956f56", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 4, "doc": {"person_id": 115968035, "visit_occurrence_id": 174248134, "death_date": null, "visit_concept_name": "Telehealth", "visit_start_datetime": "2021-02-07 00:00:00", "visit_end_datetime": "2021-02-07 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Telehealth, started at 2021-02-07 00:00:00, ended at 2021-02-07 00:00:00\nThe patient in this visit was 45 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sciatica\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 82, "patient_first_visit_date": "2012-02-25 00:00:00", "patient_last_visit_date": "2023-01-06 00:00:00", "end_obs_date": "2022-02-07", "hypertension_type": "new", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "recurrent", "asthma_one_year_diagnosis": 1, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 1, "depressive_disorder_type": "recurrent", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 69, "cumulated_visit_num": 69, "cumulated_approximate_token_count": 11418, "visit_cumulated": "## Visit\nThis visit record, was from Pharmacy visit, started at 2012-02-25 00:00:00, ended at 2012-02-25 00:00:00\nThe patient in this visit was 36 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- carvedilol 25 MG Oral Tablet, through Oral route, started on 2012-02-25, presumably until 2019-05-10, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-02-26 00:00:00, ended at 2012-02-26 00:00:00\nThe patient in this visit was 36 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR bupropion hydrochloride 300 MG Extended Release Oral Tablet, started on 2012-02-26, presumably until 2013-02-07, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-01-16 00:00:00, ended at 2013-01-16 00:00:00\nThe patient in this visit was 37 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 113 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 137 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (international unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 50 (international unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 197 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.5 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 274 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.73 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.5 (thousand per microliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.2 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 82 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L: 0.779 (micro-international unit per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 27 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.3 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.5 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 87 (international unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 57 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 31 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.38 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n\n### Procedure\n- General examination of patient\n\n### Condition\n- Primary cardiomyopathy\n- Primary diagnosis: Non-toxic multinodular goiter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-02-07 14:01:58, ended at 2013-02-07 14:47:43\nThe patient in this visit was 37 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diag\n- General examination of patient\n\n### Condition\n- Attention deficit hyperactivity disorder, predominantly inattentive type\n- Non-toxic multinodular goiter\n- Chronic nonalcoholic liver disease\n- Sleep apnea\n- Bipolar disorder\n- Primary cardiomyopathy\n\n### Drug\n- lurasidone hydrochloride 40 MG Oral Tablet, through Oral route, presumably until 2014-06-21. Instructions: take  by mouth. Split in 1/4 daily\n- lurasidone hydrochloride 20 MG Oral Tablet, through Oral route, presumably until 2014-06-21. Instructions: take  by mouth. Split in 1/4 daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-06-21 16:51:40, ended at 2014-06-21 17:20:47\nThe patient in this visit was 38 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic nonalcoholic liver disease\n- Primary diagnosis: Non-toxic multinodular goiter\n- Bipolar disorder\n- Primary cardiomyopathy\n\n### Drug\n- thyroid (USP) 60 MG Oral Tablet, through Oral route, started on 2014-06-21, presumably until 2015-08-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth Every Day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-10-04 00:00:00, ended at 2014-10-04 00:00:00\nThe patient in this visit was 38 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2014-10-04, presumably until 2015-10-25, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 to 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-04-17 14:39:32, ended at 2015-04-17 15:09:27\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 287 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 96 (international unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.2 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 83 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.9 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.6 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (international unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.3 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.5 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67 (percent)\n- Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L: 0.679 (micro-international unit per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.8 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.72 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.4 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 77 (milligram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 27.9 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Body height: 5' 1\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.38 (million per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Non-toxic multinodular goiter\n- Chronic nonalcoholic liver disease\n- Primary cardiomyopathy\n- Primary diagnosis: Dysfunction of eustachian tube\n\n### Drug\n- ethacrynic acid 25 MG Oral Tablet, through Oral route, presumably until 2015-10-25, with intended 0 refill(s). Instructions: take 2 Tabs by mouth Every Day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-04-19 00:00:00, ended at 2015-04-19 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Allergic rhinitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-05-01 00:00:00, ended at 2015-05-01 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2015-05-01, presumably until 2016-05-01, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-05-01 13:57:32, ended at 2015-05-01 14:38:58\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- General examination of patient\n\n### Condition\n- Non-toxic multinodular goiter\n- Bipolar disorder\n- Sleep apnea\n- Primary cardiomyopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-05 00:00:00, ended at 2015-08-05 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Non-toxic multinodular goiter\n\n### Drug\n- thyroid (USP) 60 MG Oral Tablet, through Oral route, started on 2015-08-05, presumably until 2015-09-02, with intended 3 refill(s). Instructions: take 1 Tab by mouth Every Day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-30 00:00:00, ended at 2015-08-30 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Non-toxic multinodular goiter\n\n### Drug\n- thyroid (USP) 60 MG Oral Tablet, through Oral route, started on 2015-09-02, presumably until 2016-05-01, with intended 6 refill(s). Instructions: take 1 Tab by mouth Every Day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-10-25 00:00:00, ended at 2015-10-25 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- NDA019430 0.3 ML epinephrine 1 MG/ML Auto-Injector, started on 2015-10-25, presumably until 2017-04-09, with intended 6 refill(s). Instructions: Use as directed\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2015-10-25, presumably until 2017-04-09, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 to 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-25 10:07:18, ended at 2015-10-25 11:09:46\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Attention deficit hyperactivity disorder\n- Posttraumatic stress disorder\n\n### Drug\n- triamcinolone acetonide 0.055 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, presumably until 2019-05-10, with intended 0 refill(s). Instructions: 55 mcg by Nasal route daily\n- bumetanide 0.5 MG Oral Tablet, started on 2015-10-25, presumably until 2017-07-20, with intended 3 refill(s). Instructions: Take 1 po daily prn swelling\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: Take 1 tablet (81 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-27 13:41:10, ended at 2016-02-27 14:07:45\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Shoulder joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-03-18 00:00:00, ended at 2016-03-18 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Shoulder joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-03-24 09:59:32, ended at 2016-03-24 11:15:21\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Shoulder joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-04-14 09:42:59, ended at 2016-04-14 10:14:56\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Shoulder joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-05-01 00:00:00, ended at 2016-05-01 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thyroid (USP) 60 MG Oral Tablet, through Oral route, started on 2016-05-01, presumably until 2016-12-16, with intended 6 refill(s). Instructions: take 1 Tab by mouth Every Day\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2016-05-01, presumably until 2016-05-08, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-05-07 00:00:00, ended at 2016-05-07 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Biceps tendinitis\n- Shoulder joint pain\n- Nontraumatic rotator cuff tear\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-05-13 09:29:30, ended at 2016-05-13 10:06:48\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cardiomyopathy\n- Primary diagnosis: Acute bronchitis\n- Non-toxic multinodular goiter\n- Sleep apnea\n\n### Drug\n- 14 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler, through Inhalation, started on 2016-05-13, presumably until 2017-05-13, with intended 3 refill(s). Instructions: 1 Puff by Inhalation route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-07-10 00:00:00, ended at 2016-07-10 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anesthesia of skin\n- Primary diagnosis: Low back pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-11-13 10:27:49, ended at 2016-11-13 11:24:59\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Non-toxic multinodular goiter\n- Primary diagnosis: Cardiomyopathy\n- Attention deficit hyperactivity disorder\n- Mixed bipolar I disorder in full remission\n- Mild intermittent asthma\n\n### Drug\n- lidocaine 0.05 MG/MG Medicated Patch, through Transdermal route, started on 2016-11-13, presumably until 2017-11-13, with intended 3 refill(s). Instructions: apply 1 Patch to skin daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-12-16 00:00:00, ended at 2016-12-16 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thyroid (USP) 60 MG Oral Tablet, through Oral route, started on 2016-12-16, presumably until 2018-04-21, with intended 11 refill(s). Instructions: take 1 Tab by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-04-09 00:00:00, ended at 2017-04-09 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2017-04-09, presumably until 2018-07-26, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 to 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-04-09 00:00:00, ended at 2017-04-09 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- NDA019430 0.3 ML epinephrine 1 MG/ML Auto-Injector, started on 2017-04-09, presumably until 2017-12-07, with intended 6 refill(s). Instructions: Use as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-04-30 10:51:26, ended at 2017-04-30 11:28:27\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diag\n\n### Condition\n- Attention deficit hyperactivity disorder\n- Non-toxic multinodular goiter\n- Sleep apnea\n- Impaired glucose tolerance\n- Mixed bipolar I disorder in full remission\n- Primary diagnosis: Cardiomyopathy\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-07-02 00:00:00, ended at 2017-07-02 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Non-toxic uninodular goiter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-20 00:00:00, ended at 2017-07-20 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bumetanide 0.5 MG Oral Tablet, started on 2017-07-21, presumably until 2019-04-07, with intended 3 refill(s). Instructions: Take one tablet by mouth daily as needed for swelling.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-27 00:00:00, ended at 2017-07-27 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2017-07-28, presumably until 2017-08-04, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-09-22 00:00:00, ended at 2017-09-22 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- No conditions.\n\n### Drug\n- 1 ML hepatitis A vaccine (inactivated) strain HM175 720 UNT/ML / hepatitis B surface antigen vaccine 0.02 MG/ML Prefilled Syringe, through Intramuscular route, started on 2017-09-23, presumably until 2017-09-24, with intended 0 refill(s). Instructions: inject 1 mL into a muscle One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-09-24 00:00:00, ended at 2017-09-24 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure)\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-10-08 13:54:03, ended at 2017-10-08 13:54:21\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-10-26 00:00:00, ended at 2017-10-26 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.5 ML typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML Prefilled Syringe, started on 2017-10-26, presumably until 2018-04-21, with intended 0 refill(s). Instructions: Injection 0.5 mL into the muscle One Time\n- 0.5 ML Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated 0.012 MG/ML Prefilled Syringe, through Intramuscular route, started on 2017-10-26, presumably until 2017-10-27, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle as directed\n- atovaquone 250 MG / proguanil hydrochloride 100 MG Oral Tablet, started on 2017-10-26, presumably until 2018-04-21, with intended 0 refill(s). Instructions: Take 1 tab po starting 1-2 days before trip,continue till one week after returning from trip\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-11-04 00:00:00, ended at 2017-11-04 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2017-11-04, presumably until 2018-04-21, with intended 1 refill(s). Instructions: take 1-2 Tabs by mouth every 4 to 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-12-07 00:00:00, ended at 2017-12-07 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- NDA019430 0.3 ML epinephrine 1 MG/ML Auto-Injector, started on 2017-12-08, presumably until 2019-06-06, with intended 6 refill(s). Instructions: Use as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-12-13 00:00:00, ended at 2017-12-13 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sleep apnea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-04-21 14:13:18, ended at 2018-04-21 14:51:16\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Sleep apnea\n- Cardiomyopathy\n- Primary diagnosis: Acute maxillary sinusitis\n- Bipolar disorder in remission\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2018-04-21, presumably until 2019-06-06, with intended 1 refill(s). Instructions: take 1-2 Tabs by mouth every 4 to 6 hours as needed\n- ergocalciferol 1.25 MG Oral Capsule, through Oral route, started on 2018-04-21, presumably until 2020-01-25, with intended 3 refill(s). Instructions: take 1 Cap by mouth every 7 days\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2018-04-21, presumably until 2018-05-01, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n- valacyclovir 500 MG Oral Tablet, through Oral route, presumably until 2018-08-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day For 1 month during breakout\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-07-26 00:00:00, ended at 2018-07-26 00:00:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mild intermittent asthma\n\n### Drug\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2018-07-27, presumably until 2019-10-12, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 to 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-08-22 00:00:00, ended at 2018-08-22 00:00:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2018-08-22, presumably until 2019-03-25, with intended 2 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 30 days For 1 month during breakout\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-18 00:00:00, ended at 2018-10-18 00:00:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- azelastine hydrochloride 0.206 MG/ACTUAT Metered Dose Nasal Spray, started on 2018-10-18, presumably until 2019-07-25, with intended 3 refill(s). Instructions: USE IN EACH NOSTRIL AS DIRECTED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-03-14 00:00:00, ended at 2019-03-14 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Kidney stone\n- Sleep apnea\n- Steatosis of liver\n- Uncomplicated asthma\n- Primary diagnosis: Urticaria due to cold and heat\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-03-25 00:00:00, ended at 2019-03-25 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ophthalmic herpes simplex\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, started on 2019-03-28, presumably until 2019-04-27, with intended 2 refill(s). Instructions: TAKE 1 TABLET BY MOUTH 2 TIMES A DAY FOR 1 MONTH DURING BREAKOUT\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-07 00:00:00, ended at 2019-04-07 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cardiomyopathy\n\n### Drug\n- bumetanide 0.5 MG Oral Tablet, started on 2019-04-07, presumably until 2020-06-14, with intended 3 refill(s). Instructions: Take one tablet by mouth daily as needed for swelling.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-10 10:43:15, ended at 2019-05-10 14:22:35\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diag\n\n### Condition\n- Sleep apnea\n- Cardiomyopathy\n\n### Drug\n- soybean preparation, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- vitamin E, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- soy protein isolate, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- cannabidiol 100 MG/ML Oral Solution, through Topical route, with intended 0 refill(s). Instructions: by Topical route Compounded cream for inflammation\n- soybean allergenic extract, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- folic acid, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- aspirin 81 MG / calcium carbonate 777 MG Oral Tablet, through Oral route, presumably until 2019-05-10, with intended 0 refill(s). Instructions: take 81 mg by mouth daily\n- triamcinolone acetonide 0.055 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, presumably until 2022-02-12, with intended 0 refill(s). Instructions: 2 Sprays by Nasal route every day\n- wheat germ oil, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- alpha tocopherol, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- valacyclovir 500 MG Oral Tablet, through Oral route, presumably until 2020-01-03, with intended 0 refill(s). Instructions: take 500 mg by mouth 2 times a day as needed\n- vitamin B complex, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-06-06 00:00:00, ended at 2019-06-06 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Generalized anxiety disorder\n- Mild intermittent asthma\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, started on 2019-06-07, presumably until 2020-07-31, with intended 1 refill(s). Instructions: TAKE 1 TO 2 TABLETS BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED\n- NDA201739 0.3 ML epinephrine 1 MG/ML Auto-Injector, started on 2019-06-07, presumably until 2021-06-21, with intended 6 refill(s). Instructions: USE AS DIRECTED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-07-25 00:00:00, ended at 2019-07-25 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Allergic rhinitis\n\n### Drug\n- azelastine hydrochloride 0.206 MG/ACTUAT Metered Dose Nasal Spray, started on 2019-07-26, presumably until 2020-01-08, with intended 2 refill(s). Instructions: use in each nostril as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-10-12 00:00:00, ended at 2019-10-12 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Mild intermittent asthma\n\n### Drug\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, started on 2019-10-12, presumably until 2020-07-31, with intended 11 refill(s). Instructions: INHALE 2 PUFFS BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-02 00:00:00, ended at 2020-01-02 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, started on 2020-01-03, presumably until 2020-07-31, with intended 1 refill(s). Instructions: 1T 2 TIMES A DAY FOR 1 MONTH DURING BREAKOUT\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-07 00:00:00, ended at 2020-01-07 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis\n\n### Drug\n- azelastine hydrochloride 0.206 MG/ACTUAT Metered Dose Nasal Spray, started on 2020-01-08, presumably until 2020-01-25, with intended 3 refill(s). Instructions: use in each nostril as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-17 00:00:00, ended at 2020-01-17 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Asteatosis cutis\n- Primary diagnosis: Disorder of skin and/or subcutaneous tissue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-22 00:00:00, ended at 2020-01-22 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis\n\n### Drug\n- azelastine hydrochloride 0.206 MG/ACTUAT Metered Dose Nasal Spray, started on 2020-01-23, presumably until 2020-01-23, with intended 2 refill(s). Instructions: use in each nostril as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-25 15:31:41, ended at 2020-01-25 16:25:04\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute pansinusitis\n- Benign neoplasm of adrenal gland\n- Allergic rhinitis\n\n### Drug\n- doxycycline hyclate 100 MG Oral Capsule, through Oral route, started on 2020-01-25, presumably until 2020-02-01, with intended 0 refill(s). Instructions: take 1 Cap (100 mg total) by mouth 2 times a day for 7 days\n- azelastine hydrochloride 0.206 MG/ACTUAT Metered Dose Nasal Spray, started on 2020-01-25, presumably until 2021-07-29, with intended 3 refill(s). Instructions: use in each nostril as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-02-29 10:04:04, ended at 2020-02-29 10:27:09\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of adrenal gland\n\n### Drug\n- dexamethasone 1 MG Oral Tablet, started on 2020-02-29, presumably until 2020-10-01, with intended 1 refill(s). Instructions: 1 tab at 11 pm\n- carvedilol 25 MG Oral Tablet, through Oral route, started on 2020-02-09, presumably until 2020-02-09, with intended 0 refill(s). Instructions: Take 1 tablet (25 mg total) by mouth Takes 1 1/2 tab daily\n- 120 ACTUAT budesonide 0.08 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler, started on 2020-02-22, presumably until 2021-02-19, with intended 0 refill(s)\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, started on 2020-02-21, presumably until 2020-10-01, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-01 00:00:00, ended at 2020-03-01 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of adrenal gland\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-07 00:00:00, ended at 2020-03-07 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- benzonatate 100 MG Oral Capsule, through Oral route, started on 2020-03-07, presumably until 2021-02-19, with intended 0 refill(s). Instructions: take 1 Cap (100 mg total) by mouth 3 times a day as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-07 00:00:00, ended at 2020-03-07 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cough\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-30 00:00:00, ended at 2020-04-30 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine 0.05 MG/MG Medicated Patch, started on 2020-04-30, presumably until 2020-06-03, with intended 1 refill(s). Instructions: Apply one patch daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-30 00:00:00, ended at 2020-04-30 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine 0.05 MG/MG Medicated Patch, started on 2020-04-30, presumably until 2020-04-30, with intended 1 refill(s). Instructions: Apply one patch daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-03 00:00:00, ended at 2020-06-03 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine 0.05 MG/MG Medicated Patch, started on 2020-06-03, presumably until 2021-02-05, with intended 6 refill(s). Instructions: Apply one patch daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-14 00:00:00, ended at 2020-06-14 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cardiomyopathy\n\n### Drug\n- bumetanide 0.5 MG Oral Tablet, started on 2020-06-14, presumably until 2022-01-04, with intended 3 refill(s). Instructions: TAKE ONE TABLET BY MOUTH DAILY AS NEEDED for swelling (please allow 48 hours for refills)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-07-31 00:00:00, ended at 2020-07-31 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Mild intermittent asthma\n\n### Drug\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, started on 2020-08-01, presumably until 2021-01-09, with intended 11 refill(s). Instructions: INHALE 2 PUFFS BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-07-31 00:00:00, ended at 2020-07-31 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Generalized anxiety disorder\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2020-08-01, presumably until 2021-06-21, with intended 1 refill(s). Instructions: take 1-2 Tabs (0.5-1 mg total) by mouth every 4 hours as needed\n- valacyclovir 500 MG Oral Tablet, started on 2020-08-01, presumably until 2021-01-09, with intended 1 refill(s). Instructions: 1To 2 TIMES A DAY FOR 1 MONTH DURING BREAKOUT\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-09-17 09:25:05, ended at 2020-09-17 09:54:27\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 45.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.78 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Cortisol Free [Mass/time] in 24 hour Urine: 15 (microgram per 24 hours)\n- Cortisol Free [Mass/volume] in Urine: 5 (microgram per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Metanephrine Free [Mass/volume] in Serum or Plasma: 15.4 (picogram per milliliter)\n- Body height: 5' 1\" (inch (US))\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Normetanephrine [Mass/volume] in Serum or Plasma: 101.4 (picogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of adrenal gland\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-09-27 00:00:00, ended at 2020-09-27 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sleep apnea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-10-01 10:21:33, ended at 2020-10-01 10:47:25\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of adrenal gland\n- Steatosis of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-12-16 00:00:00, ended at 2020-12-16 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chalazion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-09 00:00:00, ended at 2021-01-09 00:00:00\nThe patient in this visit was 45 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Mild intermittent asthma\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, started on 2021-01-09, presumably until 2021-06-21, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH 2 TIMES A DAY FOR ONE MONTH DURING BREAKOUT\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, started on 2021-01-09, presumably until 2021-06-21, with intended 10 refill(s). Instructions: INHALE 2 PUFFS BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-02-07 00:00:00, ended at 2021-02-07 00:00:00\nThe patient in this visit was 45 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sciatica\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive their first ever diagnosis of Essential hypertension within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-02-25 00:00:00, ended at 2012-02-25 00:00:00\nThe patient in this visit was 36 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- carvedilol 25 MG Oral Tablet, through Oral route, started on 2012-02-25, presumably until 2019-05-10, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-02-26 00:00:00, ended at 2012-02-26 00:00:00\nThe patient in this visit was 36 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR bupropion hydrochloride 300 MG Extended Release Oral Tablet, started on 2012-02-26, presumably until 2013-02-07, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-01-16 00:00:00, ended at 2013-01-16 00:00:00\nThe patient in this visit was 37 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 113 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 137 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (international unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 50 (international unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 197 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.5 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 274 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.73 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.5 (thousand per microliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.2 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 82 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L: 0.779 (micro-international unit per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 27 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.3 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.5 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 87 (international unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 57 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 31 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.38 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n\n### Procedure\n- General examination of patient\n\n### Condition\n- Primary cardiomyopathy\n- Primary diagnosis: Non-toxic multinodular goiter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-02-07 14:01:58, ended at 2013-02-07 14:47:43\nThe patient in this visit was 37 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diag\n- General examination of patient\n\n### Condition\n- Attention deficit hyperactivity disorder, predominantly inattentive type\n- Non-toxic multinodular goiter\n- Chronic nonalcoholic liver disease\n- Sleep apnea\n- Bipolar disorder\n- Primary cardiomyopathy\n\n### Drug\n- lurasidone hydrochloride 40 MG Oral Tablet, through Oral route, presumably until 2014-06-21. Instructions: take  by mouth. Split in 1/4 daily\n- lurasidone hydrochloride 20 MG Oral Tablet, through Oral route, presumably until 2014-06-21. Instructions: take  by mouth. Split in 1/4 daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-06-21 16:51:40, ended at 2014-06-21 17:20:47\nThe patient in this visit was 38 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic nonalcoholic liver disease\n- Primary diagnosis: Non-toxic multinodular goiter\n- Bipolar disorder\n- Primary cardiomyopathy\n\n### Drug\n- thyroid (USP) 60 MG Oral Tablet, through Oral route, started on 2014-06-21, presumably until 2015-08-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth Every Day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-10-04 00:00:00, ended at 2014-10-04 00:00:00\nThe patient in this visit was 38 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2014-10-04, presumably until 2015-10-25, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 to 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-04-17 14:39:32, ended at 2015-04-17 15:09:27\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 287 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 96 (international unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.2 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 83 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.9 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.6 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (international unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.3 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.5 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67 (percent)\n- Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L: 0.679 (micro-international unit per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.8 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.72 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.4 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 77 (milligram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 27.9 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Body height: 5' 1\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.38 (million per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Non-toxic multinodular goiter\n- Chronic nonalcoholic liver disease\n- Primary cardiomyopathy\n- Primary diagnosis: Dysfunction of eustachian tube\n\n### Drug\n- ethacrynic acid 25 MG Oral Tablet, through Oral route, presumably until 2015-10-25, with intended 0 refill(s). Instructions: take 2 Tabs by mouth Every Day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-04-19 00:00:00, ended at 2015-04-19 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Allergic rhinitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-05-01 00:00:00, ended at 2015-05-01 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2015-05-01, presumably until 2016-05-01, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-05-01 13:57:32, ended at 2015-05-01 14:38:58\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- General examination of patient\n\n### Condition\n- Non-toxic multinodular goiter\n- Bipolar disorder\n- Sleep apnea\n- Primary cardiomyopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-05 00:00:00, ended at 2015-08-05 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Non-toxic multinodular goiter\n\n### Drug\n- thyroid (USP) 60 MG Oral Tablet, through Oral route, started on 2015-08-05, presumably until 2015-09-02, with intended 3 refill(s). Instructions: take 1 Tab by mouth Every Day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-30 00:00:00, ended at 2015-08-30 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Non-toxic multinodular goiter\n\n### Drug\n- thyroid (USP) 60 MG Oral Tablet, through Oral route, started on 2015-09-02, presumably until 2016-05-01, with intended 6 refill(s). Instructions: take 1 Tab by mouth Every Day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-10-25 00:00:00, ended at 2015-10-25 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- NDA019430 0.3 ML epinephrine 1 MG/ML Auto-Injector, started on 2015-10-25, presumably until 2017-04-09, with intended 6 refill(s). Instructions: Use as directed\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2015-10-25, presumably until 2017-04-09, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 to 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-25 10:07:18, ended at 2015-10-25 11:09:46\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Attention deficit hyperactivity disorder\n- Posttraumatic stress disorder\n\n### Drug\n- triamcinolone acetonide 0.055 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, presumably until 2019-05-10, with intended 0 refill(s). Instructions: 55 mcg by Nasal route daily\n- bumetanide 0.5 MG Oral Tablet, started on 2015-10-25, presumably until 2017-07-20, with intended 3 refill(s). Instructions: Take 1 po daily prn swelling\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: Take 1 tablet (81 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-27 13:41:10, ended at 2016-02-27 14:07:45\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Shoulder joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-03-18 00:00:00, ended at 2016-03-18 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Shoulder joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-03-24 09:59:32, ended at 2016-03-24 11:15:21\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Shoulder joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-04-14 09:42:59, ended at 2016-04-14 10:14:56\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Shoulder joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-05-01 00:00:00, ended at 2016-05-01 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thyroid (USP) 60 MG Oral Tablet, through Oral route, started on 2016-05-01, presumably until 2016-12-16, with intended 6 refill(s). Instructions: take 1 Tab by mouth Every Day\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2016-05-01, presumably until 2016-05-08, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-05-07 00:00:00, ended at 2016-05-07 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Biceps tendinitis\n- Shoulder joint pain\n- Nontraumatic rotator cuff tear\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-05-13 09:29:30, ended at 2016-05-13 10:06:48\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cardiomyopathy\n- Primary diagnosis: Acute bronchitis\n- Non-toxic multinodular goiter\n- Sleep apnea\n\n### Drug\n- 14 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler, through Inhalation, started on 2016-05-13, presumably until 2017-05-13, with intended 3 refill(s). Instructions: 1 Puff by Inhalation route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-07-10 00:00:00, ended at 2016-07-10 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anesthesia of skin\n- Primary diagnosis: Low back pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-11-13 10:27:49, ended at 2016-11-13 11:24:59\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Non-toxic multinodular goiter\n- Primary diagnosis: Cardiomyopathy\n- Attention deficit hyperactivity disorder\n- Mixed bipolar I disorder in full remission\n- Mild intermittent asthma\n\n### Drug\n- lidocaine 0.05 MG/MG Medicated Patch, through Transdermal route, started on 2016-11-13, presumably until 2017-11-13, with intended 3 refill(s). Instructions: apply 1 Patch to skin daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-12-16 00:00:00, ended at 2016-12-16 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thyroid (USP) 60 MG Oral Tablet, through Oral route, started on 2016-12-16, presumably until 2018-04-21, with intended 11 refill(s). Instructions: take 1 Tab by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-04-09 00:00:00, ended at 2017-04-09 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2017-04-09, presumably until 2018-07-26, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 to 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-04-09 00:00:00, ended at 2017-04-09 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- NDA019430 0.3 ML epinephrine 1 MG/ML Auto-Injector, started on 2017-04-09, presumably until 2017-12-07, with intended 6 refill(s). Instructions: Use as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-04-30 10:51:26, ended at 2017-04-30 11:28:27\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diag\n\n### Condition\n- Attention deficit hyperactivity disorder\n- Non-toxic multinodular goiter\n- Sleep apnea\n- Impaired glucose tolerance\n- Mixed bipolar I disorder in full remission\n- Primary diagnosis: Cardiomyopathy\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-07-02 00:00:00, ended at 2017-07-02 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Non-toxic uninodular goiter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-20 00:00:00, ended at 2017-07-20 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bumetanide 0.5 MG Oral Tablet, started on 2017-07-21, presumably until 2019-04-07, with intended 3 refill(s). Instructions: Take one tablet by mouth daily as needed for swelling.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-27 00:00:00, ended at 2017-07-27 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2017-07-28, presumably until 2017-08-04, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-09-22 00:00:00, ended at 2017-09-22 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- No conditions.\n\n### Drug\n- 1 ML hepatitis A vaccine (inactivated) strain HM175 720 UNT/ML / hepatitis B surface antigen vaccine 0.02 MG/ML Prefilled Syringe, through Intramuscular route, started on 2017-09-23, presumably until 2017-09-24, with intended 0 refill(s). Instructions: inject 1 mL into a muscle One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-09-24 00:00:00, ended at 2017-09-24 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure)\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-10-08 13:54:03, ended at 2017-10-08 13:54:21\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-10-26 00:00:00, ended at 2017-10-26 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.5 ML typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML Prefilled Syringe, started on 2017-10-26, presumably until 2018-04-21, with intended 0 refill(s). Instructions: Injection 0.5 mL into the muscle One Time\n- 0.5 ML Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated 0.012 MG/ML Prefilled Syringe, through Intramuscular route, started on 2017-10-26, presumably until 2017-10-27, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle as directed\n- atovaquone 250 MG / proguanil hydrochloride 100 MG Oral Tablet, started on 2017-10-26, presumably until 2018-04-21, with intended 0 refill(s). Instructions: Take 1 tab po starting 1-2 days before trip,continue till one week after returning from trip\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-11-04 00:00:00, ended at 2017-11-04 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2017-11-04, presumably until 2018-04-21, with intended 1 refill(s). Instructions: take 1-2 Tabs by mouth every 4 to 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-12-07 00:00:00, ended at 2017-12-07 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- NDA019430 0.3 ML epinephrine 1 MG/ML Auto-Injector, started on 2017-12-08, presumably until 2019-06-06, with intended 6 refill(s). Instructions: Use as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-12-13 00:00:00, ended at 2017-12-13 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sleep apnea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-04-21 14:13:18, ended at 2018-04-21 14:51:16\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Sleep apnea\n- Cardiomyopathy\n- Primary diagnosis: Acute maxillary sinusitis\n- Bipolar disorder in remission\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2018-04-21, presumably until 2019-06-06, with intended 1 refill(s). Instructions: take 1-2 Tabs by mouth every 4 to 6 hours as needed\n- ergocalciferol 1.25 MG Oral Capsule, through Oral route, started on 2018-04-21, presumably until 2020-01-25, with intended 3 refill(s). Instructions: take 1 Cap by mouth every 7 days\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2018-04-21, presumably until 2018-05-01, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n- valacyclovir 500 MG Oral Tablet, through Oral route, presumably until 2018-08-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day For 1 month during breakout\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-07-26 00:00:00, ended at 2018-07-26 00:00:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mild intermittent asthma\n\n### Drug\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2018-07-27, presumably until 2019-10-12, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 to 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-08-22 00:00:00, ended at 2018-08-22 00:00:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2018-08-22, presumably until 2019-03-25, with intended 2 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 30 days For 1 month during breakout\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-18 00:00:00, ended at 2018-10-18 00:00:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- azelastine hydrochloride 0.206 MG/ACTUAT Metered Dose Nasal Spray, started on 2018-10-18, presumably until 2019-07-25, with intended 3 refill(s). Instructions: USE IN EACH NOSTRIL AS DIRECTED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-03-14 00:00:00, ended at 2019-03-14 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Kidney stone\n- Sleep apnea\n- Steatosis of liver\n- Uncomplicated asthma\n- Primary diagnosis: Urticaria due to cold and heat\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-03-25 00:00:00, ended at 2019-03-25 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ophthalmic herpes simplex\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, started on 2019-03-28, presumably until 2019-04-27, with intended 2 refill(s). Instructions: TAKE 1 TABLET BY MOUTH 2 TIMES A DAY FOR 1 MONTH DURING BREAKOUT\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-07 00:00:00, ended at 2019-04-07 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cardiomyopathy\n\n### Drug\n- bumetanide 0.5 MG Oral Tablet, started on 2019-04-07, presumably until 2020-06-14, with intended 3 refill(s). Instructions: Take one tablet by mouth daily as needed for swelling.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-10 10:43:15, ended at 2019-05-10 14:22:35\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diag\n\n### Condition\n- Sleep apnea\n- Cardiomyopathy\n\n### Drug\n- soybean preparation, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- vitamin E, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- soy protein isolate, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- cannabidiol 100 MG/ML Oral Solution, through Topical route, with intended 0 refill(s). Instructions: by Topical route Compounded cream for inflammation\n- soybean allergenic extract, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- folic acid, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- aspirin 81 MG / calcium carbonate 777 MG Oral Tablet, through Oral route, presumably until 2019-05-10, with intended 0 refill(s). Instructions: take 81 mg by mouth daily\n- triamcinolone acetonide 0.055 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, presumably until 2022-02-12, with intended 0 refill(s). Instructions: 2 Sprays by Nasal route every day\n- wheat germ oil, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- alpha tocopherol, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- valacyclovir 500 MG Oral Tablet, through Oral route, presumably until 2020-01-03, with intended 0 refill(s). Instructions: take 500 mg by mouth 2 times a day as needed\n- vitamin B complex, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-06-06 00:00:00, ended at 2019-06-06 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Generalized anxiety disorder\n- Mild intermittent asthma\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, started on 2019-06-07, presumably until 2020-07-31, with intended 1 refill(s). Instructions: TAKE 1 TO 2 TABLETS BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED\n- NDA201739 0.3 ML epinephrine 1 MG/ML Auto-Injector, started on 2019-06-07, presumably until 2021-06-21, with intended 6 refill(s). Instructions: USE AS DIRECTED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-07-25 00:00:00, ended at 2019-07-25 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Allergic rhinitis\n\n### Drug\n- azelastine hydrochloride 0.206 MG/ACTUAT Metered Dose Nasal Spray, started on 2019-07-26, presumably until 2020-01-08, with intended 2 refill(s). Instructions: use in each nostril as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-10-12 00:00:00, ended at 2019-10-12 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Mild intermittent asthma\n\n### Drug\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, started on 2019-10-12, presumably until 2020-07-31, with intended 11 refill(s). Instructions: INHALE 2 PUFFS BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-02 00:00:00, ended at 2020-01-02 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, started on 2020-01-03, presumably until 2020-07-31, with intended 1 refill(s). Instructions: 1T 2 TIMES A DAY FOR 1 MONTH DURING BREAKOUT\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-07 00:00:00, ended at 2020-01-07 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis\n\n### Drug\n- azelastine hydrochloride 0.206 MG/ACTUAT Metered Dose Nasal Spray, started on 2020-01-08, presumably until 2020-01-25, with intended 3 refill(s). Instructions: use in each nostril as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-17 00:00:00, ended at 2020-01-17 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Asteatosis cutis\n- Primary diagnosis: Disorder of skin and/or subcutaneous tissue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-22 00:00:00, ended at 2020-01-22 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis\n\n### Drug\n- azelastine hydrochloride 0.206 MG/ACTUAT Metered Dose Nasal Spray, started on 2020-01-23, presumably until 2020-01-23, with intended 2 refill(s). Instructions: use in each nostril as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-25 15:31:41, ended at 2020-01-25 16:25:04\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute pansinusitis\n- Benign neoplasm of adrenal gland\n- Allergic rhinitis\n\n### Drug\n- doxycycline hyclate 100 MG Oral Capsule, through Oral route, started on 2020-01-25, presumably until 2020-02-01, with intended 0 refill(s). Instructions: take 1 Cap (100 mg total) by mouth 2 times a day for 7 days\n- azelastine hydrochloride 0.206 MG/ACTUAT Metered Dose Nasal Spray, started on 2020-01-25, presumably until 2021-07-29, with intended 3 refill(s). Instructions: use in each nostril as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-02-29 10:04:04, ended at 2020-02-29 10:27:09\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of adrenal gland\n\n### Drug\n- dexamethasone 1 MG Oral Tablet, started on 2020-02-29, presumably until 2020-10-01, with intended 1 refill(s). Instructions: 1 tab at 11 pm\n- carvedilol 25 MG Oral Tablet, through Oral route, started on 2020-02-09, presumably until 2020-02-09, with intended 0 refill(s). Instructions: Take 1 tablet (25 mg total) by mouth Takes 1 1/2 tab daily\n- 120 ACTUAT budesonide 0.08 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler, started on 2020-02-22, presumably until 2021-02-19, with intended 0 refill(s)\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, started on 2020-02-21, presumably until 2020-10-01, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-01 00:00:00, ended at 2020-03-01 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of adrenal gland\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-07 00:00:00, ended at 2020-03-07 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- benzonatate 100 MG Oral Capsule, through Oral route, started on 2020-03-07, presumably until 2021-02-19, with intended 0 refill(s). Instructions: take 1 Cap (100 mg total) by mouth 3 times a day as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-07 00:00:00, ended at 2020-03-07 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cough\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-30 00:00:00, ended at 2020-04-30 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine 0.05 MG/MG Medicated Patch, started on 2020-04-30, presumably until 2020-06-03, with intended 1 refill(s). Instructions: Apply one patch daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-30 00:00:00, ended at 2020-04-30 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine 0.05 MG/MG Medicated Patch, started on 2020-04-30, presumably until 2020-04-30, with intended 1 refill(s). Instructions: Apply one patch daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-03 00:00:00, ended at 2020-06-03 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine 0.05 MG/MG Medicated Patch, started on 2020-06-03, presumably until 2021-02-05, with intended 6 refill(s). Instructions: Apply one patch daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-14 00:00:00, ended at 2020-06-14 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cardiomyopathy\n\n### Drug\n- bumetanide 0.5 MG Oral Tablet, started on 2020-06-14, presumably until 2022-01-04, with intended 3 refill(s). Instructions: TAKE ONE TABLET BY MOUTH DAILY AS NEEDED for swelling (please allow 48 hours for refills)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-07-31 00:00:00, ended at 2020-07-31 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Mild intermittent asthma\n\n### Drug\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, started on 2020-08-01, presumably until 2021-01-09, with intended 11 refill(s). Instructions: INHALE 2 PUFFS BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-07-31 00:00:00, ended at 2020-07-31 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Generalized anxiety disorder\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2020-08-01, presumably until 2021-06-21, with intended 1 refill(s). Instructions: take 1-2 Tabs (0.5-1 mg total) by mouth every 4 hours as needed\n- valacyclovir 500 MG Oral Tablet, started on 2020-08-01, presumably until 2021-01-09, with intended 1 refill(s). Instructions: 1To 2 TIMES A DAY FOR 1 MONTH DURING BREAKOUT\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-09-17 09:25:05, ended at 2020-09-17 09:54:27\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 45.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.78 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Cortisol Free [Mass/time] in 24 hour Urine: 15 (microgram per 24 hours)\n- Cortisol Free [Mass/volume] in Urine: 5 (microgram per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Metanephrine Free [Mass/volume] in Serum or Plasma: 15.4 (picogram per milliliter)\n- Body height: 5' 1\" (inch (US))\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Normetanephrine [Mass/volume] in Serum or Plasma: 101.4 (picogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of adrenal gland\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-09-27 00:00:00, ended at 2020-09-27 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sleep apnea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-10-01 10:21:33, ended at 2020-10-01 10:47:25\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of adrenal gland\n- Steatosis of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-12-16 00:00:00, ended at 2020-12-16 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chalazion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-09 00:00:00, ended at 2021-01-09 00:00:00\nThe patient in this visit was 45 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Mild intermittent asthma\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, started on 2021-01-09, presumably until 2021-06-21, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH 2 TIMES A DAY FOR ONE MONTH DURING BREAKOUT\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, started on 2021-01-09, presumably until 2021-06-21, with intended 10 refill(s). Instructions: INHALE 2 PUFFS BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-02-07 00:00:00, ended at 2021-02-07 00:00:00\nThe patient in this visit was 45 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sciatica\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive their first ever diagnosis of Essential hypertension within the next year (we could not find any prior history of this condition in their medical records before)\n- the condition of hypertension means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "5a54a251c8fab7ff4520c8d2bb85622cc73b5c225566671138e0a6db41926e31", "prompt_hash": "e79ee51990897afb05d30b097a98ab91e0dbd27d5195374179e9f542ab9823f8", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 5, "doc": {"person_id": 115968044, "visit_occurrence_id": 40081595, "death_date": null, "visit_concept_name": "Outpatient Visit", "visit_start_datetime": "2010-07-05 08:11:00", "visit_end_datetime": "2010-07-05 23:59:00", "visit_length_in_hours": 15.8, "integrated_visit_record": "## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-05 08:11:00, ended at 2010-07-05 23:59:00\nThe patient in this visit was 26 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bone and/or joint imaging; whole body\n\n### Condition\n- Disorder of bone and articular cartilage\n- Joint pain\n- Primary malignant neoplasm of long bone of lower limb\n- Amputated above knee\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 114, "patient_first_visit_date": "2008-10-07 00:00:00", "patient_last_visit_date": "2011-07-05 08:37:00", "end_obs_date": "2011-07-05", "hypertension_type": "new", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 9, "cumulated_visit_num": 9, "cumulated_approximate_token_count": 4322, "visit_cumulated": "## Visit\nThis visit record, was from Case Management Visit, started at 2008-10-07 00:00:00, ended at 2008-10-07 00:00:00\nThe patient in this visit was 24 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.3 (percent)\n- MCV [Entitic volume] by Automated count: 87.5 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.75 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.74 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- MCH [Entitic mass] by Automated count: 29.6 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 287 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.95 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.1 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.84 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.7 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2008-10-08 05:20:00, ended at 2008-10-11 12:30:00\nThe patient in this visit was 24 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.0 (thousand per microliter)\n- Prothrombin time (PT): 22.9 (second)\n- MCHC [Mass/volume] by Automated count: 35.1 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.1 (ratio)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.01 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 2.17 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.8 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.51 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 88.2 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 17.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 39.7 (second)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 195 (thousand per microliter)\n- Body height: 6' 1\" (inch (US))\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 9.07 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of long bone of lower limb\n- Acute posthemorrhagic anemia\n- Pulmonary embolism with pulmonary infarction\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2008-10-08, presumably until 2008-10-08\n- 1 ML meperidine hydrochloride 25 MG/ML Cartridge, started on 2008-10-08, presumably until 2008-10-08\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2008-10-08, presumably until 2008-10-08\n- lorazepam 1 MG Oral Tablet, through Oral route. Instructions: take 1 mg by mouth as needed \n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2008-10-08, presumably until 2008-11-10, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day. \n- 0.8 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2008-10-09, presumably until 2008-10-11\n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2008-10-08, presumably until 2008-10-09\n- 2 ML ondansetron 2 MG/ML Injection, started on 2008-10-08, presumably until 2008-10-10\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, started on 2008-10-08, presumably until 2008-10-09\n- 12 HR oxycodone hydrochloride 10 MG Extended Release Oral Tablet, through Oral route, started on 2008-10-08, presumably until 2008-12-30, with quantity of 20.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours. \n- 2 ML metoclopramide 5 MG/ML Injection, started on 2008-10-09, presumably until 2008-10-09\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2008-10-08, presumably until 2008-10-08\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2008-10-08, presumably until 2008-10-11\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2008-10-10, presumably until 2008-12-30, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed \n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2008-10-08, presumably until 2008-10-08\n- warfarin sodium 5 MG Oral Tablet, through Oral route, started on 2008-10-09, presumably until 2008-11-10, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- warfarin sodium 6 MG Oral Tablet, through Oral route, started on 2008-10-10, presumably until 2008-10-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2008-11-10 07:03:00, ended at 2008-11-10 12:17:00\nThe patient in this visit was 24 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of long bone of lower limb\n\n### Drug\n- hydromorphone hydrochloride 4 MG Oral Tablet, through Oral route, presumably until 2008-12-30. Instructions: take by mouth as needed \n- 1 ML hydromorphone hydrochloride 4 MG/ML Injection, presumably until 2008-12-30. Instructions: by Injection route as needed \n- 0.8 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route. Instructions: by SUBCUTANEOUS route 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-12-30 00:00:00, ended at 2008-12-30 00:00:00\nThe patient in this visit was 25 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.46 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.09 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.49 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.1 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 90.6 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 279 (thousand per microliter)\n- Prothrombin time (PT): 13.1 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.4 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 58 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.3 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 24.7 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2009-01-05 05:59:00, ended at 2009-01-08 12:05:00\nThe patient in this visit was 25 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 20.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.3 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 2.6 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 38 (percent)\n- Platelets [#/volume] in Blood by Automated count: 212 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 31 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.97 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.54 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 48.9 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 2.61 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.8 (thousand per microliter)\n- Body height: 6' 1\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.56 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 93.2 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 25 (percent)\n- Neutrophils [#/volume] in Blood by Manual count: 2.8 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 43.3 (percent)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 28.1 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of long bone of lower limb\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2009-01-05, presumably until 2009-01-06\n- mirtazapine 15 MG Oral Tablet, through Oral route, started on 2009-01-06, presumably until 2009-01-07. Instructions: take 7.5 mg by mouth daily. \n- 12 HR oxycodone hydrochloride 20 MG Extended Release Oral Tablet, through Oral route, started on 2009-01-05, presumably until 2009-07-07, with quantity of 42.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours. \n- cefazolin 1000 MG Injection, through Intravenous route, started on 2009-01-05, presumably until 2009-01-06\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2009-01-05, presumably until 2009-01-07. Instructions: take 1 mg by mouth as needed \n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2009-01-05, presumably until 2009-01-06\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2009-01-05, presumably until 2009-01-08\n- dronabinol 5 MG Oral Capsule, through Oral route, started on 2009-01-05, presumably until 2009-01-07. Instructions: take by mouth 3 times a day as needed\n- 0.8 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2009-01-06, presumably until 2009-01-08. Instructions: by SUBCUTANEOUS route 2 times a day.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2009-01-06, presumably until 2009-01-06\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2009-01-05, presumably until 2009-01-06\n- morphine sulfate 1 MG/ML Injection, through Intravenous route, started on 2009-01-05, presumably until 2009-01-06\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2009-01-08, presumably until 2009-07-07, with quantity of 50.0, with intended 1 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-29 13:08:00, ended at 2009-09-29 23:59:00\nThe patient in this visit was 25 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bone and/or joint imaging; whole body\n\n### Condition\n- Primary malignant neoplasm\n- Malignant neoplasm of skeletal system\n- Primary malignant neoplasm of soft tissues of lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-12 09:35:00, ended at 2010-01-12 23:59:00\nThe patient in this visit was 26 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bone and/or joint imaging; whole body\n\n### Condition\n- Abnormal finding on evaluation procedure\n- Malignant neoplasm of skeletal system\n- Primary malignant neoplasm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-07 09:08:00, ended at 2010-04-07 23:59:00\nThe patient in this visit was 26 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bone and/or joint imaging; whole body\n\n### Condition\n- Malignant neoplasm of skeletal system\n- Traumatic amputation of lower extremity\n- Primary malignant neoplasm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-05 08:11:00, ended at 2010-07-05 23:59:00\nThe patient in this visit was 26 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bone and/or joint imaging; whole body\n\n### Condition\n- Disorder of bone and articular cartilage\n- Joint pain\n- Primary malignant neoplasm of long bone of lower limb\n- Amputated above knee\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive their first ever diagnosis of Essential hypertension within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-10-07 00:00:00, ended at 2008-10-07 00:00:00\nThe patient in this visit was 24 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.3 (percent)\n- MCV [Entitic volume] by Automated count: 87.5 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.75 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.74 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- MCH [Entitic mass] by Automated count: 29.6 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 287 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.95 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.1 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.84 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.7 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2008-10-08 05:20:00, ended at 2008-10-11 12:30:00\nThe patient in this visit was 24 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.0 (thousand per microliter)\n- Prothrombin time (PT): 22.9 (second)\n- MCHC [Mass/volume] by Automated count: 35.1 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.1 (ratio)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.01 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 2.17 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.8 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.51 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 88.2 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 17.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 39.7 (second)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 195 (thousand per microliter)\n- Body height: 6' 1\" (inch (US))\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 9.07 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of long bone of lower limb\n- Acute posthemorrhagic anemia\n- Pulmonary embolism with pulmonary infarction\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2008-10-08, presumably until 2008-10-08\n- 1 ML meperidine hydrochloride 25 MG/ML Cartridge, started on 2008-10-08, presumably until 2008-10-08\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2008-10-08, presumably until 2008-10-08\n- lorazepam 1 MG Oral Tablet, through Oral route. Instructions: take 1 mg by mouth as needed \n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2008-10-08, presumably until 2008-11-10, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day. \n- 0.8 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2008-10-09, presumably until 2008-10-11\n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2008-10-08, presumably until 2008-10-09\n- 2 ML ondansetron 2 MG/ML Injection, started on 2008-10-08, presumably until 2008-10-10\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, started on 2008-10-08, presumably until 2008-10-09\n- 12 HR oxycodone hydrochloride 10 MG Extended Release Oral Tablet, through Oral route, started on 2008-10-08, presumably until 2008-12-30, with quantity of 20.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours. \n- 2 ML metoclopramide 5 MG/ML Injection, started on 2008-10-09, presumably until 2008-10-09\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2008-10-08, presumably until 2008-10-08\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2008-10-08, presumably until 2008-10-11\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2008-10-10, presumably until 2008-12-30, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed \n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2008-10-08, presumably until 2008-10-08\n- warfarin sodium 5 MG Oral Tablet, through Oral route, started on 2008-10-09, presumably until 2008-11-10, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- warfarin sodium 6 MG Oral Tablet, through Oral route, started on 2008-10-10, presumably until 2008-10-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2008-11-10 07:03:00, ended at 2008-11-10 12:17:00\nThe patient in this visit was 24 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of long bone of lower limb\n\n### Drug\n- hydromorphone hydrochloride 4 MG Oral Tablet, through Oral route, presumably until 2008-12-30. Instructions: take by mouth as needed \n- 1 ML hydromorphone hydrochloride 4 MG/ML Injection, presumably until 2008-12-30. Instructions: by Injection route as needed \n- 0.8 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route. Instructions: by SUBCUTANEOUS route 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-12-30 00:00:00, ended at 2008-12-30 00:00:00\nThe patient in this visit was 25 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.46 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.09 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.49 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.1 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 90.6 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 279 (thousand per microliter)\n- Prothrombin time (PT): 13.1 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.4 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 58 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.3 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 24.7 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2009-01-05 05:59:00, ended at 2009-01-08 12:05:00\nThe patient in this visit was 25 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 20.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.3 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 2.6 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 38 (percent)\n- Platelets [#/volume] in Blood by Automated count: 212 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 31 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.97 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.54 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 48.9 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 2.61 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.8 (thousand per microliter)\n- Body height: 6' 1\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.56 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 93.2 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 25 (percent)\n- Neutrophils [#/volume] in Blood by Manual count: 2.8 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 43.3 (percent)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 28.1 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of long bone of lower limb\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2009-01-05, presumably until 2009-01-06\n- mirtazapine 15 MG Oral Tablet, through Oral route, started on 2009-01-06, presumably until 2009-01-07. Instructions: take 7.5 mg by mouth daily. \n- 12 HR oxycodone hydrochloride 20 MG Extended Release Oral Tablet, through Oral route, started on 2009-01-05, presumably until 2009-07-07, with quantity of 42.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours. \n- cefazolin 1000 MG Injection, through Intravenous route, started on 2009-01-05, presumably until 2009-01-06\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2009-01-05, presumably until 2009-01-07. Instructions: take 1 mg by mouth as needed \n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2009-01-05, presumably until 2009-01-06\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2009-01-05, presumably until 2009-01-08\n- dronabinol 5 MG Oral Capsule, through Oral route, started on 2009-01-05, presumably until 2009-01-07. Instructions: take by mouth 3 times a day as needed\n- 0.8 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2009-01-06, presumably until 2009-01-08. Instructions: by SUBCUTANEOUS route 2 times a day.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2009-01-06, presumably until 2009-01-06\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2009-01-05, presumably until 2009-01-06\n- morphine sulfate 1 MG/ML Injection, through Intravenous route, started on 2009-01-05, presumably until 2009-01-06\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2009-01-08, presumably until 2009-07-07, with quantity of 50.0, with intended 1 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-29 13:08:00, ended at 2009-09-29 23:59:00\nThe patient in this visit was 25 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bone and/or joint imaging; whole body\n\n### Condition\n- Primary malignant neoplasm\n- Malignant neoplasm of skeletal system\n- Primary malignant neoplasm of soft tissues of lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-12 09:35:00, ended at 2010-01-12 23:59:00\nThe patient in this visit was 26 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bone and/or joint imaging; whole body\n\n### Condition\n- Abnormal finding on evaluation procedure\n- Malignant neoplasm of skeletal system\n- Primary malignant neoplasm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-07 09:08:00, ended at 2010-04-07 23:59:00\nThe patient in this visit was 26 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bone and/or joint imaging; whole body\n\n### Condition\n- Malignant neoplasm of skeletal system\n- Traumatic amputation of lower extremity\n- Primary malignant neoplasm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-05 08:11:00, ended at 2010-07-05 23:59:00\nThe patient in this visit was 26 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bone and/or joint imaging; whole body\n\n### Condition\n- Disorder of bone and articular cartilage\n- Joint pain\n- Primary malignant neoplasm of long bone of lower limb\n- Amputated above knee\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive their first ever diagnosis of Essential hypertension within the next year (we could not find any prior history of this condition in their medical records before)\n- the condition of hypertension means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "c254a001ee48bb21c36a773eae51b70e69d01534063de796472cacfa88740c7d", "prompt_hash": "72b36a41666bda775d7db9494e4d42b776bda466066066244595c7ced1b35265", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 6, "doc": {"person_id": 115968263, "visit_occurrence_id": 33366398, "death_date": null, "visit_concept_name": "Case Management Visit", "visit_start_datetime": "2009-07-02 00:00:00", "visit_end_datetime": "2009-07-02 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Case Management Visit, started at 2009-07-02 00:00:00, ended at 2009-07-02 00:00:00\nThe patient in this visit was 50 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Multiple myeloma\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 87, "patient_first_visit_date": "2008-03-14 00:00:00", "patient_last_visit_date": "2022-07-14 00:00:00", "end_obs_date": "2010-07-02", "hypertension_type": "new", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 37, "cumulated_visit_num": 37, "cumulated_approximate_token_count": 19730, "visit_cumulated": "## Visit\nThis visit record, was from Case Management Visit, started at 2008-03-14 00:00:00, ended at 2008-03-14 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.56 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.3 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.0 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- aPTT in Platelet poor plasma by Coagulation assay: 27.6 (second)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 34.1 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 111 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.1 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 98.3 (femtoliter)\n- Prothrombin time (PT): 15.2 (second)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-03-15 00:00:00, ended at 2008-03-15 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.9 (percent)\n- MCH [Entitic mass] by Automated count: 33.9 (picogram)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.02 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.2 (percent)\n- MCV [Entitic volume] by Automated count: 98.9 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.36 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.04 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.1 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 77 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 124 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-03-16 00:00:00, ended at 2008-03-16 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.91 (million per microliter)\n- MCV [Entitic volume] by Automated count: 97.5 (femtoliter)\n- Hemoglobin [Mass/volume] in Blood: 10.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 112 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 166 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 34.9 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 35.8 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2008-03-18 12:23:00, ended at 2008-03-18 23:59:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.1 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 38 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 17.2 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.8 (percent)\n- MCH [Entitic mass] by Automated count: 32.5 (picogram)\n- MCV [Entitic volume] by Automated count: 92.4 (femtoliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.11 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 35.2 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Multiple myeloma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-03-27 00:00:00, ended at 2008-03-27 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.9 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- MCHC [Mass/volume] by Automated count: 35.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 91.6 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.59 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 10.18 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 40 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.38 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.8 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.3 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.2 (picogram)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.31 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.20 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.1 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-04-10 00:00:00, ended at 2008-04-10 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.01 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 53 (percent)\n- MCH [Entitic mass] by Automated count: 33.8 (picogram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 57 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 115 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 11 (percent)\n- Platelets [#/volume] in Blood by Automated count: 380 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Basophils [#/volume] in Blood by Manual count: 0.1 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Manual count: 2.1 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.2 (percent)\n- MCV [Entitic volume] by Automated count: 97.1 (femtoliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.1 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.3 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 18 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.6 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Manual count: 3 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-04-11 00:00:00, ended at 2008-04-11 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.1 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-04-12 00:00:00, ended at 2008-04-12 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 156 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 34.2 (picogram)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.74 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.1 (percent)\n- MCV [Entitic volume] by Automated count: 98.8 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 298 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.1 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2008-04-22 18:45:00, ended at 2008-04-23 02:30:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 20.5 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.66 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 18.48 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 96 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 121 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 101 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 95.6 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.27 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.35 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 1.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 90.1 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Neutropenic disorder\n- Abnormal body temperature\n- Benign prostatic hyperplasia without outflow obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-04-24 00:00:00, ended at 2008-04-24 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 142 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.50 (million per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 28.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.3 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 26 (percent)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.21 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.0 (picogram)\n- Leukocytes [#/volume] in Specimen by Automated count: 31.4 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 94.6 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 7 (percent)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 1 (percent)\n- Monocytes [#/volume] in Blood by Manual count: 2.2 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.1 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-04-25 00:00:00, ended at 2008-04-25 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 35.6 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.30 (million per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- MCV [Entitic volume] by Automated count: 94.4 (femtoliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 125 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 33.0 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-04-26 00:00:00, ended at 2008-04-26 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 10.9 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.5 (picogram)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.25 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 121 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 95.4 (femtoliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 39.6 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.1 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.33 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-05 00:00:00, ended at 2008-05-05 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 5.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 176 (unit per liter)\n- Basophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 52 (percent)\n- Platelets [#/volume] in Blood by Automated count: 274 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.3 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.7 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Manual count: 2.0 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 109 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Manual count: 0.0 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.2 (percent)\n- MCV [Entitic volume] by Automated count: 93.1 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.92 (million per microliter)\n- MCH [Entitic mass] by Automated count: 32.9 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.0 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 24 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-08 00:00:00, ended at 2008-05-08 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.3 (ratio)\n- Monocytes [#/volume] in Blood by Automated count: 0.70 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.2 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 28.4 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.7 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.96 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.7 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 177 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 201 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.2 (percent)\n- MCV [Entitic volume] by Automated count: 94.5 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 22.3 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.35 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 11 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.6 (percent)\n- Prothrombin time (PT): 15.3 (second)\n- Neutrophils [#/volume] in Blood by Automated count: 2.02 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-10 00:00:00, ended at 2008-05-10 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Manual count: 1.9 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.9 (percent)\n- Monocytes [#/volume] in Blood by Manual count: 0.4 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Basophils [#/volume] in Blood by Manual count: 0.0 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.06 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.6 (picogram)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Manual count: 13 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 58 (percent)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 20 (percent)\n- Basophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.54 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.2 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 141 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.6 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-11 00:00:00, ended at 2008-05-11 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.58 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.7 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.8 (percent)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 81 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 35.3 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 133 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.2 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-12 00:00:00, ended at 2008-05-12 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- MCHC [Mass/volume] by Automated count: 35.3 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 54 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.80 (million per microliter)\n- MCV [Entitic volume] by Automated count: 94.1 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 66 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.9 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 114 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.99 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.2 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.67 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 92.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-13 00:00:00, ended at 2008-05-13 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 19.2 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.06 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.3 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 106 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.50 (million per microliter)\n- MCV [Entitic volume] by Automated count: 94.6 (femtoliter)\n- Glucose [Mass/volume] in Serum or Plasma: 134 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.1 (picogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-14 00:00:00, ended at 2008-05-14 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.94 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.6 (percent)\n- MCV [Entitic volume] by Automated count: 97.0 (femtoliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 1.6 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 86 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.47 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 114 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2008-05-15 14:00:00, ended at 2008-05-15 23:59:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 1.28 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.52 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 1.5 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 56 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 102 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.3 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 68 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.8 (percent)\n- MCV [Entitic volume] by Automated count: 94.5 (femtoliter)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.6 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-16 00:00:00, ended at 2008-05-16 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.31 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 35 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.9 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.9 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.7 (percent)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.4 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.8 (femtoliter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 1.1 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2008-05-17 11:30:00, ended at 2008-05-17 23:59:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: Not avail (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 0.4 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.25 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 35.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 51 (unit per liter)\n- Platelets [#/volume] in Blood by Automated count: 22 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.8 (percent)\n- MCV [Entitic volume] by Automated count: 94.6 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.8 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2008-05-18 09:30:00, ended at 2008-05-18 16:06:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.0 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 125 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.7 (picogram)\n- MCHC [Mass/volume] by Automated count: 35.6 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 9 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 0.2 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.1 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.99 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.01 (million per microliter)\n- MCV [Entitic volume] by Automated count: 94.6 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: Not avail (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2008-05-18 16:07:00, ended at 2008-05-27 18:15:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 74 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.0 (percent)\n- MCH [Entitic mass] by Automated count: 33.7 (picogram)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 144 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 39.6 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 78 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Body height: 5' 7\" (inch (US))\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.8 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 94.4 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.38 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 35.8 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 2.31 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.35 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: Not avail (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Imaging of thorax abnormal\n\n### Drug\n- glycerin, through Topical route, started on 2008-05-20, presumably until 2008-05-20\n- hydrocortisone 100 MG Injection, started on 2008-05-24, presumably until 2008-05-24\n- 72 HR fentanyl 0.025 MG/HR Transdermal System, through Transdermal route, started on 2008-05-24, presumably until 2008-05-24\n- 0.5 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2008-05-19, presumably until 2008-05-23\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2008-05-18, presumably until 2008-05-27\n- water, through Topical route, started on 2008-05-20, presumably until 2008-05-20\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2008-05-18, presumably until 2008-05-27\n- codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML Oral Solution, through Oral route, started on 2008-05-22, presumably until 2008-05-22\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2008-05-23, presumably until 2008-05-24\n- dimethicone, through Topical route, started on 2008-05-20, presumably until 2008-05-20\n- acyclovir 400 MG Oral Tablet, through Oral route, started on 2008-05-27, presumably until 2014-05-19, with quantity of 60.0, with intended 5 refill(s). Instructions: take 400 mg by mouth 3 times a day. \n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2008-05-27, presumably until 2008-05-27\n- bisacodyl 5 MG Delayed Release Oral Tablet, through Oral route, started on 2008-05-25, presumably until 2008-05-25\n- voriconazole 200 MG Injection, through Intravenous route, started on 2008-05-23, presumably until 2008-05-27\n- diphenhydramine hydrochloride 2.5 MG/ML Oral Solution, through Oral route, started on 2008-05-19, presumably until 2008-05-20\n- heparin sodium, porcine 100 UNT/ML Injectable Solution, through Intravenous route, started on 2008-05-27, presumably until 2008-05-27\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2008-05-18, presumably until 2008-05-25\n- 1 ML meperidine hydrochloride 25 MG/ML Cartridge, started on 2008-05-24, presumably until 2008-05-24\n- lorazepam 1 MG Oral Tablet, through Oral route. Instructions: take 1 mg by mouth every 4 hours as needed \n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2008-05-18, presumably until 2008-05-24. Instructions: take 500 mg by mouth 2 times a day. \n- clotrimazole 10 MG Oral Lozenge, through Submucosal route, started on 2008-05-18, presumably until 2008-05-25. Instructions: by Mucous Membrane route 4 times a day. \n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2008-05-24, presumably until 2008-05-27\n- voriconazole 200 MG Oral Tablet, through Oral route, started on 2008-05-27, presumably until 2009-05-27, with quantity of 60.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- azithromycin 500 MG Oral Tablet, through Oral route, started on 2008-05-28, presumably until 2009-06-06, with quantity of 10.0, with intended 0 refill(s). Instructions: take 500 mg by mouth daily. \n- soybean oil 100 MG/ML Injectable Suspension, through Intravenous route, started on 2008-05-21, presumably until 2008-05-23\n- cefepime 2000 MG Injection, through Intravenous route, started on 2008-05-18, presumably until 2008-05-20\n- 50 ML immunoglobulin G, human 100 MG/ML Injection, through Intravenous route, started on 2008-05-23, presumably until 2008-05-23\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2008-05-18, presumably until 2008-05-24\n- lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution, through Submucosal route, started on 2008-05-19, presumably until 2008-05-20\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2008-05-21, presumably until 2008-05-21\n- 250 ML heparin sodium, porcine 100 UNT/ML Injection, through Intravenous route, started on 2008-05-18, presumably until 2008-05-23\n- 100 ML potassium chloride 0.2 MEQ/ML Injection, through Intravenous route, started on 2008-05-19, presumably until 2008-05-25\n- 72 HR scopolamine 0.0139 MG/HR Transdermal System, through Transdermal route, started on 2008-05-19, presumably until 2008-05-19\n- 72 HR fentanyl 0.05 MG/HR Transdermal System, through Transdermal route, started on 2008-05-21, presumably until 2008-05-21\n- petrolatum, through Topical route, started on 2008-05-20, presumably until 2008-05-20\n- aluminum hydroxide 40 MG/ML / magnesium hydroxide 40 MG/ML / simethicone 4 MG/ML Oral Suspension, through Oral route, started on 2008-05-19, presumably until 2008-05-23\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2008-05-29 13:30:00, ended at 2008-05-29 23:59:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 191 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.6 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 94.0 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 73 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.88 (million per microliter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.4 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2008-05-31 10:00:00, ended at 2008-05-31 23:59:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.90 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.3 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 222 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 45 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.2 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.8 (percent)\n- MCH [Entitic mass] by Automated count: 32.5 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 110 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 47 (unit per liter)\n- Basophils [#/volume] in Blood by Manual count: 0.0 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 8 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.91 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.4 (percent)\n- MCV [Entitic volume] by Automated count: 93.4 (femtoliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.2 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 39 (percent)\n- Neutrophils [#/volume] in Blood by Manual count: 1.7 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Manual count: 1 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-06-05 00:00:00, ended at 2008-06-05 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.9 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.70 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.98 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.5 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 27.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 205 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.1 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.4 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.38 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.08 (million per microliter)\n- MCV [Entitic volume] by Automated count: 94.5 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.87 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 56.4 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-06-09 00:00:00, ended at 2008-06-09 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 4.01 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.6 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 54 (percent)\n- Eosinophils [#/volume] in Blood by Manual count: 0.1 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 10 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Manual count: 3.1 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 64 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.4 (femtoliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 34.0 (picogram)\n- Monocytes [#/volume] in Blood by Manual count: 1.8 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 137 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 33 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-06-21 00:00:00, ended at 2008-06-21 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.06 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.69 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.8 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.34 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.10 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 81 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 34.0 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.17 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.1 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 98.2 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 170 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.8 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.7 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-07-03 00:00:00, ended at 2008-07-03 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.03 (million per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.6 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.8 (percent)\n- MCH [Entitic mass] by Automated count: 34.7 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 145 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 100.3 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 184 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.16 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.78 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.84 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-07-14 00:00:00, ended at 2008-07-14 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Neutrophils/100 leukocytes in Blood by Automated count: 79.1 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.9 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 35.1 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.8 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.37 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 62 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.9 (percent)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 191 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 102 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 101.5 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.85 (million per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-07-20 00:00:00, ended at 2008-07-20 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.73 (million per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 58 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.86 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.6 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.6 (percent)\n- MCH [Entitic mass] by Automated count: 35.5 (picogram)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 74.2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.89 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 102.0 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 195 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-07-28 00:00:00, ended at 2008-07-28 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 35.7 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.9 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 61 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.96 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.5 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.63 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.4 (percent)\n- MCV [Entitic volume] by Automated count: 102.9 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 132 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 238 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.1 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-08-03 00:00:00, ended at 2008-08-03 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.2 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 214 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.20 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 102.8 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.93 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.20 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 35.6 (picogram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.0 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.7 (percent)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-08-16 00:00:00, ended at 2008-08-16 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Monocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.4 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.71 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 104.0 (femtoliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.27 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 36.5 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.1 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.1 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 56 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 53 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.74 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 196 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2008-09-04 11:30:00, ended at 2008-09-04 23:59:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- CD3 cells [#/volume] in Blood: 219 (per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.3 (percent)\n- MCHC [Mass/volume] by Automated count: 35.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.64 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.8 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- CD19 cells [#/volume] in Blood: 129 (per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.93 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 101.4 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 168 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.46 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.6 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 56 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.1 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 35.9 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- CD3 cells/100 cells in Blood: 46 (percent)\n- CD3+CD4+ (T4 helper) cells [#/volume] in Blood: 95 (per microliter)\n- CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood: 196 (per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- CD19 cells/100 cells in Blood: 27 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.90 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.8 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-07-02 00:00:00, ended at 2009-07-02 00:00:00\nThe patient in this visit was 50 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Multiple myeloma\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive their first ever diagnosis of Essential hypertension within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-03-14 00:00:00, ended at 2008-03-14 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.56 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.3 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.0 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- aPTT in Platelet poor plasma by Coagulation assay: 27.6 (second)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 34.1 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 111 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.1 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 98.3 (femtoliter)\n- Prothrombin time (PT): 15.2 (second)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-03-15 00:00:00, ended at 2008-03-15 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.9 (percent)\n- MCH [Entitic mass] by Automated count: 33.9 (picogram)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.02 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.2 (percent)\n- MCV [Entitic volume] by Automated count: 98.9 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.36 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.04 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.1 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 77 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 124 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-03-16 00:00:00, ended at 2008-03-16 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.91 (million per microliter)\n- MCV [Entitic volume] by Automated count: 97.5 (femtoliter)\n- Hemoglobin [Mass/volume] in Blood: 10.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 112 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 166 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 34.9 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 35.8 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2008-03-18 12:23:00, ended at 2008-03-18 23:59:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.1 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 38 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 17.2 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.8 (percent)\n- MCH [Entitic mass] by Automated count: 32.5 (picogram)\n- MCV [Entitic volume] by Automated count: 92.4 (femtoliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.11 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 35.2 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Multiple myeloma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-03-27 00:00:00, ended at 2008-03-27 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.9 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- MCHC [Mass/volume] by Automated count: 35.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 91.6 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.59 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 10.18 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 40 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.38 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.8 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.3 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.2 (picogram)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.31 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.20 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.1 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-04-10 00:00:00, ended at 2008-04-10 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.01 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 53 (percent)\n- MCH [Entitic mass] by Automated count: 33.8 (picogram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 57 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 115 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 11 (percent)\n- Platelets [#/volume] in Blood by Automated count: 380 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Basophils [#/volume] in Blood by Manual count: 0.1 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Manual count: 2.1 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.2 (percent)\n- MCV [Entitic volume] by Automated count: 97.1 (femtoliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.1 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.3 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 18 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.6 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Manual count: 3 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-04-11 00:00:00, ended at 2008-04-11 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.1 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-04-12 00:00:00, ended at 2008-04-12 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 156 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 34.2 (picogram)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.74 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.1 (percent)\n- MCV [Entitic volume] by Automated count: 98.8 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 298 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.1 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2008-04-22 18:45:00, ended at 2008-04-23 02:30:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 20.5 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.66 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 18.48 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 96 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 121 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 101 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 95.6 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.27 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.35 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 1.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 90.1 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Neutropenic disorder\n- Abnormal body temperature\n- Benign prostatic hyperplasia without outflow obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-04-24 00:00:00, ended at 2008-04-24 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 142 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.50 (million per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 28.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.3 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 26 (percent)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.21 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.0 (picogram)\n- Leukocytes [#/volume] in Specimen by Automated count: 31.4 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 94.6 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 7 (percent)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 1 (percent)\n- Monocytes [#/volume] in Blood by Manual count: 2.2 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.1 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-04-25 00:00:00, ended at 2008-04-25 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 35.6 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.30 (million per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- MCV [Entitic volume] by Automated count: 94.4 (femtoliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 125 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 33.0 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-04-26 00:00:00, ended at 2008-04-26 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 10.9 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.5 (picogram)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.25 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 121 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 95.4 (femtoliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 39.6 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.1 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.33 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-05 00:00:00, ended at 2008-05-05 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 5.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 176 (unit per liter)\n- Basophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 52 (percent)\n- Platelets [#/volume] in Blood by Automated count: 274 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.3 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.7 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Manual count: 2.0 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 109 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Manual count: 0.0 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.2 (percent)\n- MCV [Entitic volume] by Automated count: 93.1 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.92 (million per microliter)\n- MCH [Entitic mass] by Automated count: 32.9 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.0 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 24 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-08 00:00:00, ended at 2008-05-08 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.3 (ratio)\n- Monocytes [#/volume] in Blood by Automated count: 0.70 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.2 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 28.4 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.7 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.96 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.7 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 177 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 201 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.2 (percent)\n- MCV [Entitic volume] by Automated count: 94.5 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 22.3 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.35 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 11 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.6 (percent)\n- Prothrombin time (PT): 15.3 (second)\n- Neutrophils [#/volume] in Blood by Automated count: 2.02 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-10 00:00:00, ended at 2008-05-10 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Manual count: 1.9 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.9 (percent)\n- Monocytes [#/volume] in Blood by Manual count: 0.4 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Basophils [#/volume] in Blood by Manual count: 0.0 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.06 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.6 (picogram)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Manual count: 13 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 58 (percent)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 20 (percent)\n- Basophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.54 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.2 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 141 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.6 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-11 00:00:00, ended at 2008-05-11 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.58 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.7 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.8 (percent)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 81 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 35.3 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 133 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.2 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-12 00:00:00, ended at 2008-05-12 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- MCHC [Mass/volume] by Automated count: 35.3 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 54 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.80 (million per microliter)\n- MCV [Entitic volume] by Automated count: 94.1 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 66 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.9 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 114 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.99 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.2 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.67 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 92.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-13 00:00:00, ended at 2008-05-13 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 19.2 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.06 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.3 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 106 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.50 (million per microliter)\n- MCV [Entitic volume] by Automated count: 94.6 (femtoliter)\n- Glucose [Mass/volume] in Serum or Plasma: 134 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.1 (picogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-14 00:00:00, ended at 2008-05-14 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.94 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.6 (percent)\n- MCV [Entitic volume] by Automated count: 97.0 (femtoliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 1.6 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 86 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.47 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 114 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2008-05-15 14:00:00, ended at 2008-05-15 23:59:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 1.28 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.52 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 1.5 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 56 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 102 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.3 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 68 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.8 (percent)\n- MCV [Entitic volume] by Automated count: 94.5 (femtoliter)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.6 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-16 00:00:00, ended at 2008-05-16 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.31 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 35 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.9 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.9 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.7 (percent)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.4 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.8 (femtoliter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 1.1 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2008-05-17 11:30:00, ended at 2008-05-17 23:59:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: Not avail (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 0.4 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.25 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 35.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 51 (unit per liter)\n- Platelets [#/volume] in Blood by Automated count: 22 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.8 (percent)\n- MCV [Entitic volume] by Automated count: 94.6 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.8 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2008-05-18 09:30:00, ended at 2008-05-18 16:06:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.0 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 125 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.7 (picogram)\n- MCHC [Mass/volume] by Automated count: 35.6 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 9 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 0.2 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.1 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.99 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.01 (million per microliter)\n- MCV [Entitic volume] by Automated count: 94.6 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: Not avail (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2008-05-18 16:07:00, ended at 2008-05-27 18:15:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 74 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.0 (percent)\n- MCH [Entitic mass] by Automated count: 33.7 (picogram)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 144 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 39.6 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 78 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Body height: 5' 7\" (inch (US))\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.8 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 94.4 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.38 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 35.8 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 2.31 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.35 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: Not avail (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Imaging of thorax abnormal\n\n### Drug\n- glycerin, through Topical route, started on 2008-05-20, presumably until 2008-05-20\n- hydrocortisone 100 MG Injection, started on 2008-05-24, presumably until 2008-05-24\n- 72 HR fentanyl 0.025 MG/HR Transdermal System, through Transdermal route, started on 2008-05-24, presumably until 2008-05-24\n- 0.5 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2008-05-19, presumably until 2008-05-23\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2008-05-18, presumably until 2008-05-27\n- water, through Topical route, started on 2008-05-20, presumably until 2008-05-20\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2008-05-18, presumably until 2008-05-27\n- codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML Oral Solution, through Oral route, started on 2008-05-22, presumably until 2008-05-22\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2008-05-23, presumably until 2008-05-24\n- dimethicone, through Topical route, started on 2008-05-20, presumably until 2008-05-20\n- acyclovir 400 MG Oral Tablet, through Oral route, started on 2008-05-27, presumably until 2014-05-19, with quantity of 60.0, with intended 5 refill(s). Instructions: take 400 mg by mouth 3 times a day. \n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2008-05-27, presumably until 2008-05-27\n- bisacodyl 5 MG Delayed Release Oral Tablet, through Oral route, started on 2008-05-25, presumably until 2008-05-25\n- voriconazole 200 MG Injection, through Intravenous route, started on 2008-05-23, presumably until 2008-05-27\n- diphenhydramine hydrochloride 2.5 MG/ML Oral Solution, through Oral route, started on 2008-05-19, presumably until 2008-05-20\n- heparin sodium, porcine 100 UNT/ML Injectable Solution, through Intravenous route, started on 2008-05-27, presumably until 2008-05-27\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2008-05-18, presumably until 2008-05-25\n- 1 ML meperidine hydrochloride 25 MG/ML Cartridge, started on 2008-05-24, presumably until 2008-05-24\n- lorazepam 1 MG Oral Tablet, through Oral route. Instructions: take 1 mg by mouth every 4 hours as needed \n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2008-05-18, presumably until 2008-05-24. Instructions: take 500 mg by mouth 2 times a day. \n- clotrimazole 10 MG Oral Lozenge, through Submucosal route, started on 2008-05-18, presumably until 2008-05-25. Instructions: by Mucous Membrane route 4 times a day. \n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2008-05-24, presumably until 2008-05-27\n- voriconazole 200 MG Oral Tablet, through Oral route, started on 2008-05-27, presumably until 2009-05-27, with quantity of 60.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- azithromycin 500 MG Oral Tablet, through Oral route, started on 2008-05-28, presumably until 2009-06-06, with quantity of 10.0, with intended 0 refill(s). Instructions: take 500 mg by mouth daily. \n- soybean oil 100 MG/ML Injectable Suspension, through Intravenous route, started on 2008-05-21, presumably until 2008-05-23\n- cefepime 2000 MG Injection, through Intravenous route, started on 2008-05-18, presumably until 2008-05-20\n- 50 ML immunoglobulin G, human 100 MG/ML Injection, through Intravenous route, started on 2008-05-23, presumably until 2008-05-23\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2008-05-18, presumably until 2008-05-24\n- lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution, through Submucosal route, started on 2008-05-19, presumably until 2008-05-20\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2008-05-21, presumably until 2008-05-21\n- 250 ML heparin sodium, porcine 100 UNT/ML Injection, through Intravenous route, started on 2008-05-18, presumably until 2008-05-23\n- 100 ML potassium chloride 0.2 MEQ/ML Injection, through Intravenous route, started on 2008-05-19, presumably until 2008-05-25\n- 72 HR scopolamine 0.0139 MG/HR Transdermal System, through Transdermal route, started on 2008-05-19, presumably until 2008-05-19\n- 72 HR fentanyl 0.05 MG/HR Transdermal System, through Transdermal route, started on 2008-05-21, presumably until 2008-05-21\n- petrolatum, through Topical route, started on 2008-05-20, presumably until 2008-05-20\n- aluminum hydroxide 40 MG/ML / magnesium hydroxide 40 MG/ML / simethicone 4 MG/ML Oral Suspension, through Oral route, started on 2008-05-19, presumably until 2008-05-23\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2008-05-29 13:30:00, ended at 2008-05-29 23:59:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 191 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.6 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 94.0 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 73 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.88 (million per microliter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.4 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2008-05-31 10:00:00, ended at 2008-05-31 23:59:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.90 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.3 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 222 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 45 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.2 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.8 (percent)\n- MCH [Entitic mass] by Automated count: 32.5 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 110 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 47 (unit per liter)\n- Basophils [#/volume] in Blood by Manual count: 0.0 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 8 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.91 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.4 (percent)\n- MCV [Entitic volume] by Automated count: 93.4 (femtoliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.2 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 39 (percent)\n- Neutrophils [#/volume] in Blood by Manual count: 1.7 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Manual count: 1 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-06-05 00:00:00, ended at 2008-06-05 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.9 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.70 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.98 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.5 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 27.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 205 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.1 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.4 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.38 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.08 (million per microliter)\n- MCV [Entitic volume] by Automated count: 94.5 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.87 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 56.4 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-06-09 00:00:00, ended at 2008-06-09 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 4.01 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.6 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 54 (percent)\n- Eosinophils [#/volume] in Blood by Manual count: 0.1 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 10 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Manual count: 3.1 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 64 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.4 (femtoliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 34.0 (picogram)\n- Monocytes [#/volume] in Blood by Manual count: 1.8 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 137 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 33 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-06-21 00:00:00, ended at 2008-06-21 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.06 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.69 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.8 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.34 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.10 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 81 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 34.0 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.17 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.1 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 98.2 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 170 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.8 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.7 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-07-03 00:00:00, ended at 2008-07-03 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.03 (million per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.6 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.8 (percent)\n- MCH [Entitic mass] by Automated count: 34.7 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 145 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 100.3 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 184 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.16 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.78 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.84 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-07-14 00:00:00, ended at 2008-07-14 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Neutrophils/100 leukocytes in Blood by Automated count: 79.1 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.9 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 35.1 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.8 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.37 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 62 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.9 (percent)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 191 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 102 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 101.5 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.85 (million per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-07-20 00:00:00, ended at 2008-07-20 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.73 (million per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 58 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.86 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.6 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.6 (percent)\n- MCH [Entitic mass] by Automated count: 35.5 (picogram)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 74.2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.89 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 102.0 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 195 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-07-28 00:00:00, ended at 2008-07-28 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 35.7 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.9 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 61 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.96 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.5 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.63 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.4 (percent)\n- MCV [Entitic volume] by Automated count: 102.9 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 132 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 238 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.1 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-08-03 00:00:00, ended at 2008-08-03 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.2 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 214 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.20 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 102.8 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.93 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.20 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 35.6 (picogram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.0 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.7 (percent)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-08-16 00:00:00, ended at 2008-08-16 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Monocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.4 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.71 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 104.0 (femtoliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.27 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 36.5 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.1 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.1 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 56 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 53 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.74 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 196 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2008-09-04 11:30:00, ended at 2008-09-04 23:59:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- CD3 cells [#/volume] in Blood: 219 (per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.3 (percent)\n- MCHC [Mass/volume] by Automated count: 35.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.64 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.8 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- CD19 cells [#/volume] in Blood: 129 (per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.93 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 101.4 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 168 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.46 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.6 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 56 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.1 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 35.9 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- CD3 cells/100 cells in Blood: 46 (percent)\n- CD3+CD4+ (T4 helper) cells [#/volume] in Blood: 95 (per microliter)\n- CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood: 196 (per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- CD19 cells/100 cells in Blood: 27 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.90 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.8 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-07-02 00:00:00, ended at 2009-07-02 00:00:00\nThe patient in this visit was 50 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Multiple myeloma\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive their first ever diagnosis of Essential hypertension within the next year (we could not find any prior history of this condition in their medical records before)\n- the condition of hypertension means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "d335bcaa75bc1f3eeda3d57a3bdfd760f67565c67d5e0fe4ba38db425b81ef14", "prompt_hash": "77c9035deea80bfb4408b94166ba6481ed3c0d8848710776d8aaea19eb769f47", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 7, "doc": {"person_id": 115968289, "visit_occurrence_id": 180707418, "death_date": null, "visit_concept_name": "Office Visit", "visit_start_datetime": "2021-06-20 12:23:34", "visit_end_datetime": "2021-06-20 13:13:32", "visit_length_in_hours": 0.8327777777777777, "integrated_visit_record": "## Visit\nThis visit record, was from Office Visit, started at 2021-06-20 12:23:34, ended at 2021-06-20 13:13:32\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 89, "patient_first_visit_date": "2020-01-10 00:00:00", "patient_last_visit_date": "2022-10-21 13:54:00", "end_obs_date": "2022-06-20", "hypertension_type": "new", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "recurrent", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "recurrent", "prostate_cancer_one_year_diagnosis": 1, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 26, "cumulated_visit_num": 26, "cumulated_approximate_token_count": 6569, "visit_cumulated": "## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-10 00:00:00, ended at 2020-01-10 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-10 12:00:00, ended at 2020-01-10 23:59:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Consultation and report on referred slides prepared elsewhere\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-20 10:51:00, ended at 2020-02-20 14:11:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2020-02-20, presumably until 2020-02-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-20 14:12:00, ended at 2020-02-20 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n- Raised prostate specific antigen\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-20 14:12:00, ended at 2020-02-20 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-21 09:54:00, ended at 2020-02-21 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- 3D rendering with interpretation and reporting of computed tomography, magnetic resonance imaging, ultrasound, or other tomographic modality with image postprocessing under concurrent supervision; requiring image postprocessing on an independent workstati\n\n### Condition\n- Neoplasm of uncertain behavior of prostate\n- Illness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-06 08:56:20, ended at 2020-08-06 10:06:55\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-08-13 13:54:00, ended at 2020-08-13 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.38 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 28.6 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Globulin [Mass/volume] in Serum: 2.2 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.1 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.6 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 223 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.78 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.86 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.6 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.40 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.0 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.7 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2020-08-14 00:00:00, ended at 2020-08-14 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bupivacaine hydrochloride 2.5 MG/ML Injectable Solution, started on 2020-08-14, presumably until 2020-08-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2020-08-14 00:00:00, ended at 2020-08-14 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for extraperitoneal procedures in lower abdomen, including urinary tract; radical prostatectomy (suprapubic, retropubic)\n- Venipuncture, age 3 years or older, necessitating the skill of a physician or other qualified health care professional (separate procedure), for diagnostic or therapeutic purposes (not to be used for routine venipuncture)\n\n### Condition\n- Secondary malignant neoplasm of intrapelvic lymph nodes\n- Primary malignant neoplasm of prostate\n- Spermatocele\n\n### Drug\n- 2 ML sugammadex 100 MG/ML Injection, through Intravenous route, started on 2020-08-14, presumably until 2020-08-14\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2020-08-14, presumably until 2020-08-14\n- calcium gluconate 100 MG/ML Injectable Solution, through Intravenous route, started on 2020-08-14, presumably until 2020-08-14\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2020-08-14, presumably until 2020-08-14\n- cefazolin 1000 MG Injection, started on 2020-08-14, presumably until 2020-08-14\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2020-08-14, presumably until 2020-08-14\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2020-08-14, presumably until 2020-08-14\n- 2 ML ondansetron 2 MG/ML Injection, started on 2020-08-14, presumably until 2020-08-14\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2020-08-14, presumably until 2020-08-14\n- ketamine 100 MG/ML Injectable Solution, started on 2020-08-14, presumably until 2020-08-14\n- midazolam 1 MG/ML Injectable Solution, started on 2020-08-14, presumably until 2020-08-14\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2020-08-14, presumably until 2020-08-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-08-14 10:44:00, ended at 2020-08-15 14:51:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 16 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 11.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.11 (million per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 197 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.7 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 202 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Body height: 5' 11.5\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.82 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 32.4 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 97.1 (femtoliter)\n\n### Procedure\n- Excision of spermatocele, with or without epididymectomy\n- Collection of venous blood by venipuncture\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Laparoscopy, surgical prostatectomy, retropubic radical, including nerve sparing, includes robotic assistance, when performed\n- Laparoscopy, surgical; with bilateral total pelvic lymphadenectomy\n\n### Condition\n- Illness\n- Hydrocele of tunica vaginalis\n- Major depression, single episode\n- Secondary malignant neoplasm of intrapelvic lymph nodes\n- Obstructive sleep apnea syndrome\n- Spermatocele\n- Primary malignant neoplasm of prostate\n\n### Drug\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2020-08-14, presumably until 2021-08-15, with intended 0 refill(s). Instructions: take 2 Tabs (1,000 mg total) by mouth every 6 hours\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2020-08-14, presumably until 2020-08-14\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2020-08-14, presumably until 2020-08-15\n- cefazolin 1000 MG Injection, started on 2020-08-15, presumably until 2020-08-15\n- sodium chloride 9 MG/ML Injection, started on 2020-08-15, presumably until 2020-08-15\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2020-08-14, presumably until 2020-08-15\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2020-08-14, presumably until 2020-08-14\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2020-08-14, presumably until 2020-08-15\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2020-08-14, presumably until 2020-08-14\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2020-08-14, presumably until 2020-08-15\n- lidocaine 0.05 MG/MG Medicated Patch, through Topical route, started on 2020-08-15, presumably until 2020-08-15\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2020-08-14, presumably until 2020-08-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-09-30 00:00:00, ended at 2020-09-30 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Prostate specific Ag [Mass/volume] in Serum or Plasma by Detection limit <= 0.01 ng/mL: 0.67 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-10-11 00:00:00, ended at 2020-10-11 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-11-27 00:00:00, ended at 2020-11-27 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n- Solitary nodule of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-12-24 00:00:00, ended at 2020-12-24 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Prostate specific Ag [Mass/volume] in Serum or Plasma by Detection limit <= 0.01 ng/mL: 1.02 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-12-25 00:00:00, ended at 2020-12-25 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-01-06 08:18:34, ended at 2021-01-06 08:49:37\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- sildenafil 100 MG Oral Tablet, through Oral route, started on 2021-01-06, presumably until 2021-04-07, with intended 11 refill(s). Instructions: take 1 Tab (100 mg total) by mouth as needed Take 1/2 tab 1 hour prior to sexual intercourse. Increase to full tab as needed.\n- tadalafil 5 MG Oral Tablet, through Oral route, started on 2021-01-06, presumably until 2021-07-07, with intended 11 refill(s). Instructions: take 1 Tab (5 mg total) by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-01-07 09:15:17, ended at 2021-01-07 09:33:45\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abnormal findings on diagnostic imaging of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-01-10 09:45:13, ended at 2021-01-10 11:37:05\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.496\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2021-01-15, presumably until 2022-09-15, with intended 11 refill(s). Instructions: take 1 Tab (5 mg total) by mouth 2 times a day\n- abiraterone acetate 250 MG Oral Tablet, through Oral route, started on 2021-01-15, presumably until 2021-07-07, with intended 11 refill(s). Instructions: take 4 Tabs (1,000 mg total) by mouth daily . Swallow tablets whole with water on an empty stomach.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-04-07 07:58:27, ended at 2021-04-07 08:24:07\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- sildenafil 100 MG Oral Tablet, through Oral route, started on 2021-04-07, presumably until 2022-04-07, with intended 3 refill(s). Instructions: take 1 Tab (100 mg total) by mouth as needed Take 1/2 tab 1 hour prior to sexual intercourse. Increase to full tab as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-05-07 00:00:00, ended at 2021-05-07 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.8 (calculated)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 84 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.9 (percent)\n- Testosterone [Mass/volume] in Serum or Plasma: 472 (nanogram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.8 (percent)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma by Detection limit <= 0.01 ng/mL: 1.36 (nanogram per milliliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 41 (cells per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.51 (million per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.1 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2534 (cells per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.72 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 253 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 10.6 (femtoliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter calculated)\n- MCH [Entitic mass] by Automated count: 32.8 (picogram)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 21 (cells per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1046 (cells per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 459 (cells per microliter)\n- Nucleated erythrocytes [#/volume] in Blood: 0 (cells per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 11.6 (percent)\n- MCV [Entitic volume] by Automated count: 95.1 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-05-13 15:14:07, ended at 2021-05-13 16:14:55\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-06-10 12:10:00, ended at 2021-06-10 14:26:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 14.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.52 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.80 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.52 (million per microliter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- MCV [Entitic volume] by Automated count: 98.2 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 261 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.07 (thousand per microliter)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 1.3 (nanogram per milliliter)\n- Testosterone [Mass/volume] in Serum or Plasma: 483 (nanogram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Cortisol [Mass/volume] in Serum or Plasma: 11.3 (microgram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.4 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.0 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.3 (percent)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-06-10 14:27:00, ended at 2021-06-10 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Primary malignant neoplasm of prostate\n- Raised prostate specific antigen\n- Abnormal findings on diagnostic imaging of lung\n- Imaging of musculoskeletal system abnormal\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-06-17 12:05:23, ended at 2021-06-17 12:39:30\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2021-06-20 12:23:34, ended at 2021-06-20 13:13:32\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive their first ever diagnosis of Essential hypertension within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-10 00:00:00, ended at 2020-01-10 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-10 12:00:00, ended at 2020-01-10 23:59:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Consultation and report on referred slides prepared elsewhere\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-20 10:51:00, ended at 2020-02-20 14:11:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2020-02-20, presumably until 2020-02-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-20 14:12:00, ended at 2020-02-20 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n- Raised prostate specific antigen\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-20 14:12:00, ended at 2020-02-20 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-21 09:54:00, ended at 2020-02-21 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- 3D rendering with interpretation and reporting of computed tomography, magnetic resonance imaging, ultrasound, or other tomographic modality with image postprocessing under concurrent supervision; requiring image postprocessing on an independent workstati\n\n### Condition\n- Neoplasm of uncertain behavior of prostate\n- Illness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-06 08:56:20, ended at 2020-08-06 10:06:55\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-08-13 13:54:00, ended at 2020-08-13 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.38 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 28.6 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Globulin [Mass/volume] in Serum: 2.2 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.1 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.6 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 223 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.78 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.86 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.6 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.40 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.0 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.7 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2020-08-14 00:00:00, ended at 2020-08-14 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bupivacaine hydrochloride 2.5 MG/ML Injectable Solution, started on 2020-08-14, presumably until 2020-08-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2020-08-14 00:00:00, ended at 2020-08-14 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for extraperitoneal procedures in lower abdomen, including urinary tract; radical prostatectomy (suprapubic, retropubic)\n- Venipuncture, age 3 years or older, necessitating the skill of a physician or other qualified health care professional (separate procedure), for diagnostic or therapeutic purposes (not to be used for routine venipuncture)\n\n### Condition\n- Secondary malignant neoplasm of intrapelvic lymph nodes\n- Primary malignant neoplasm of prostate\n- Spermatocele\n\n### Drug\n- 2 ML sugammadex 100 MG/ML Injection, through Intravenous route, started on 2020-08-14, presumably until 2020-08-14\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2020-08-14, presumably until 2020-08-14\n- calcium gluconate 100 MG/ML Injectable Solution, through Intravenous route, started on 2020-08-14, presumably until 2020-08-14\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2020-08-14, presumably until 2020-08-14\n- cefazolin 1000 MG Injection, started on 2020-08-14, presumably until 2020-08-14\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2020-08-14, presumably until 2020-08-14\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2020-08-14, presumably until 2020-08-14\n- 2 ML ondansetron 2 MG/ML Injection, started on 2020-08-14, presumably until 2020-08-14\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2020-08-14, presumably until 2020-08-14\n- ketamine 100 MG/ML Injectable Solution, started on 2020-08-14, presumably until 2020-08-14\n- midazolam 1 MG/ML Injectable Solution, started on 2020-08-14, presumably until 2020-08-14\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2020-08-14, presumably until 2020-08-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-08-14 10:44:00, ended at 2020-08-15 14:51:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 16 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 11.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.11 (million per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 197 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.7 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 202 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Body height: 5' 11.5\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.82 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 32.4 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 97.1 (femtoliter)\n\n### Procedure\n- Excision of spermatocele, with or without epididymectomy\n- Collection of venous blood by venipuncture\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Laparoscopy, surgical prostatectomy, retropubic radical, including nerve sparing, includes robotic assistance, when performed\n- Laparoscopy, surgical; with bilateral total pelvic lymphadenectomy\n\n### Condition\n- Illness\n- Hydrocele of tunica vaginalis\n- Major depression, single episode\n- Secondary malignant neoplasm of intrapelvic lymph nodes\n- Obstructive sleep apnea syndrome\n- Spermatocele\n- Primary malignant neoplasm of prostate\n\n### Drug\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2020-08-14, presumably until 2021-08-15, with intended 0 refill(s). Instructions: take 2 Tabs (1,000 mg total) by mouth every 6 hours\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2020-08-14, presumably until 2020-08-14\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2020-08-14, presumably until 2020-08-15\n- cefazolin 1000 MG Injection, started on 2020-08-15, presumably until 2020-08-15\n- sodium chloride 9 MG/ML Injection, started on 2020-08-15, presumably until 2020-08-15\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2020-08-14, presumably until 2020-08-15\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2020-08-14, presumably until 2020-08-14\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2020-08-14, presumably until 2020-08-15\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2020-08-14, presumably until 2020-08-14\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2020-08-14, presumably until 2020-08-15\n- lidocaine 0.05 MG/MG Medicated Patch, through Topical route, started on 2020-08-15, presumably until 2020-08-15\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2020-08-14, presumably until 2020-08-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-09-30 00:00:00, ended at 2020-09-30 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Prostate specific Ag [Mass/volume] in Serum or Plasma by Detection limit <= 0.01 ng/mL: 0.67 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-10-11 00:00:00, ended at 2020-10-11 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-11-27 00:00:00, ended at 2020-11-27 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n- Solitary nodule of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-12-24 00:00:00, ended at 2020-12-24 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Prostate specific Ag [Mass/volume] in Serum or Plasma by Detection limit <= 0.01 ng/mL: 1.02 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-12-25 00:00:00, ended at 2020-12-25 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-01-06 08:18:34, ended at 2021-01-06 08:49:37\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- sildenafil 100 MG Oral Tablet, through Oral route, started on 2021-01-06, presumably until 2021-04-07, with intended 11 refill(s). Instructions: take 1 Tab (100 mg total) by mouth as needed Take 1/2 tab 1 hour prior to sexual intercourse. Increase to full tab as needed.\n- tadalafil 5 MG Oral Tablet, through Oral route, started on 2021-01-06, presumably until 2021-07-07, with intended 11 refill(s). Instructions: take 1 Tab (5 mg total) by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-01-07 09:15:17, ended at 2021-01-07 09:33:45\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abnormal findings on diagnostic imaging of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-01-10 09:45:13, ended at 2021-01-10 11:37:05\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.496\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2021-01-15, presumably until 2022-09-15, with intended 11 refill(s). Instructions: take 1 Tab (5 mg total) by mouth 2 times a day\n- abiraterone acetate 250 MG Oral Tablet, through Oral route, started on 2021-01-15, presumably until 2021-07-07, with intended 11 refill(s). Instructions: take 4 Tabs (1,000 mg total) by mouth daily . Swallow tablets whole with water on an empty stomach.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-04-07 07:58:27, ended at 2021-04-07 08:24:07\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- sildenafil 100 MG Oral Tablet, through Oral route, started on 2021-04-07, presumably until 2022-04-07, with intended 3 refill(s). Instructions: take 1 Tab (100 mg total) by mouth as needed Take 1/2 tab 1 hour prior to sexual intercourse. Increase to full tab as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-05-07 00:00:00, ended at 2021-05-07 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.8 (calculated)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 84 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.9 (percent)\n- Testosterone [Mass/volume] in Serum or Plasma: 472 (nanogram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.8 (percent)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma by Detection limit <= 0.01 ng/mL: 1.36 (nanogram per milliliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 41 (cells per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.51 (million per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.1 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2534 (cells per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.72 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 253 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 10.6 (femtoliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter calculated)\n- MCH [Entitic mass] by Automated count: 32.8 (picogram)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 21 (cells per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1046 (cells per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 459 (cells per microliter)\n- Nucleated erythrocytes [#/volume] in Blood: 0 (cells per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 11.6 (percent)\n- MCV [Entitic volume] by Automated count: 95.1 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-05-13 15:14:07, ended at 2021-05-13 16:14:55\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-06-10 12:10:00, ended at 2021-06-10 14:26:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 14.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.52 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.80 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.52 (million per microliter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- MCV [Entitic volume] by Automated count: 98.2 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 261 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.07 (thousand per microliter)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 1.3 (nanogram per milliliter)\n- Testosterone [Mass/volume] in Serum or Plasma: 483 (nanogram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Cortisol [Mass/volume] in Serum or Plasma: 11.3 (microgram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.4 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.0 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.3 (percent)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-06-10 14:27:00, ended at 2021-06-10 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Primary malignant neoplasm of prostate\n- Raised prostate specific antigen\n- Abnormal findings on diagnostic imaging of lung\n- Imaging of musculoskeletal system abnormal\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-06-17 12:05:23, ended at 2021-06-17 12:39:30\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2021-06-20 12:23:34, ended at 2021-06-20 13:13:32\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive their first ever diagnosis of Essential hypertension within the next year (we could not find any prior history of this condition in their medical records before)\n- the condition of hypertension means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "c481ef563b30a2b17b7f1475d3c02917a852c9c6bfa8f4133c30241b30d96a54", "prompt_hash": "b288f58e26ba19b55e95d5009ec2b172a42c9eaefad2460b9a88a44a42ada019", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 8, "doc": {"person_id": 115968320, "visit_occurrence_id": 50986730, "death_date": null, "visit_concept_name": "Office Visit", "visit_start_datetime": "2012-11-27 08:50:07", "visit_end_datetime": "2012-11-27 11:05:12", "visit_length_in_hours": 2.251388888888889, "integrated_visit_record": "## Visit\nThis visit record, was from Office Visit, started at 2012-11-27 08:50:07, ended at 2012-11-27 11:05:12\nThe patient in this visit was 48 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of left eye: 13 (millimeter mercury column)\n- Intraocular pressure of right eye: 18 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Cystoid macular retinal degeneration\n- Nuclear senile cataract\n- Primary diagnosis: Epiretinal membrane\n- Vitreous degeneration\n- Horseshoe retinal tear without detachment\n- Retinal lattice degeneration\n\n### Drug\n- ketorolac tromethamine 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2012-11-27, presumably until 2014-03-31, with intended 1 refill(s). Instructions: instill 1 Drop to left eye 4 times a day.\n\n", "approximate_token_count": 236, "patient_first_visit_date": "2010-11-14 10:48:14", "patient_last_visit_date": "2022-04-25 09:07:15", "end_obs_date": "2013-11-27", "hypertension_type": "new", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 17, "cumulated_visit_num": 17, "cumulated_approximate_token_count": 2793, "visit_cumulated": "## Visit\nThis visit record, was from Office Visit, started at 2010-11-14 10:48:14, ended at 2010-11-14 14:13:17\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of right eye: 12 (millimeter mercury column)\n- Intraocular pressure of left eye: 12 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, (eg, scanning laser) with interpretation and report, unilateral\n- Ophthalmoscopy, extended, with retinal drawing (eg, for retinal detachment, melanoma), with interpretation and report; initial\n\n### Condition\n- Retinal detachment with retinal defect\n- Nuclear senile cataract\n- Vitreous degeneration\n\n### Drug\n- lisinopril 10 MG Oral Tablet, through Oral route. Instructions: take 1 Tablet (10 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-14 12:55:00, ended at 2010-11-14 18:40:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 2\" (inch (US))\n\n### Procedure\n- Repair of retinal detachment; scleral buckling (such as lamellar scleral dissection, imbrication or encircling procedure), including, when performed, implant, cryotherapy, photocoagulation, and drainage of subretinal fluid\n- Other scleral buckling\n\n### Condition\n- Retinal detachment with retinal defect\n- Vitreous degeneration\n- Nuclear senile cataract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-15 14:33:37, ended at 2010-11-15 15:08:10\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of right eye: 15 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Retinal detachment with retinal defect\n- Nuclear senile cataract\n- Vitreous degeneration\n\n### Drug\n- prednisolone acetate 10 MG/ML Ophthalmic Suspension, through Intraocular route, started on 2010-11-15, presumably until 2011-02-24, with intended 2 refill(s). Instructions: 1 Drop by Right Eye route 4 times a day. \n- atropine sulfate 10 MG/ML Ophthalmic Solution, through Intraocular route, started on 2010-11-15, presumably until 2011-01-02, with quantity of 10.0. Instructions: 1 Drop by Ophthalmic route 2 times a day. Right eye \n- moxifloxacin 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2010-11-15, presumably until 2011-01-02. Instructions: 1 Drop by Ophthalmic route 4 times a day. Right eye \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-17 15:26:54, ended at 2010-11-17 16:25:42\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of right eye: 12 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, (eg, scanning laser) with interpretation and report, unilateral\n\n### Condition\n- Nuclear senile cataract\n- Retinal detachment with retinal defect\n- Vitreous degeneration\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-26 00:00:00, ended at 2010-11-26 09:16:50\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Retinal detachment with retinal defect\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-29 14:33:21, ended at 2010-11-29 15:52:31\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of right eye: 15 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Vitreous degeneration\n- Nuclear senile cataract\n- Retinal detachment with retinal defect\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-12-02 10:14:02, ended at 2010-12-02 11:53:35\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of right eye: 19 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Retinal detachment with retinal defect\n- Vitreous degeneration\n- Nuclear senile cataract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-01-02 08:45:53, ended at 2011-01-02 10:08:21\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of left eye: 13 (millimeter mercury column)\n- Intraocular pressure of right eye: 12 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, (eg, scanning laser) with interpretation and report, unilateral\n\n### Condition\n- Nuclear senile cataract\n- Primary diagnosis: Retinal detachment with retinal defect\n- Vitreous degeneration\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-02-01 08:45:32, ended at 2011-02-01 11:23:11\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of left eye: 16 (millimeter mercury column)\n- Intraocular pressure of right eye: 12 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Retinal lattice degeneration\n- Vitreous degeneration\n- Nuclear senile cataract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-02-24 08:46:26, ended at 2011-02-24 10:39:10\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of left eye: 15 (millimeter mercury column)\n- Intraocular pressure of right eye: 16 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Retinal detachment with retinal defect\n- Vitreous degeneration\n- Retinal lattice degeneration\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-03-22 08:27:15, ended at 2011-03-22 09:38:14\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of left eye: 14 (millimeter mercury column)\n- Intraocular pressure of right eye: 14 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Nuclear senile cataract\n- Retinal lattice degeneration\n- Vitreous degeneration\n\n### Drug\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, presumably until 2014-03-31. Instructions: take 81 mg by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-05-01 10:44:17, ended at 2011-05-01 12:14:21\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of right eye: 16 (millimeter mercury column)\n- Intraocular pressure of left eye: 16 (millimeter mercury column)\n\n### Procedure\n- Prophylaxis of retinal detachment (eg, retinal break, lattice degeneration) without drainage; photocoagulation\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Horseshoe retinal tear without detachment\n- Retinal lattice degeneration\n- Vitreous degeneration\n- Nuclear senile cataract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-05-17 09:00:18, ended at 2011-05-17 10:01:11\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of left eye: 12 (millimeter mercury column)\n- Intraocular pressure of right eye: 16 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Horseshoe retinal tear without detachment\n- Nuclear senile cataract\n- Retinal lattice degeneration\n- Epiretinal membrane\n- Vitreous degeneration\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-06-28 08:50:35, ended at 2011-06-28 10:17:33\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of left eye: 15 (millimeter mercury column)\n- Intraocular pressure of right eye: 15 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Horseshoe retinal tear without detachment\n- Epiretinal membrane\n- Retinal lattice degeneration\n- Nuclear senile cataract\n- Vitreous degeneration\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-12-28 09:42:46, ended at 2011-12-28 11:58:11\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of left eye: 14 (millimeter mercury column)\n- Intraocular pressure of right eye: 13 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Vitreous degeneration\n- Horseshoe retinal tear without detachment\n- Retinal lattice degeneration\n- Epiretinal membrane\n- Nuclear senile cataract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-10-16 14:50:31, ended at 2012-10-16 16:45:56\nThe patient in this visit was 48 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of left eye: 13 (millimeter mercury column)\n- Intraocular pressure of right eye: 15 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Cystoid macular retinal degeneration\n- Retinal lattice degeneration\n- Horseshoe retinal tear without detachment\n- Vitreous degeneration\n- Epiretinal membrane\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-11-27 08:50:07, ended at 2012-11-27 11:05:12\nThe patient in this visit was 48 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of left eye: 13 (millimeter mercury column)\n- Intraocular pressure of right eye: 18 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Cystoid macular retinal degeneration\n- Nuclear senile cataract\n- Primary diagnosis: Epiretinal membrane\n- Vitreous degeneration\n- Horseshoe retinal tear without detachment\n- Retinal lattice degeneration\n\n### Drug\n- ketorolac tromethamine 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2012-11-27, presumably until 2014-03-31, with intended 1 refill(s). Instructions: instill 1 Drop to left eye 4 times a day.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive their first ever diagnosis of Essential hypertension within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-14 10:48:14, ended at 2010-11-14 14:13:17\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of right eye: 12 (millimeter mercury column)\n- Intraocular pressure of left eye: 12 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, (eg, scanning laser) with interpretation and report, unilateral\n- Ophthalmoscopy, extended, with retinal drawing (eg, for retinal detachment, melanoma), with interpretation and report; initial\n\n### Condition\n- Retinal detachment with retinal defect\n- Nuclear senile cataract\n- Vitreous degeneration\n\n### Drug\n- lisinopril 10 MG Oral Tablet, through Oral route. Instructions: take 1 Tablet (10 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-14 12:55:00, ended at 2010-11-14 18:40:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 2\" (inch (US))\n\n### Procedure\n- Repair of retinal detachment; scleral buckling (such as lamellar scleral dissection, imbrication or encircling procedure), including, when performed, implant, cryotherapy, photocoagulation, and drainage of subretinal fluid\n- Other scleral buckling\n\n### Condition\n- Retinal detachment with retinal defect\n- Vitreous degeneration\n- Nuclear senile cataract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-15 14:33:37, ended at 2010-11-15 15:08:10\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of right eye: 15 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Retinal detachment with retinal defect\n- Nuclear senile cataract\n- Vitreous degeneration\n\n### Drug\n- prednisolone acetate 10 MG/ML Ophthalmic Suspension, through Intraocular route, started on 2010-11-15, presumably until 2011-02-24, with intended 2 refill(s). Instructions: 1 Drop by Right Eye route 4 times a day. \n- atropine sulfate 10 MG/ML Ophthalmic Solution, through Intraocular route, started on 2010-11-15, presumably until 2011-01-02, with quantity of 10.0. Instructions: 1 Drop by Ophthalmic route 2 times a day. Right eye \n- moxifloxacin 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2010-11-15, presumably until 2011-01-02. Instructions: 1 Drop by Ophthalmic route 4 times a day. Right eye \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-17 15:26:54, ended at 2010-11-17 16:25:42\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of right eye: 12 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, (eg, scanning laser) with interpretation and report, unilateral\n\n### Condition\n- Nuclear senile cataract\n- Retinal detachment with retinal defect\n- Vitreous degeneration\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-26 00:00:00, ended at 2010-11-26 09:16:50\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Retinal detachment with retinal defect\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-29 14:33:21, ended at 2010-11-29 15:52:31\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of right eye: 15 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Vitreous degeneration\n- Nuclear senile cataract\n- Retinal detachment with retinal defect\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-12-02 10:14:02, ended at 2010-12-02 11:53:35\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of right eye: 19 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Retinal detachment with retinal defect\n- Vitreous degeneration\n- Nuclear senile cataract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-01-02 08:45:53, ended at 2011-01-02 10:08:21\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of left eye: 13 (millimeter mercury column)\n- Intraocular pressure of right eye: 12 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, (eg, scanning laser) with interpretation and report, unilateral\n\n### Condition\n- Nuclear senile cataract\n- Primary diagnosis: Retinal detachment with retinal defect\n- Vitreous degeneration\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-02-01 08:45:32, ended at 2011-02-01 11:23:11\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of left eye: 16 (millimeter mercury column)\n- Intraocular pressure of right eye: 12 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Retinal lattice degeneration\n- Vitreous degeneration\n- Nuclear senile cataract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-02-24 08:46:26, ended at 2011-02-24 10:39:10\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of left eye: 15 (millimeter mercury column)\n- Intraocular pressure of right eye: 16 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Retinal detachment with retinal defect\n- Vitreous degeneration\n- Retinal lattice degeneration\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-03-22 08:27:15, ended at 2011-03-22 09:38:14\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of left eye: 14 (millimeter mercury column)\n- Intraocular pressure of right eye: 14 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Nuclear senile cataract\n- Retinal lattice degeneration\n- Vitreous degeneration\n\n### Drug\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, presumably until 2014-03-31. Instructions: take 81 mg by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-05-01 10:44:17, ended at 2011-05-01 12:14:21\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of right eye: 16 (millimeter mercury column)\n- Intraocular pressure of left eye: 16 (millimeter mercury column)\n\n### Procedure\n- Prophylaxis of retinal detachment (eg, retinal break, lattice degeneration) without drainage; photocoagulation\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Horseshoe retinal tear without detachment\n- Retinal lattice degeneration\n- Vitreous degeneration\n- Nuclear senile cataract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-05-17 09:00:18, ended at 2011-05-17 10:01:11\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of left eye: 12 (millimeter mercury column)\n- Intraocular pressure of right eye: 16 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Horseshoe retinal tear without detachment\n- Nuclear senile cataract\n- Retinal lattice degeneration\n- Epiretinal membrane\n- Vitreous degeneration\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-06-28 08:50:35, ended at 2011-06-28 10:17:33\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of left eye: 15 (millimeter mercury column)\n- Intraocular pressure of right eye: 15 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Horseshoe retinal tear without detachment\n- Epiretinal membrane\n- Retinal lattice degeneration\n- Nuclear senile cataract\n- Vitreous degeneration\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-12-28 09:42:46, ended at 2011-12-28 11:58:11\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of left eye: 14 (millimeter mercury column)\n- Intraocular pressure of right eye: 13 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Vitreous degeneration\n- Horseshoe retinal tear without detachment\n- Retinal lattice degeneration\n- Epiretinal membrane\n- Nuclear senile cataract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-10-16 14:50:31, ended at 2012-10-16 16:45:56\nThe patient in this visit was 48 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of left eye: 13 (millimeter mercury column)\n- Intraocular pressure of right eye: 15 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Cystoid macular retinal degeneration\n- Retinal lattice degeneration\n- Horseshoe retinal tear without detachment\n- Vitreous degeneration\n- Epiretinal membrane\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-11-27 08:50:07, ended at 2012-11-27 11:05:12\nThe patient in this visit was 48 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of left eye: 13 (millimeter mercury column)\n- Intraocular pressure of right eye: 18 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Cystoid macular retinal degeneration\n- Nuclear senile cataract\n- Primary diagnosis: Epiretinal membrane\n- Vitreous degeneration\n- Horseshoe retinal tear without detachment\n- Retinal lattice degeneration\n\n### Drug\n- ketorolac tromethamine 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2012-11-27, presumably until 2014-03-31, with intended 1 refill(s). Instructions: instill 1 Drop to left eye 4 times a day.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive their first ever diagnosis of Essential hypertension within the next year (we could not find any prior history of this condition in their medical records before)\n- the condition of hypertension means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "6ab701e4f4d09fb798f69408ff4916ceb1a44e7293673985ea88bd75dbf20df9", "prompt_hash": "68a66ad43ab692c17c4268d331235e5f8295b8ada4e45661abd1e1acd2af123d", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 9, "doc": {"person_id": 115968582, "visit_occurrence_id": 38992355, "death_date": null, "visit_concept_name": "Outpatient Visit", "visit_start_datetime": "2010-04-30 07:20:00", "visit_end_datetime": "2010-04-30 08:03:00", "visit_length_in_hours": 0.7166666666666667, "integrated_visit_record": "## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-30 07:20:00, ended at 2010-04-30 08:03:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.5 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.9 (percent)\n- MCV [Entitic volume] by Automated count: 86.3 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 157 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.65 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.39 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.33 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 51 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 75 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.5 (percent)\n- MCH [Entitic mass] by Automated count: 29.7 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Anion gap in Serum or Plasma: 16 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.41 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.41 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.6 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 75.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 117 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- aprepitant 125 MG Oral Capsule, through Oral route, started on 2010-04-30, presumably until 2010-04-30\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2010-04-30, presumably until 2010-04-30\n- sodium chloride 9 MG/ML Injection, started on 2010-04-30, presumably until 2010-04-30\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-04-30, presumably until 2010-04-30\n\n", "approximate_token_count": 869, "patient_first_visit_date": "2009-03-19 00:00:00", "patient_last_visit_date": "2015-08-28 15:07:22", "end_obs_date": "2011-04-30", "hypertension_type": "new", "hypertension_one_year_diagnosis": 1, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 80, "cumulated_visit_num": 80, "cumulated_approximate_token_count": 24323, "visit_cumulated": "## Visit\nThis visit record, was from Case Management Visit, started at 2009-03-19 00:00:00, ended at 2009-03-19 00:00:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.0 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.4 (percent)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.9 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.12 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.1 (percent)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 4.83 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.32 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 249 (thousand per microliter)\n- Prothrombin time (PT): 14.0 (second)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.80 (million per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 85.7 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.2 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 59 (milliliter per minute per square meter)\n- aPTT in Platelet poor plasma by Coagulation assay: 32.3 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2009-03-20 11:04:00, ended at 2009-03-22 11:50:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 4\" (inch (US))\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.9 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Branchial cleft cyst\n\n### Drug\n- docusate sodium 10 MG/ML Oral Solution, through Oral route, started on 2009-03-21, presumably until 2009-06-08, with quantity of 30.0, with intended 0 refill(s). Instructions: take 25 mL by mouth daily. \n- bacitracin zinc 0.5 UNT/MG Topical Ointment, through Topical route, started on 2009-03-22, presumably until 2009-06-08. Instructions: by Topical route 3 times a day. \n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2009-03-20, presumably until 2009-03-21\n- amoxicillin 80 MG/ML / clavulanate 11.4 MG/ML Oral Suspension, through Oral route, started on 2009-03-21, presumably until 2009-03-21\n- acetaminophen 33.3 MG/ML / hydrocodone bitartrate 0.5 MG/ML Oral Solution, through Oral route, started on 2009-03-21, presumably until 2009-03-21\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, started on 2009-03-20, presumably until 2009-03-21\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2009-03-21, presumably until 2009-06-08, with quantity of 14.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours. \n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2009-03-21, presumably until 2009-06-08, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain. \n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2009-03-20, presumably until 2009-03-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-06-08 06:25:00, ended at 2009-06-08 12:10:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 4\" (inch (US))\n- Glucose [Mass/volume] in Serum or Plasma: 109 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant neoplastic disease\n\n### Drug\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2009-06-08, presumably until 2009-06-08\n- docusate sodium 10 MG/ML Oral Solution, through Oral route, started on 2009-06-08, presumably until 2010-02-26, with quantity of 60.0, with intended 0 refill(s). Instructions: take 25 mL by mouth 2 times a day. \n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2009-06-08, presumably until 2009-12-05, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-06 08:57:00, ended at 2009-12-06 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 4\" (inch (US))\n\n### Procedure\n- Laryngoscopy, flexible; diagnostic\n\n### Condition\n- Primary malignant neoplasm of base of tongue\n- Neoplasm of lymph node\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-28 09:29:00, ended at 2009-12-28 11:31:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, extremity, nonvascular, real time with image documentation\n- Biopsy or excision of lymph node(s); by needle, superficial (eg, cervical, inguinal, axillary)\n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n\n### Condition\n- Malignant tumor of head and neck\n- Primary malignant neoplasm of tonsil\n- Primary malignant neoplasm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-28 11:32:00, ended at 2009-12-28 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Lymphadenitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-10 17:10:00, ended at 2010-01-10 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of hematopoietic structure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-02-07 00:00:00, ended at 2010-02-07 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Malignant neoplastic disease\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2010-02-07, presumably until 2010-05-14, with quantity of 30.0, with intended 2 refill(s). Instructions: take 1 Tab by mouth as directed. Take 1 tab by mouth three times daily on days 2 and 3 of chemotherapy and then three times daily, as needed, thereafter. \n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2010-02-07, presumably until 2010-05-14, with quantity of 32.0, with intended 2 refill(s). Instructions: take 2 Tabs by mouth as directed. Take 8mg twice daily starting the day before chemotherapy and continue x 4 days total. \n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2010-02-07, presumably until 2010-05-14, with quantity of 30.0, with intended 2 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed For nausea and vomiting. \n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2010-02-07, presumably until 2010-02-26, with quantity of 20.0, with intended 2 refill(s). Instructions: take 1 Tab by mouth 2 times a day. Start Cipro 500 mg BID on day 5.  Take for 10 days. \n- aprepitant 80 MG Oral Capsule, through Oral route, started on 2010-02-07, presumably until 2010-03-12, with quantity of 2.0, with intended 2 refill(s). Instructions: take 1 Cap by mouth daily. Take  in a.m. on days 2 and 3 of chemotherapy cycle. \n- prochlorperazine 10 MG Oral Tablet, through Oral route, started on 2010-02-07, presumably until 2010-03-12, with quantity of 30.0, with intended 2 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed For nausea and vomiting. \n- metoclopramide 10 MG Oral Tablet, through Oral route, started on 2010-02-07, presumably until 2010-03-12, with quantity of 30.0, with intended 2 refill(s). Instructions: take 1-2 Tabs by mouth 4 times a day. Take 1-2 tabs every 6hours as needed for nausea/vomiting \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-07 09:00:00, ended at 2010-02-07 14:09:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 3.394\" (inch (US))\n\n### Procedure\n- Laryngoscopy, flexible; diagnostic\n\n### Condition\n- Lymphadenopathy\n- Neoplasm of lymph node\n- Primary malignant neoplasm of base of tongue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-07 14:10:00, ended at 2010-02-07 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Lymphadenopathy\n- Primary malignant neoplasm of base of tongue\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-02-08 00:00:00, ended at 2010-02-08 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of oropharynx\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-12 15:00:00, ended at 2010-02-12 18:01:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 4\" (inch (US))\n\n### Procedure\n- Laryngoscopy, flexible; diagnostic\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n- Lymphadenopathy\n- Malignant neoplastic disease\n- Sensorineural hearing loss\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-12 18:02:00, ended at 2010-02-12 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.4 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.36 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 15.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.75 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 29.2 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 102 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.7 (percent)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 59 (milliliter per minute per square meter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 29.1 (percent)\n- MCV [Entitic volume] by Automated count: 86.8 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.35 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 58.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 222 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 59 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.49 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Lymphadenopathy\n- Malignant neoplastic disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-14 08:00:00, ended at 2010-02-14 11:58:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n- Therapeutic radiology simulation-aided field setting; complex\n\n### Condition\n- Primary malignant neoplasm of base of tongue\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-14 11:59:00, ended at 2010-02-14 13:26:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML sodium bicarbonate 84 MG/ML Injection, through Intravenous route, started on 2010-02-14, presumably until 2010-02-14\n- lidocaine hydrochloride 20 MG/ML Injectable Solution, started on 2010-02-14, presumably until 2010-02-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-14 13:27:00, ended at 2010-02-14 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest; single view, frontal\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-15 09:00:00, ended at 2010-02-15 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- aprepitant 125 MG Oral Capsule, through Oral route, started on 2010-02-15, presumably until 2010-02-15\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2010-02-15, presumably until 2010-02-15\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2010-02-15, presumably until 2010-02-15\n- sodium chloride 9 MG/ML Injection, started on 2010-02-15, presumably until 2010-02-15\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-02-15, presumably until 2010-02-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-16 15:00:00, ended at 2010-02-16 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-02-16, presumably until 2010-02-16\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-17 11:00:00, ended at 2010-02-17 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- loperamide hydrochloride 2 MG Oral Capsule, through Oral route, started on 2010-02-17, presumably until 2010-02-17\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-02-17, presumably until 2010-02-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-19 14:10:00, ended at 2010-02-19 14:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Platelets [#/volume] in Blood by Automated count: 140 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.26 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.1 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.9 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.28 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.15 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.5 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.5 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 84.7 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 54 (unit per liter)\n- Anion gap in Serum or Plasma: 3 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 15.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 131 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 0.5 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant neoplastic disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-19 15:00:00, ended at 2010-02-19 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-02-21 00:00:00, ended at 2010-02-21 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of oropharynx\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-21 16:00:00, ended at 2010-02-21 17:29:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atropine sulfate 0.025 MG / diphenoxylate hydrochloride 2.5 MG Oral Tablet, through Oral route, started on 2010-02-21, presumably until 2010-02-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-02-22 00:00:00, ended at 2010-02-22 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of oropharynx\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-22 10:47:00, ended at 2010-02-22 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.3 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 5.6 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.6 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.59 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 0.63 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.3 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 7.4 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 48.2 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 68 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.57 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 45.0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 54 (milliliter per minute per square meter)\n- Leukocytes [#/volume] in Specimen by Automated count: 1.3 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 83.9 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 103 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.8 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant neoplastic disease\n- Primary malignant neoplasm of base of tongue\n- Primary malignant neoplasm of oropharynx\n- Swelling / lump finding\n- Diarrhea\n- Dehydration\n- Finding of head and neck region\n\n### Drug\n- 0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2010-02-22, presumably until 2010-02-22\n- atropine sulfate 0.025 MG / diphenoxylate hydrochloride 2.5 MG Oral Tablet, through Oral route, presumably until 2010-02-26. Instructions: take by mouth as needed \n- 2 ML ondansetron 2 MG/ML Injection, started on 2010-02-22, presumably until 2010-02-22\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-02-22, presumably until 2010-02-22\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-23 09:30:00, ended at 2010-02-23 15:32:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Finding of head and neck region\n- Swelling / lump finding\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- lisinopril 10 MG Oral Tablet, through Oral route, presumably until 2010-02-26. Instructions: take 10 mg by mouth daily. \n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-02-23, presumably until 2010-02-23\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2010-02-23 15:33:00, ended at 2010-02-26 13:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Manual count: 2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 61 (percent)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Body height: 6' 4\" (inch (US))\n- Carbon dioxide [Partial pressure] in Blood: 38.8 (millimeter mercury column)\n- Eosinophils [#/volume] in Blood by Manual count: 0.1 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 35.8 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.92 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 2.4 (thousand per microliter)\n- Prothrombin time (PT): 16.4 (second)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 6.3 (microgram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 78 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.1 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.2 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 97 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 7 (milligram per deciliter)\n- Base excess in Blood by calculation: 1.0 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 35.3 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 2.3 (gram per deciliter)\n- Basophils [#/volume] in Blood by Manual count: 0.1 (thousand per microliter)\n- Bicarbonate [Moles/volume] in Specimen: 25.1 (milliequivalent per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.36 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.3 (percent)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- MCV [Entitic volume] by Automated count: 86.1 (femtoliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.5 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 30 (percent)\n- Oxygen [Partial pressure] in Blood: 57 (millimeter mercury column)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.01 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 66 (unit per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.4 (ratio)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 9.69 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 80.4 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.13 (million per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Radiologic examination, chest; single view, frontal\n- Collection of venous blood by venipuncture\n- Removal of other device from thorax\n- Venous catheterization, not elsewhere classified\n- Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study\n\n### Condition\n- Neutropenic disorder\n- Disturbance in speech\n- Lymphadenopathy\n- Primary malignant neoplasm of oropharynx\n- Candidiasis of mouth\n- Infection of intravenous catheter\n- Sepsis\n- Ulcerative stomatitis\n- Fever\n- Low blood pressure\n- Neoplasm of lymph node\n- Acute deep venous thrombosis of upper extremity\n- Finding of head and neck region\n- Lung field abnormal\n- Phlebitis\n- Acute renal failure syndrome\n- Dehydration\n- Diarrhea\n- Disorder of upper extremity\n- Swelling / lump finding\n- Primary malignant neoplasm of pharynx\n\n### Drug\n- 50 ML sodium bicarbonate 84 MG/ML Injection, through Intravenous route, started on 2010-02-25, presumably until 2010-02-25\n- fluconazole 200 MG Oral Tablet, through Oral route, started on 2010-02-24, presumably until 2010-05-14, with quantity of 14.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-02-24, presumably until 2010-02-25\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2010-02-24, presumably until 2010-02-24\n- hypromellose 25 MG/ML Ophthalmic Solution, through Intraocular route, started on 2010-02-26, presumably until 2010-03-12, with intended 0 refill(s). Instructions: 1 Drop by Right Eye route 3 times a day as needed \n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2010-02-24, presumably until 2010-05-14, with quantity of 30.0, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily. \n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2010-02-24, presumably until 2010-02-24\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2010-02-24, presumably until 2010-05-17, with quantity of 30.0, with intended 1 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed for Insomnia. \n- diphenhydramine hydrochloride 2.5 MG/ML Oral Solution, through Oral route, started on 2010-02-23, presumably until 2010-02-26\n- lidocaine 40 MG/ML Topical Cream, through Topical route, started on 2010-02-25, presumably until 2010-02-25\n- ondansetron 0.8 MG/ML Oral Solution, through Oral route, started on 2010-02-26, presumably until 2010-03-12, with intended 0 refill(s). Instructions: take 4 mg by mouth One Time. \n- prochlorperazine 5 MG/ML Injectable Solution, started on 2010-02-24, presumably until 2010-02-25\n- 0.8 ML enoxaparin sodium 150 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2010-02-24, presumably until 2010-06-25, with intended 1 refill(s). Instructions: 0.8 mL by SUBCUTANEOUS route every 12 hours. \n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2010-02-23, presumably until 2010-03-12, with intended 0 refill(s). Instructions: take 5 mL by mouth 4 times a day. \n- potassium chloride 1.33 MEQ/ML Oral Solution, through Oral route, started on 2010-02-23, presumably until 2010-02-23\n- loperamide hydrochloride 0.2 MG/ML Oral Solution, through Oral route, started on 2010-02-23, presumably until 2010-05-14, with quantity of 30.0, with intended 1 refill(s). Instructions: take by mouth as needed\n- cefepime 2000 MG Injection, through Intravenous route, started on 2010-02-23, presumably until 2010-02-25\n- lisinopril 5 MG Oral Tablet, through Oral route, started on 2010-02-26, presumably until 2010-03-12, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- 2 ML ondansetron 2 MG/ML Injection, started on 2010-02-23, presumably until 2010-02-25\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2010-02-24, presumably until 2010-02-25\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-02-24, presumably until 2010-02-24\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, started on 2010-02-23, presumably until 2010-02-25\n- prochlorperazine 5 MG Oral Tablet, through Oral route, started on 2010-02-26, presumably until 2010-05-14, with quantity of 30.0, with intended 1 refill(s). Instructions: take 5 mg by mouth every 6 hours as needed for Nausea/Vomiting. \n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2010-02-25, presumably until 2010-03-12, with quantity of 28.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2010-02-24, presumably until 2010-05-14, with quantity of 30.0, with intended 1 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed for Pain. \n- lidocaine hydrochloride 20 MG/ML Injectable Solution, started on 2010-02-25, presumably until 2010-02-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-01 08:30:00, ended at 2010-03-01 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 85.0 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 254 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.2 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 171 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 29.7 (picogram)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.5 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 54 (milliliter per minute per square meter)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 16.71 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 109 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 20.1 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 222 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.3 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.20 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.29 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.49 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.86 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Finding of head and neck region\n- Diarrhea\n- Malignant neoplastic disease\n- Primary malignant neoplasm of oropharynx\n- Swelling / lump finding\n- Fever\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-03-01, presumably until 2010-03-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-02 13:00:00, ended at 2010-03-02 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n- Swelling / lump finding\n- Finding of head and neck region\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-03-02, presumably until 2010-03-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-03-04 13:14:12, ended at 2010-03-04 13:36:26\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Iridocyclitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-05 17:16:00, ended at 2010-03-05 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Swelling / lump finding\n- Primary malignant neoplasm of oropharynx\n- Finding of head and neck region\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-03-05, presumably until 2010-03-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-07 16:00:00, ended at 2010-03-07 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Swelling / lump finding\n- Finding of head and neck region\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-03-07, presumably until 2010-03-07\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-08 08:00:00, ended at 2010-03-08 08:42:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Globulin [Mass/volume] in Serum: 5.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 86.0 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 7 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.18 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 9.37 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.5 (percent)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.5 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 2.2 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.89 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 135 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 109 (unit per liter)\n- Platelets [#/volume] in Blood by Automated count: 428 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant neoplastic disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-08 08:43:00, ended at 2010-03-08 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 3.984\" (inch (US))\n\n### Procedure\n- Nasopharyngoscopy with endoscope (separate procedure)\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2010-03-09 16:34:00, ended at 2010-03-14 20:38:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 54 (unit per liter)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.3 (percent)\n- MCH [Entitic mass] by Automated count: 30.4 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.2 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.0 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.70 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 413 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.4 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 35.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 85.9 (femtoliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 96 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Body height: 6' 4.181\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.3 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 2.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.32 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.01 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n\n### Procedure\n- Infusion chemotherapy for malignant neoplasm\n- Collection of venous blood by venipuncture\n\n### Condition\n- Chronic deep venous thrombosis of upper extremity\n- Mental disorder\n- Neoplasm of lymph node\n- Primary malignant neoplasm of oropharynx\n- Gastroesophageal reflux disease\n- Diarrhea\n- Iridocyclitis\n\n### Drug\n- fluconazole 200 MG Oral Tablet, through Oral route, started on 2010-03-10, presumably until 2010-03-14\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2010-03-09, presumably until 2010-06-25, with quantity of 60.0, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- aprepitant 125 MG Oral Capsule, through Oral route, started on 2010-03-09, presumably until 2010-03-09\n- loperamide hydrochloride 2 MG Oral Capsule, through Oral route, started on 2010-03-11, presumably until 2010-03-14\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2010-03-13, presumably until 2010-03-14\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2010-03-09, presumably until 2010-03-14\n- prochlorperazine 5 MG/ML Injectable Solution, started on 2010-03-13, presumably until 2010-03-13\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2010-03-09, presumably until 2010-03-11\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2010-03-14, presumably until 2010-03-14\n- 0.8 ML enoxaparin sodium 150 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2010-03-09, presumably until 2010-03-14\n- sodium chloride 9 MG/ML Injection, started on 2010-03-09, presumably until 2010-03-09\n- aprepitant 80 MG Oral Capsule, through Oral route, started on 2010-03-10, presumably until 2010-03-11\n- atropine sulfate 0.025 MG / diphenoxylate hydrochloride 2.5 MG Oral Tablet, through Oral route, started on 2010-03-11, presumably until 2010-05-14, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day as needed Use immodium 2 tabs first and if not responsive use lomotil up to 2 x a day. If having diahrrea infor Dr. Delerme office \n- 2 ML ondansetron 2 MG/ML Injection, started on 2010-03-12, presumably until 2010-03-12\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-03-09, presumably until 2010-03-14\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2010-03-09, presumably until 2010-03-11\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2010-03-11, presumably until 2010-03-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-16 15:24:00, ended at 2010-03-16 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- 0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2010-03-16, presumably until 2010-03-16\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2010-03-16, presumably until 2010-05-14, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-19 12:10:00, ended at 2010-03-19 12:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 2 (percent)\n- Neutrophils [#/volume] in Blood by Manual count: 4.8 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 54 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.0 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- MCV [Entitic volume] by Automated count: 85.4 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 13 (percent)\n- Eosinophils [#/volume] in Blood by Manual count: 0.2 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 25 (percent)\n- MCHC [Mass/volume] by Automated count: 35.3 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 41 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 117 (unit per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.86 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 2.0 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.0 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 181 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 68 (unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant neoplastic disease\n- Iridocyclitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-19 13:00:00, ended at 2010-03-19 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, presumably until 2010-05-14, with quantity of 30.0, with intended 2 refill(s). Instructions: take 1 Tab by mouth as directed. Take 1 tab by mouth three times daily on days 2 and 3 of chemotherapy and then three times daily, as needed, thereafter. \n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2010-03-19, presumably until 2010-05-14, with quantity of 24.0, with intended 2 refill(s). Instructions: take 2 Tabs by mouth as directed. Take 2 in the a.m. on days 2,3,4 of chemotherapy. \n- lorazepam 1 MG Oral Tablet, through Oral route, presumably until 2010-05-14, with quantity of 30.0, with intended 2 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed For nausea and vomiting. \n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2010-03-19, presumably until 2010-05-14, with quantity of 20.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- aprepitant 80 MG Oral Capsule, through Oral route, presumably until 2010-05-14, with quantity of 2.0, with intended 2 refill(s). Instructions: take 1 Cap by mouth daily. Take  in a.m. on days 2 and 3 of chemotherapy cycle. \n- prochlorperazine 10 MG Oral Tablet, through Oral route, presumably until 2010-05-14, with quantity of 30.0, with intended 2 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed For nausea and vomiting. \n- metoclopramide 10 MG Oral Tablet, through Oral route, started on 2010-03-19, presumably until 2010-05-14, with quantity of 30.0, with intended 2 refill(s). Instructions: take 1-2 Tabs by mouth 4 times a day. Take 1-2 tabs every 6hours as needed for nausea/vomiting \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-03-25 00:00:00, ended at 2010-03-25 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of oropharynx\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-25 10:30:00, ended at 2010-03-25 11:29:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 192 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.29 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.76 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.55 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.9 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 50 (milliliter per minute per square meter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.0 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 25.8 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 22.90 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 195 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.4 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.3 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 86.3 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Fever\n- Swelling / lump finding\n- Finding of head and neck region\n- Malignant neoplastic disease\n- Primary malignant neoplasm of oropharynx\n- Diarrhea\n- Primary malignant neoplasm of posterior wall of nasopharynx\n- Pain in throat\n\n### Drug\n- sucralfate 1000 MG Oral Tablet, through Oral route, started on 2010-03-25, presumably until 2010-05-17, with quantity of 120.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 4 times a day. Take 1 tablet and add to 30cc of water, drink the slurry 4 times a day for throat pain. \n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2010-03-25, presumably until 2010-04-02, with intended 0 refill(s). Instructions: take 5 mL by mouth 4 times a day. \n- lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution, through Oral route, started on 2010-03-25, presumably until 2010-05-17, with intended 6 refill(s). Instructions: take 10 mL by mouth One Time. Take 10 ml and add to 10 ml of antacid and shake up gargle and swallow 3 times a day as needed for throat pain. \n- 50 ML magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2010-03-25, presumably until 2010-03-25\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2010-03-25, presumably until 2010-03-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-25 11:30:00, ended at 2010-03-25 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Lymphadenopathy\n- Swelling / lump finding\n- Primary malignant neoplasm of base of tongue\n- Primary malignant neoplasm of oropharynx\n- Finding of head and neck region\n\n### Drug\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2010-03-25, presumably until 2010-03-25\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-03-25, presumably until 2010-03-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-04-02 00:00:00, ended at 2010-04-02 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n- Swelling / lump finding\n- Finding of head and neck region\n\n### Drug\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2010-04-02, presumably until 2010-05-14, with intended 0 refill(s). Instructions: take 5 mL by mouth 4 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-02 13:00:00, ended at 2010-04-02 14:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 2.1 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 5.4 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.5 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.05 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.28 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 544 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 222 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.42 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.05 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.9 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 29.9 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 81.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.2 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 86.7 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n- Lymphadenopathy\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2010-04-01, presumably until 2010-06-25, with quantity of 30.0, with intended 2 refill(s). Instructions: take 1 Tab by mouth as directed. Take 1 tab by mouth three times daily on days 2 and 3 of chemotherapy and then three times daily, as needed, thereafter. \n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2010-04-01, presumably until 2010-05-14, with quantity of 24.0, with intended 2 refill(s). Instructions: take 2 Tabs by mouth as directed. Take 2 in the a.m. on days 2,3,4 of chemotherapy. \n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2010-04-01, presumably until 2010-05-14, with quantity of 30.0, with intended 2 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed For nausea and vomiting. \n- aprepitant 80 MG Oral Capsule, through Oral route, started on 2010-04-01, presumably until 2010-05-14, with quantity of 2.0, with intended 2 refill(s). Instructions: take 1 Cap by mouth daily. Take  in a.m. on days 2 and 3 of chemotherapy cycle. \n- prochlorperazine 10 MG Oral Tablet, through Oral route, started on 2010-04-01, presumably until 2010-05-14, with quantity of 30.0, with intended 2 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed For nausea and vomiting. \n- metoclopramide 10 MG Oral Tablet, through Oral route, started on 2010-04-01, presumably until 2010-05-14, with quantity of 30.0, with intended 2 refill(s). Instructions: take 1-2 Tabs by mouth 4 times a day. Take 1-2 tabs every 6hours as needed for nausea/vomiting \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-02 15:00:00, ended at 2010-04-02 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n- Radiation treatment management, 5 treatments\n\n### Condition\n- Primary malignant neoplasm of base of tongue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-03 09:30:00, ended at 2010-04-03 14:47:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- aprepitant 125 MG Oral Capsule, through Oral route, started on 2010-04-03, presumably until 2010-04-03\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2010-04-03, presumably until 2010-04-03\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2010-04-03, presumably until 2010-04-03\n- sodium chloride 9 MG/ML Injection, started on 2010-04-03, presumably until 2010-04-03\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-04-03, presumably until 2010-04-03\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2010-04-03, presumably until 2010-04-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-03 14:48:00, ended at 2010-04-03 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of base of tongue\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2010-04-03, presumably until 2010-04-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-04 11:00:00, ended at 2010-04-04 15:43:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-04-04, presumably until 2010-04-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-04 15:44:00, ended at 2010-04-04 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of base of tongue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-05 09:30:00, ended at 2010-04-05 15:47:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-04-05, presumably until 2010-04-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-05 15:48:00, ended at 2010-04-05 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of base of tongue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-08 15:48:00, ended at 2010-04-08 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of base of tongue\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2010-04-08, presumably until 2010-04-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-09 08:20:00, ended at 2010-04-09 08:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.1 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 53 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.18 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 86.8 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.4 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.0 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.4 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 102 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.22 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 454 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 181 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.22 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 132 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- aprepitant 125 MG Oral Capsule, through Oral route, started on 2010-04-09, presumably until 2010-04-09\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2010-04-09, presumably until 2010-04-09\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2010-04-09, presumably until 2010-04-09\n- sodium chloride 9 MG/ML Injection, started on 2010-04-09, presumably until 2010-04-09\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-04-09, presumably until 2010-04-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-09 09:00:00, ended at 2010-04-09 16:20:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-09 16:21:00, ended at 2010-04-09 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n- Radiation treatment management, 5 treatments\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n- Primary malignant neoplasm of base of tongue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-10 17:15:00, ended at 2010-04-10 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of base of tongue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-11 15:00:00, ended at 2010-04-11 16:39:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2010-04-11, presumably until 2010-04-11\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2010-04-11, presumably until 2010-04-11\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-04-11, presumably until 2010-04-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-11 16:40:00, ended at 2010-04-11 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of base of tongue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-12 17:15:00, ended at 2010-04-12 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of base of tongue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-15 16:54:00, ended at 2010-04-15 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of base of tongue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-04-16 00:00:00, ended at 2010-04-16 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of oropharynx\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-16 08:30:00, ended at 2010-04-16 16:04:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-16 16:05:00, ended at 2010-04-16 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n- Radiation treatment management, 5 treatments\n\n### Condition\n- Primary malignant neoplasm of base of tongue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-17 10:30:00, ended at 2010-04-17 16:06:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- aprepitant 125 MG Oral Capsule, through Oral route, started on 2010-04-17, presumably until 2010-04-17\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2010-04-17, presumably until 2010-04-17\n- sodium chloride 9 MG/ML Injection, started on 2010-04-17, presumably until 2010-04-17\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-04-17, presumably until 2010-04-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-17 16:07:00, ended at 2010-04-17 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of base of tongue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-18 14:55:00, ended at 2010-04-18 16:10:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2010-04-18, presumably until 2010-04-18\n- aprepitant 80 MG Oral Capsule, through Oral route, started on 2010-04-18, presumably until 2010-04-18\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-04-18, presumably until 2010-04-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-18 16:11:00, ended at 2010-04-18 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of base of tongue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-19 15:30:00, ended at 2010-04-19 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of base of tongue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-22 14:30:00, ended at 2010-04-22 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of base of tongue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-23 07:20:00, ended at 2010-04-23 08:12:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 87.4 (femtoliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.46 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.93 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.71 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.6 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 142 (unit per liter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.5 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.4 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.67 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 158 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.3 (percent)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.64 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 78 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- aprepitant 125 MG Oral Capsule, through Oral route, started on 2010-04-23, presumably until 2010-04-23\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2010-04-23, presumably until 2010-04-23\n- sodium chloride 9 MG/ML Injection, started on 2010-04-23, presumably until 2010-04-23\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-04-23, presumably until 2010-04-23\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-23 08:13:00, ended at 2010-04-23 14:29:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 3.984\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- fluconazole 100 MG Oral Tablet, through Oral route, started on 2010-04-23, presumably until 2010-07-12, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-23 14:30:00, ended at 2010-04-23 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiation treatment management, 5 treatments\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of base of tongue\n\n### Drug\n- 72 HR fentanyl 0.025 MG/HR Transdermal System, through Transdermal route, presumably until 2010-05-20. Instructions: by Transdermal route. 25mcq transdermal patch q3day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-24 09:45:00, ended at 2010-04-24 10:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of base of tongue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-24 11:00:00, ended at 2010-04-24 12:25:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic radiology simulation-aided field setting; complex\n\n### Condition\n- Primary malignant neoplasm of base of tongue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-24 12:26:00, ended at 2010-04-24 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- aprepitant 80 MG Oral Capsule, through Oral route, started on 2010-04-24, presumably until 2010-04-24\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-04-24, presumably until 2010-04-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-25 14:30:00, ended at 2010-04-25 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Lymphadenopathy\n- Primary malignant neoplasm of base of tongue\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-26 12:40:00, ended at 2010-04-26 14:29:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diarrhea\n- Fever\n- Malignant neoplastic disease\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2010-04-26, presumably until 2010-04-26\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-04-26, presumably until 2010-04-26\n- morphine sulfate 2 MG/ML Oral Solution, through Oral route, presumably until 2010-06-25. Instructions: take 5 mg by mouth every 3 to 4 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-26 14:30:00, ended at 2010-04-26 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of base of tongue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-29 14:30:00, ended at 2010-04-29 17:04:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of base of tongue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-29 17:05:00, ended at 2010-04-29 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n- Finding of head and neck region\n- Swelling / lump finding\n\n### Drug\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2010-04-29, presumably until 2010-04-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-30 07:20:00, ended at 2010-04-30 08:03:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.5 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.9 (percent)\n- MCV [Entitic volume] by Automated count: 86.3 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 157 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.65 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.39 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.33 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 51 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 75 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.5 (percent)\n- MCH [Entitic mass] by Automated count: 29.7 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Anion gap in Serum or Plasma: 16 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.41 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.41 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.6 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 75.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 117 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- aprepitant 125 MG Oral Capsule, through Oral route, started on 2010-04-30, presumably until 2010-04-30\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2010-04-30, presumably until 2010-04-30\n- sodium chloride 9 MG/ML Injection, started on 2010-04-30, presumably until 2010-04-30\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-04-30, presumably until 2010-04-30\n\n"}, "target": "Yes", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive their first ever diagnosis of Essential hypertension within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-03-19 00:00:00, ended at 2009-03-19 00:00:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.0 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.4 (percent)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.9 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.12 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.1 (percent)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 4.83 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.32 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 249 (thousand per microliter)\n- Prothrombin time (PT): 14.0 (second)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.80 (million per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 85.7 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.2 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 59 (milliliter per minute per square meter)\n- aPTT in Platelet poor plasma by Coagulation assay: 32.3 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2009-03-20 11:04:00, ended at 2009-03-22 11:50:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 4\" (inch (US))\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.9 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Branchial cleft cyst\n\n### Drug\n- docusate sodium 10 MG/ML Oral Solution, through Oral route, started on 2009-03-21, presumably until 2009-06-08, with quantity of 30.0, with intended 0 refill(s). Instructions: take 25 mL by mouth daily. \n- bacitracin zinc 0.5 UNT/MG Topical Ointment, through Topical route, started on 2009-03-22, presumably until 2009-06-08. Instructions: by Topical route 3 times a day. \n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2009-03-20, presumably until 2009-03-21\n- amoxicillin 80 MG/ML / clavulanate 11.4 MG/ML Oral Suspension, through Oral route, started on 2009-03-21, presumably until 2009-03-21\n- acetaminophen 33.3 MG/ML / hydrocodone bitartrate 0.5 MG/ML Oral Solution, through Oral route, started on 2009-03-21, presumably until 2009-03-21\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, started on 2009-03-20, presumably until 2009-03-21\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2009-03-21, presumably until 2009-06-08, with quantity of 14.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours. \n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2009-03-21, presumably until 2009-06-08, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain. \n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2009-03-20, presumably until 2009-03-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-06-08 06:25:00, ended at 2009-06-08 12:10:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 4\" (inch (US))\n- Glucose [Mass/volume] in Serum or Plasma: 109 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant neoplastic disease\n\n### Drug\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2009-06-08, presumably until 2009-06-08\n- docusate sodium 10 MG/ML Oral Solution, through Oral route, started on 2009-06-08, presumably until 2010-02-26, with quantity of 60.0, with intended 0 refill(s). Instructions: take 25 mL by mouth 2 times a day. \n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2009-06-08, presumably until 2009-12-05, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-06 08:57:00, ended at 2009-12-06 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 4\" (inch (US))\n\n### Procedure\n- Laryngoscopy, flexible; diagnostic\n\n### Condition\n- Primary malignant neoplasm of base of tongue\n- Neoplasm of lymph node\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-28 09:29:00, ended at 2009-12-28 11:31:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, extremity, nonvascular, real time with image documentation\n- Biopsy or excision of lymph node(s); by needle, superficial (eg, cervical, inguinal, axillary)\n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n\n### Condition\n- Malignant tumor of head and neck\n- Primary malignant neoplasm of tonsil\n- Primary malignant neoplasm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-28 11:32:00, ended at 2009-12-28 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Lymphadenitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-10 17:10:00, ended at 2010-01-10 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of hematopoietic structure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-02-07 00:00:00, ended at 2010-02-07 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Malignant neoplastic disease\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2010-02-07, presumably until 2010-05-14, with quantity of 30.0, with intended 2 refill(s). Instructions: take 1 Tab by mouth as directed. Take 1 tab by mouth three times daily on days 2 and 3 of chemotherapy and then three times daily, as needed, thereafter. \n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2010-02-07, presumably until 2010-05-14, with quantity of 32.0, with intended 2 refill(s). Instructions: take 2 Tabs by mouth as directed. Take 8mg twice daily starting the day before chemotherapy and continue x 4 days total. \n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2010-02-07, presumably until 2010-05-14, with quantity of 30.0, with intended 2 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed For nausea and vomiting. \n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2010-02-07, presumably until 2010-02-26, with quantity of 20.0, with intended 2 refill(s). Instructions: take 1 Tab by mouth 2 times a day. Start Cipro 500 mg BID on day 5.  Take for 10 days. \n- aprepitant 80 MG Oral Capsule, through Oral route, started on 2010-02-07, presumably until 2010-03-12, with quantity of 2.0, with intended 2 refill(s). Instructions: take 1 Cap by mouth daily. Take  in a.m. on days 2 and 3 of chemotherapy cycle. \n- prochlorperazine 10 MG Oral Tablet, through Oral route, started on 2010-02-07, presumably until 2010-03-12, with quantity of 30.0, with intended 2 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed For nausea and vomiting. \n- metoclopramide 10 MG Oral Tablet, through Oral route, started on 2010-02-07, presumably until 2010-03-12, with quantity of 30.0, with intended 2 refill(s). Instructions: take 1-2 Tabs by mouth 4 times a day. Take 1-2 tabs every 6hours as needed for nausea/vomiting \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-07 09:00:00, ended at 2010-02-07 14:09:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 3.394\" (inch (US))\n\n### Procedure\n- Laryngoscopy, flexible; diagnostic\n\n### Condition\n- Lymphadenopathy\n- Neoplasm of lymph node\n- Primary malignant neoplasm of base of tongue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-07 14:10:00, ended at 2010-02-07 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Lymphadenopathy\n- Primary malignant neoplasm of base of tongue\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-02-08 00:00:00, ended at 2010-02-08 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of oropharynx\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-12 15:00:00, ended at 2010-02-12 18:01:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 4\" (inch (US))\n\n### Procedure\n- Laryngoscopy, flexible; diagnostic\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n- Lymphadenopathy\n- Malignant neoplastic disease\n- Sensorineural hearing loss\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-12 18:02:00, ended at 2010-02-12 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.4 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.36 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 15.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.75 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 29.2 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 102 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.7 (percent)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 59 (milliliter per minute per square meter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 29.1 (percent)\n- MCV [Entitic volume] by Automated count: 86.8 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.35 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 58.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 222 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 59 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.49 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Lymphadenopathy\n- Malignant neoplastic disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-14 08:00:00, ended at 2010-02-14 11:58:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n- Therapeutic radiology simulation-aided field setting; complex\n\n### Condition\n- Primary malignant neoplasm of base of tongue\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-14 11:59:00, ended at 2010-02-14 13:26:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML sodium bicarbonate 84 MG/ML Injection, through Intravenous route, started on 2010-02-14, presumably until 2010-02-14\n- lidocaine hydrochloride 20 MG/ML Injectable Solution, started on 2010-02-14, presumably until 2010-02-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-14 13:27:00, ended at 2010-02-14 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest; single view, frontal\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-15 09:00:00, ended at 2010-02-15 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- aprepitant 125 MG Oral Capsule, through Oral route, started on 2010-02-15, presumably until 2010-02-15\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2010-02-15, presumably until 2010-02-15\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2010-02-15, presumably until 2010-02-15\n- sodium chloride 9 MG/ML Injection, started on 2010-02-15, presumably until 2010-02-15\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-02-15, presumably until 2010-02-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-16 15:00:00, ended at 2010-02-16 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-02-16, presumably until 2010-02-16\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-17 11:00:00, ended at 2010-02-17 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- loperamide hydrochloride 2 MG Oral Capsule, through Oral route, started on 2010-02-17, presumably until 2010-02-17\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-02-17, presumably until 2010-02-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-19 14:10:00, ended at 2010-02-19 14:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Platelets [#/volume] in Blood by Automated count: 140 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.26 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.1 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.9 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.28 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.15 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.5 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.5 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 84.7 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 54 (unit per liter)\n- Anion gap in Serum or Plasma: 3 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 15.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 131 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 0.5 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant neoplastic disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-19 15:00:00, ended at 2010-02-19 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-02-21 00:00:00, ended at 2010-02-21 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of oropharynx\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-21 16:00:00, ended at 2010-02-21 17:29:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atropine sulfate 0.025 MG / diphenoxylate hydrochloride 2.5 MG Oral Tablet, through Oral route, started on 2010-02-21, presumably until 2010-02-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-02-22 00:00:00, ended at 2010-02-22 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of oropharynx\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-22 10:47:00, ended at 2010-02-22 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.3 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 5.6 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.6 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.59 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 0.63 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.3 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 7.4 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 48.2 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 68 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.57 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 45.0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 54 (milliliter per minute per square meter)\n- Leukocytes [#/volume] in Specimen by Automated count: 1.3 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 83.9 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 103 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.8 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant neoplastic disease\n- Primary malignant neoplasm of base of tongue\n- Primary malignant neoplasm of oropharynx\n- Swelling / lump finding\n- Diarrhea\n- Dehydration\n- Finding of head and neck region\n\n### Drug\n- 0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2010-02-22, presumably until 2010-02-22\n- atropine sulfate 0.025 MG / diphenoxylate hydrochloride 2.5 MG Oral Tablet, through Oral route, presumably until 2010-02-26. Instructions: take by mouth as needed \n- 2 ML ondansetron 2 MG/ML Injection, started on 2010-02-22, presumably until 2010-02-22\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-02-22, presumably until 2010-02-22\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-23 09:30:00, ended at 2010-02-23 15:32:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Finding of head and neck region\n- Swelling / lump finding\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- lisinopril 10 MG Oral Tablet, through Oral route, presumably until 2010-02-26. Instructions: take 10 mg by mouth daily. \n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-02-23, presumably until 2010-02-23\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2010-02-23 15:33:00, ended at 2010-02-26 13:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Manual count: 2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 61 (percent)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Body height: 6' 4\" (inch (US))\n- Carbon dioxide [Partial pressure] in Blood: 38.8 (millimeter mercury column)\n- Eosinophils [#/volume] in Blood by Manual count: 0.1 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 35.8 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.92 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 2.4 (thousand per microliter)\n- Prothrombin time (PT): 16.4 (second)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 6.3 (microgram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 78 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.1 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.2 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 97 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 7 (milligram per deciliter)\n- Base excess in Blood by calculation: 1.0 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 35.3 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 2.3 (gram per deciliter)\n- Basophils [#/volume] in Blood by Manual count: 0.1 (thousand per microliter)\n- Bicarbonate [Moles/volume] in Specimen: 25.1 (milliequivalent per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.36 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.3 (percent)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- MCV [Entitic volume] by Automated count: 86.1 (femtoliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.5 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 30 (percent)\n- Oxygen [Partial pressure] in Blood: 57 (millimeter mercury column)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.01 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 66 (unit per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.4 (ratio)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 9.69 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 80.4 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.13 (million per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Radiologic examination, chest; single view, frontal\n- Collection of venous blood by venipuncture\n- Removal of other device from thorax\n- Venous catheterization, not elsewhere classified\n- Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study\n\n### Condition\n- Neutropenic disorder\n- Disturbance in speech\n- Lymphadenopathy\n- Primary malignant neoplasm of oropharynx\n- Candidiasis of mouth\n- Infection of intravenous catheter\n- Sepsis\n- Ulcerative stomatitis\n- Fever\n- Low blood pressure\n- Neoplasm of lymph node\n- Acute deep venous thrombosis of upper extremity\n- Finding of head and neck region\n- Lung field abnormal\n- Phlebitis\n- Acute renal failure syndrome\n- Dehydration\n- Diarrhea\n- Disorder of upper extremity\n- Swelling / lump finding\n- Primary malignant neoplasm of pharynx\n\n### Drug\n- 50 ML sodium bicarbonate 84 MG/ML Injection, through Intravenous route, started on 2010-02-25, presumably until 2010-02-25\n- fluconazole 200 MG Oral Tablet, through Oral route, started on 2010-02-24, presumably until 2010-05-14, with quantity of 14.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-02-24, presumably until 2010-02-25\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2010-02-24, presumably until 2010-02-24\n- hypromellose 25 MG/ML Ophthalmic Solution, through Intraocular route, started on 2010-02-26, presumably until 2010-03-12, with intended 0 refill(s). Instructions: 1 Drop by Right Eye route 3 times a day as needed \n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2010-02-24, presumably until 2010-05-14, with quantity of 30.0, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily. \n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2010-02-24, presumably until 2010-02-24\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2010-02-24, presumably until 2010-05-17, with quantity of 30.0, with intended 1 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed for Insomnia. \n- diphenhydramine hydrochloride 2.5 MG/ML Oral Solution, through Oral route, started on 2010-02-23, presumably until 2010-02-26\n- lidocaine 40 MG/ML Topical Cream, through Topical route, started on 2010-02-25, presumably until 2010-02-25\n- ondansetron 0.8 MG/ML Oral Solution, through Oral route, started on 2010-02-26, presumably until 2010-03-12, with intended 0 refill(s). Instructions: take 4 mg by mouth One Time. \n- prochlorperazine 5 MG/ML Injectable Solution, started on 2010-02-24, presumably until 2010-02-25\n- 0.8 ML enoxaparin sodium 150 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2010-02-24, presumably until 2010-06-25, with intended 1 refill(s). Instructions: 0.8 mL by SUBCUTANEOUS route every 12 hours. \n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2010-02-23, presumably until 2010-03-12, with intended 0 refill(s). Instructions: take 5 mL by mouth 4 times a day. \n- potassium chloride 1.33 MEQ/ML Oral Solution, through Oral route, started on 2010-02-23, presumably until 2010-02-23\n- loperamide hydrochloride 0.2 MG/ML Oral Solution, through Oral route, started on 2010-02-23, presumably until 2010-05-14, with quantity of 30.0, with intended 1 refill(s). Instructions: take by mouth as needed\n- cefepime 2000 MG Injection, through Intravenous route, started on 2010-02-23, presumably until 2010-02-25\n- lisinopril 5 MG Oral Tablet, through Oral route, started on 2010-02-26, presumably until 2010-03-12, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- 2 ML ondansetron 2 MG/ML Injection, started on 2010-02-23, presumably until 2010-02-25\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2010-02-24, presumably until 2010-02-25\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-02-24, presumably until 2010-02-24\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, started on 2010-02-23, presumably until 2010-02-25\n- prochlorperazine 5 MG Oral Tablet, through Oral route, started on 2010-02-26, presumably until 2010-05-14, with quantity of 30.0, with intended 1 refill(s). Instructions: take 5 mg by mouth every 6 hours as needed for Nausea/Vomiting. \n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2010-02-25, presumably until 2010-03-12, with quantity of 28.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2010-02-24, presumably until 2010-05-14, with quantity of 30.0, with intended 1 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed for Pain. \n- lidocaine hydrochloride 20 MG/ML Injectable Solution, started on 2010-02-25, presumably until 2010-02-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-01 08:30:00, ended at 2010-03-01 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 85.0 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 254 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.2 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 171 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 29.7 (picogram)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.5 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 54 (milliliter per minute per square meter)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 16.71 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 109 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 20.1 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 222 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.3 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.20 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.29 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.49 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.86 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Finding of head and neck region\n- Diarrhea\n- Malignant neoplastic disease\n- Primary malignant neoplasm of oropharynx\n- Swelling / lump finding\n- Fever\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-03-01, presumably until 2010-03-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-02 13:00:00, ended at 2010-03-02 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n- Swelling / lump finding\n- Finding of head and neck region\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-03-02, presumably until 2010-03-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-03-04 13:14:12, ended at 2010-03-04 13:36:26\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Iridocyclitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-05 17:16:00, ended at 2010-03-05 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Swelling / lump finding\n- Primary malignant neoplasm of oropharynx\n- Finding of head and neck region\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-03-05, presumably until 2010-03-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-07 16:00:00, ended at 2010-03-07 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Swelling / lump finding\n- Finding of head and neck region\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-03-07, presumably until 2010-03-07\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-08 08:00:00, ended at 2010-03-08 08:42:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Globulin [Mass/volume] in Serum: 5.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 86.0 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 7 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.18 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 9.37 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.5 (percent)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.5 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 2.2 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.89 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 135 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 109 (unit per liter)\n- Platelets [#/volume] in Blood by Automated count: 428 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant neoplastic disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-08 08:43:00, ended at 2010-03-08 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 3.984\" (inch (US))\n\n### Procedure\n- Nasopharyngoscopy with endoscope (separate procedure)\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2010-03-09 16:34:00, ended at 2010-03-14 20:38:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 54 (unit per liter)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.3 (percent)\n- MCH [Entitic mass] by Automated count: 30.4 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.2 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.0 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.70 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 413 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.4 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 35.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 85.9 (femtoliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 96 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Body height: 6' 4.181\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.3 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 2.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.32 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.01 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n\n### Procedure\n- Infusion chemotherapy for malignant neoplasm\n- Collection of venous blood by venipuncture\n\n### Condition\n- Chronic deep venous thrombosis of upper extremity\n- Mental disorder\n- Neoplasm of lymph node\n- Primary malignant neoplasm of oropharynx\n- Gastroesophageal reflux disease\n- Diarrhea\n- Iridocyclitis\n\n### Drug\n- fluconazole 200 MG Oral Tablet, through Oral route, started on 2010-03-10, presumably until 2010-03-14\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2010-03-09, presumably until 2010-06-25, with quantity of 60.0, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- aprepitant 125 MG Oral Capsule, through Oral route, started on 2010-03-09, presumably until 2010-03-09\n- loperamide hydrochloride 2 MG Oral Capsule, through Oral route, started on 2010-03-11, presumably until 2010-03-14\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2010-03-13, presumably until 2010-03-14\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2010-03-09, presumably until 2010-03-14\n- prochlorperazine 5 MG/ML Injectable Solution, started on 2010-03-13, presumably until 2010-03-13\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2010-03-09, presumably until 2010-03-11\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2010-03-14, presumably until 2010-03-14\n- 0.8 ML enoxaparin sodium 150 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2010-03-09, presumably until 2010-03-14\n- sodium chloride 9 MG/ML Injection, started on 2010-03-09, presumably until 2010-03-09\n- aprepitant 80 MG Oral Capsule, through Oral route, started on 2010-03-10, presumably until 2010-03-11\n- atropine sulfate 0.025 MG / diphenoxylate hydrochloride 2.5 MG Oral Tablet, through Oral route, started on 2010-03-11, presumably until 2010-05-14, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day as needed Use immodium 2 tabs first and if not responsive use lomotil up to 2 x a day. If having diahrrea infor Dr. Delerme office \n- 2 ML ondansetron 2 MG/ML Injection, started on 2010-03-12, presumably until 2010-03-12\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-03-09, presumably until 2010-03-14\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2010-03-09, presumably until 2010-03-11\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2010-03-11, presumably until 2010-03-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-16 15:24:00, ended at 2010-03-16 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- 0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2010-03-16, presumably until 2010-03-16\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2010-03-16, presumably until 2010-05-14, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-19 12:10:00, ended at 2010-03-19 12:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 2 (percent)\n- Neutrophils [#/volume] in Blood by Manual count: 4.8 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 54 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.0 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- MCV [Entitic volume] by Automated count: 85.4 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 13 (percent)\n- Eosinophils [#/volume] in Blood by Manual count: 0.2 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 25 (percent)\n- MCHC [Mass/volume] by Automated count: 35.3 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 41 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 117 (unit per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.86 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 2.0 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.0 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 181 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 68 (unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant neoplastic disease\n- Iridocyclitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-19 13:00:00, ended at 2010-03-19 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, presumably until 2010-05-14, with quantity of 30.0, with intended 2 refill(s). Instructions: take 1 Tab by mouth as directed. Take 1 tab by mouth three times daily on days 2 and 3 of chemotherapy and then three times daily, as needed, thereafter. \n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2010-03-19, presumably until 2010-05-14, with quantity of 24.0, with intended 2 refill(s). Instructions: take 2 Tabs by mouth as directed. Take 2 in the a.m. on days 2,3,4 of chemotherapy. \n- lorazepam 1 MG Oral Tablet, through Oral route, presumably until 2010-05-14, with quantity of 30.0, with intended 2 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed For nausea and vomiting. \n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2010-03-19, presumably until 2010-05-14, with quantity of 20.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- aprepitant 80 MG Oral Capsule, through Oral route, presumably until 2010-05-14, with quantity of 2.0, with intended 2 refill(s). Instructions: take 1 Cap by mouth daily. Take  in a.m. on days 2 and 3 of chemotherapy cycle. \n- prochlorperazine 10 MG Oral Tablet, through Oral route, presumably until 2010-05-14, with quantity of 30.0, with intended 2 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed For nausea and vomiting. \n- metoclopramide 10 MG Oral Tablet, through Oral route, started on 2010-03-19, presumably until 2010-05-14, with quantity of 30.0, with intended 2 refill(s). Instructions: take 1-2 Tabs by mouth 4 times a day. Take 1-2 tabs every 6hours as needed for nausea/vomiting \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-03-25 00:00:00, ended at 2010-03-25 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of oropharynx\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-25 10:30:00, ended at 2010-03-25 11:29:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 192 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.29 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.76 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.55 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.9 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 50 (milliliter per minute per square meter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.0 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 25.8 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 22.90 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 195 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.4 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.3 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 86.3 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Fever\n- Swelling / lump finding\n- Finding of head and neck region\n- Malignant neoplastic disease\n- Primary malignant neoplasm of oropharynx\n- Diarrhea\n- Primary malignant neoplasm of posterior wall of nasopharynx\n- Pain in throat\n\n### Drug\n- sucralfate 1000 MG Oral Tablet, through Oral route, started on 2010-03-25, presumably until 2010-05-17, with quantity of 120.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 4 times a day. Take 1 tablet and add to 30cc of water, drink the slurry 4 times a day for throat pain. \n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2010-03-25, presumably until 2010-04-02, with intended 0 refill(s). Instructions: take 5 mL by mouth 4 times a day. \n- lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution, through Oral route, started on 2010-03-25, presumably until 2010-05-17, with intended 6 refill(s). Instructions: take 10 mL by mouth One Time. Take 10 ml and add to 10 ml of antacid and shake up gargle and swallow 3 times a day as needed for throat pain. \n- 50 ML magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2010-03-25, presumably until 2010-03-25\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2010-03-25, presumably until 2010-03-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-25 11:30:00, ended at 2010-03-25 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Lymphadenopathy\n- Swelling / lump finding\n- Primary malignant neoplasm of base of tongue\n- Primary malignant neoplasm of oropharynx\n- Finding of head and neck region\n\n### Drug\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2010-03-25, presumably until 2010-03-25\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-03-25, presumably until 2010-03-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-04-02 00:00:00, ended at 2010-04-02 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n- Swelling / lump finding\n- Finding of head and neck region\n\n### Drug\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2010-04-02, presumably until 2010-05-14, with intended 0 refill(s). Instructions: take 5 mL by mouth 4 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-02 13:00:00, ended at 2010-04-02 14:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 2.1 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 5.4 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.5 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.05 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.28 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 544 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 222 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.42 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.05 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.9 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 29.9 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 81.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.2 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 86.7 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n- Lymphadenopathy\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2010-04-01, presumably until 2010-06-25, with quantity of 30.0, with intended 2 refill(s). Instructions: take 1 Tab by mouth as directed. Take 1 tab by mouth three times daily on days 2 and 3 of chemotherapy and then three times daily, as needed, thereafter. \n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2010-04-01, presumably until 2010-05-14, with quantity of 24.0, with intended 2 refill(s). Instructions: take 2 Tabs by mouth as directed. Take 2 in the a.m. on days 2,3,4 of chemotherapy. \n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2010-04-01, presumably until 2010-05-14, with quantity of 30.0, with intended 2 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed For nausea and vomiting. \n- aprepitant 80 MG Oral Capsule, through Oral route, started on 2010-04-01, presumably until 2010-05-14, with quantity of 2.0, with intended 2 refill(s). Instructions: take 1 Cap by mouth daily. Take  in a.m. on days 2 and 3 of chemotherapy cycle. \n- prochlorperazine 10 MG Oral Tablet, through Oral route, started on 2010-04-01, presumably until 2010-05-14, with quantity of 30.0, with intended 2 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed For nausea and vomiting. \n- metoclopramide 10 MG Oral Tablet, through Oral route, started on 2010-04-01, presumably until 2010-05-14, with quantity of 30.0, with intended 2 refill(s). Instructions: take 1-2 Tabs by mouth 4 times a day. Take 1-2 tabs every 6hours as needed for nausea/vomiting \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-02 15:00:00, ended at 2010-04-02 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n- Radiation treatment management, 5 treatments\n\n### Condition\n- Primary malignant neoplasm of base of tongue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-03 09:30:00, ended at 2010-04-03 14:47:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- aprepitant 125 MG Oral Capsule, through Oral route, started on 2010-04-03, presumably until 2010-04-03\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2010-04-03, presumably until 2010-04-03\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2010-04-03, presumably until 2010-04-03\n- sodium chloride 9 MG/ML Injection, started on 2010-04-03, presumably until 2010-04-03\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-04-03, presumably until 2010-04-03\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2010-04-03, presumably until 2010-04-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-03 14:48:00, ended at 2010-04-03 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of base of tongue\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2010-04-03, presumably until 2010-04-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-04 11:00:00, ended at 2010-04-04 15:43:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-04-04, presumably until 2010-04-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-04 15:44:00, ended at 2010-04-04 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of base of tongue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-05 09:30:00, ended at 2010-04-05 15:47:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-04-05, presumably until 2010-04-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-05 15:48:00, ended at 2010-04-05 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of base of tongue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-08 15:48:00, ended at 2010-04-08 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of base of tongue\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2010-04-08, presumably until 2010-04-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-09 08:20:00, ended at 2010-04-09 08:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.1 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 53 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.18 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 86.8 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.4 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.0 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.4 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 102 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.22 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 454 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 181 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.22 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 132 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- aprepitant 125 MG Oral Capsule, through Oral route, started on 2010-04-09, presumably until 2010-04-09\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2010-04-09, presumably until 2010-04-09\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2010-04-09, presumably until 2010-04-09\n- sodium chloride 9 MG/ML Injection, started on 2010-04-09, presumably until 2010-04-09\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-04-09, presumably until 2010-04-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-09 09:00:00, ended at 2010-04-09 16:20:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-09 16:21:00, ended at 2010-04-09 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n- Radiation treatment management, 5 treatments\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n- Primary malignant neoplasm of base of tongue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-10 17:15:00, ended at 2010-04-10 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of base of tongue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-11 15:00:00, ended at 2010-04-11 16:39:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2010-04-11, presumably until 2010-04-11\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2010-04-11, presumably until 2010-04-11\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-04-11, presumably until 2010-04-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-11 16:40:00, ended at 2010-04-11 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of base of tongue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-12 17:15:00, ended at 2010-04-12 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of base of tongue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-15 16:54:00, ended at 2010-04-15 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of base of tongue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-04-16 00:00:00, ended at 2010-04-16 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of oropharynx\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-16 08:30:00, ended at 2010-04-16 16:04:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-16 16:05:00, ended at 2010-04-16 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n- Radiation treatment management, 5 treatments\n\n### Condition\n- Primary malignant neoplasm of base of tongue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-17 10:30:00, ended at 2010-04-17 16:06:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- aprepitant 125 MG Oral Capsule, through Oral route, started on 2010-04-17, presumably until 2010-04-17\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2010-04-17, presumably until 2010-04-17\n- sodium chloride 9 MG/ML Injection, started on 2010-04-17, presumably until 2010-04-17\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-04-17, presumably until 2010-04-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-17 16:07:00, ended at 2010-04-17 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of base of tongue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-18 14:55:00, ended at 2010-04-18 16:10:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2010-04-18, presumably until 2010-04-18\n- aprepitant 80 MG Oral Capsule, through Oral route, started on 2010-04-18, presumably until 2010-04-18\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-04-18, presumably until 2010-04-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-18 16:11:00, ended at 2010-04-18 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of base of tongue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-19 15:30:00, ended at 2010-04-19 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of base of tongue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-22 14:30:00, ended at 2010-04-22 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of base of tongue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-23 07:20:00, ended at 2010-04-23 08:12:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 87.4 (femtoliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.46 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.93 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.71 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.6 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 142 (unit per liter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.5 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.4 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.67 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 158 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.3 (percent)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.64 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 78 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- aprepitant 125 MG Oral Capsule, through Oral route, started on 2010-04-23, presumably until 2010-04-23\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2010-04-23, presumably until 2010-04-23\n- sodium chloride 9 MG/ML Injection, started on 2010-04-23, presumably until 2010-04-23\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-04-23, presumably until 2010-04-23\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-23 08:13:00, ended at 2010-04-23 14:29:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 3.984\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- fluconazole 100 MG Oral Tablet, through Oral route, started on 2010-04-23, presumably until 2010-07-12, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-23 14:30:00, ended at 2010-04-23 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiation treatment management, 5 treatments\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of base of tongue\n\n### Drug\n- 72 HR fentanyl 0.025 MG/HR Transdermal System, through Transdermal route, presumably until 2010-05-20. Instructions: by Transdermal route. 25mcq transdermal patch q3day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-24 09:45:00, ended at 2010-04-24 10:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of base of tongue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-24 11:00:00, ended at 2010-04-24 12:25:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic radiology simulation-aided field setting; complex\n\n### Condition\n- Primary malignant neoplasm of base of tongue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-24 12:26:00, ended at 2010-04-24 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- aprepitant 80 MG Oral Capsule, through Oral route, started on 2010-04-24, presumably until 2010-04-24\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-04-24, presumably until 2010-04-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-25 14:30:00, ended at 2010-04-25 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Lymphadenopathy\n- Primary malignant neoplasm of base of tongue\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-26 12:40:00, ended at 2010-04-26 14:29:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diarrhea\n- Fever\n- Malignant neoplastic disease\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2010-04-26, presumably until 2010-04-26\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-04-26, presumably until 2010-04-26\n- morphine sulfate 2 MG/ML Oral Solution, through Oral route, presumably until 2010-06-25. Instructions: take 5 mg by mouth every 3 to 4 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-26 14:30:00, ended at 2010-04-26 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of base of tongue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-29 14:30:00, ended at 2010-04-29 17:04:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of base of tongue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-29 17:05:00, ended at 2010-04-29 23:59:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n- Finding of head and neck region\n- Swelling / lump finding\n\n### Drug\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2010-04-29, presumably until 2010-04-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-30 07:20:00, ended at 2010-04-30 08:03:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.5 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.9 (percent)\n- MCV [Entitic volume] by Automated count: 86.3 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 157 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.65 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.39 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.33 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 51 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 75 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.5 (percent)\n- MCH [Entitic mass] by Automated count: 29.7 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Anion gap in Serum or Plasma: 16 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.41 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.41 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.6 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 75.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 117 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of oropharynx\n\n### Drug\n- aprepitant 125 MG Oral Capsule, through Oral route, started on 2010-04-30, presumably until 2010-04-30\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2010-04-30, presumably until 2010-04-30\n- sodium chloride 9 MG/ML Injection, started on 2010-04-30, presumably until 2010-04-30\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-04-30, presumably until 2010-04-30\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive their first ever diagnosis of Essential hypertension within the next year (we could not find any prior history of this condition in their medical records before)\n- the condition of hypertension means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "050ed5bdbb9164fc731b7679a82f7b7c8f2c24c91a11761b1e44e919b5e8c379", "prompt_hash": "6de1884312860d1da0611e3abc8ea8b8164453099558cc100b4c53dcda8abe05", "target_hash": "85a39ab345d672ff8ca9b9c6876f3adcacf45ee7c1e2dbd2408fd338bd55e07e", "exact_match": 0.0, "f1_gu_yn": [1, 0], "recall_gu_yn": [1, 0]}
